Semester 3 Handbook - NW School of Psychiatry · 2019-06-07 · Seminars in Child and Adolescent...
Embed Size (px)
Transcript of Semester 3 Handbook - NW School of Psychiatry · 2019-06-07 · Seminars in Child and Adolescent...

1
Semester 3 Handbook
MRCPsych Course
2018 – 2020
A Psychiatry Medical Education Collaborative between Mental Health Trusts and Health Education North West.
Course director – Dr Latha Hackett, Consultant in Child and Adolescent Psychiatry
Deputy course Director – Dr Dushyanthan Mahadevan, Consultant in Child and Adolescent
Psychiatry

2
Contents
Brief guidelines for case conference presentation ............................................................. 18
Brief guidelines for journal club presentation ..................................................................................... 19
Syllabus Links ........................................................................................................................................ 20
Curriculum Mapping ............................................................................................................................. 21
Links to Critical Appraisal Checklists .................................................................................................... 22
Session 13: Psychosis-3 ......................................................................................................................... 23
Learning Objectives .............................................................................................................................. 23
Expert Led Session ................................................................................................................................ 23
Case Presentation ................................................................................................................................. 23
Journal Club Presentation (Select 1 paper) ......................................................................................... 23
‘555’ Topics (Select 1 topic; 5 slides with no more than 5 bullet points) ........................................... 23
Session 14: Depression-3 ...................................................................................................................... 25
Learning Objectives .............................................................................................................................. 25
Expert Led Session ................................................................................................................................ 25
Case Presentation ................................................................................................................................. 25
Journal Club Presentation (Select 1 paper) ......................................................................................... 25
‘555’ Topics (Select 1 topic; 5 slides with no more than 5 bullet points) ........................................... 26
MCQs ..................................................................................................................................................... 26
Session 15: Bipolar Disorder-3 ............................................................................................................. 28
Learning Objectives .............................................................................................................................. 28
Expert Led Session ................................................................................................................................ 28
Case Presentation ................................................................................................................................. 28
Journal Club Presentation (Select 1 paper) ......................................................................................... 28
‘555’ Topics (Select 1 topic; 5 slides with no more than 5 bullet points) ........................................... 29
MCQs ................................................................................................................................................... 29
Session 16: Anxiety disorders-2 (GAD, panic disorder, phobic anxiety disorders) .................. 31
Learning Objectives ............................................................................................................................ 31
Expert Led Session ............................................................................................................................ 31

3
Case Presentation .............................................................................................................................. 31
Journal Club Presentation (Select 1 paper) ................................................................................... 31
‘555’ Topics (Select 1 topic; 5 slides with no more than 5 bullet points) .................................... 31
MCQs ..................................................................................................................................................... 32
Session 17: Suicide/self-harm-2 ........................................................................................................... 34
Learning Objectives .............................................................................................................................. 34
Expert Led Session ................................................................................................................................ 34
Case Presentation ................................................................................................................................. 34
Journal Club Presentation (Select 1 paper) ......................................................................................... 34
‘555’ Topics (Select 1 topic; 5 slides with no more than 5 bullet points) ........................................... 34
MCQs ..................................................................................................................................................... 35
Session 18: Perinatal psychiatry ...................................................................................................... 37
Learning Objectives ............................................................................................................................ 37
Expert Led Session ............................................................................................................................ 37
Case Presentation .............................................................................................................................. 37
Journal Club Presentation (Select 1 paper) ................................................................................... 37
Ennis, Z. and Damkier, P. (2015). Pregnancy Exposure to Olanzapine, Quetiapine, Risperidone,
Aripiprazole and Risk of Congenital Malformations. A Systematic Review. Basic & Clinical
Pharmacology & Toxicology, 116(4), pp.315-320. ................................................................................ 37
Boden, R., Lundgren, M., Brandt, L., Reutfors, J., Andersen, M. and Kieler, H. (2012). Risks of
adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for
bipolar disorder: population based cohort study. BMJ, 345(nov07 6), pp.e7085. ............................... 37
Uguz, F. (2016). Second-Generation Antipsychotics During the Lactation Period: A Comparative
Systematic Review on Infant Safety. Journal of Clinical Psychopharmacology, 36(3), pp.244-252. ..... 37
‘555’ Topics (Select 1 topic; 5 slides with no more than 5 bullet points) .................................... 37
MCQs ................................................................................................................................................... 38
Further Reading .................................................................................................................................... 39
Other resources .................................................................................................................................... 43
Session 1: Cognition ............................................................................................................... 44

4
Learning Objectives ............................................................................................................................... 44
Curriculum Links .................................................................................................................................... 44
Expert Led Session ................................................................................................................................. 44
Case Presentation .................................................................................................................................. 44
Journal Club Presentation ..................................................................................................................... 44
‘555’ Topic (5 slides with no more than 5 bullet points per slide) ........................................................ 45
MCQs ..................................................................................................................................................... 45
Additional Resources / Reading Material .............................................................................................. 46
Session 2: Alzheimer’s Disease .............................................................................................. 48
Learning Objectives ............................................................................................................................... 48
Curriculum Links .................................................................................................................................... 48
Expert Led Session ................................................................................................................................. 48
Case Presentation .................................................................................................................................. 48
Journal Club Presentation ..................................................................................................................... 48
‘555’ Topic (5 slides with no more than 5 bullet points per slide) ........................................................ 49
MCQs ..................................................................................................................................................... 49
Additional Resources / Reading Materials ............................................................................................ 50
Session 3: Other Neuro Degenerative Disorders ..................................................................... 52
Learning Objectives ............................................................................................................................... 52
Curriculum Links .................................................................................................................................... 52
Expert Led Session ................................................................................................................................. 52
Case Presentation .................................................................................................................................. 52
Journal Club Presentation ..................................................................................................................... 52
‘555’ Topic (5 slides with no more than 5 bullet points per slide) ........................................................ 53
MCQs ..................................................................................................................................................... 53
Additional Resources / Reading Material .............................................................................................. 54
Session 4: Delirium ................................................................................................................. 56
Learning Objectives ............................................................................................................................... 56

5
Curriculum Links .................................................................................................................................... 56
Expert Led Session ................................................................................................................................. 56
Case Presentation .................................................................................................................................. 56
Journal Club Presentation ..................................................................................................................... 56
‘555’ Topic (5 slides with no more than 5 bullet points per slide) ........................................................ 57
MCQs ..................................................................................................................................................... 58
Additional Resources / Reading Materials ............................................................................................ 59
Session 5: Mood Disorders in the Older Person ...................................................................... 60
Learning Objectives ............................................................................................................................... 60
Curriculum Links .................................................................................................................................... 60
Expert Led Session ................................................................................................................................. 60
Case Presentation .................................................................................................................................. 61
Journal Club Presentation ..................................................................................................................... 61
‘555’ Topic (5 slides with no more than 5 bullet points per slide) ........................................................ 61
MCQs ..................................................................................................................................................... 62
Additional Resources / Reading Materials ............................................................................................ 63
Session 6: Psychosis in the Older Person ............................................................................... 65
Learning Objectives ............................................................................................................................... 65
Curriculum Links .................................................................................................................................... 65
Expert Led Session ................................................................................................................................. 65
Case Presentation .................................................................................................................................. 65
Journal Club Presentation ..................................................................................................................... 65
‘555’ Topic (5 slides with no more than 5 bullet points per slide) ........................................................ 66
MCQs ..................................................................................................................................................... 66
Additional Resources / Reading Material .............................................................................................. 67
Session 7: Anxiety Disorders in the Older Person ................................................................... 69
Learning Objectives ............................................................................................................................... 69
Curriculum Links .................................................................................................................................... 69

6
Expert Led Session ................................................................................................................................. 69
Case Presentation .................................................................................................................................. 69
Journal Club Presentation ..................................................................................................................... 69
‘555’ Topic (5 slides with no more than 5 bullet points per slide) ........................................................ 70
MCQs ..................................................................................................................................................... 70
Additional Resources / Reading Material .............................................................................................. 71
Session 8: Medico Legal Issues in Old Age Psychiatry ........................................................... 73
Learning Objectives ............................................................................................................................... 73
Curriculum Links .................................................................................................................................... 73
Expert Led Session ................................................................................................................................. 73
Case Presentation .................................................................................................................................. 73
Journal Club Presentation ..................................................................................................................... 73
‘555’ Topic (5 slides with no more than 5 bullet points per slide) ........................................................ 74
MCQs ..................................................................................................................................................... 74
Additional Resources / Reading Material .............................................................................................. 75
Curriculum Mapping ................................................................................................................ 77
Session 1: Assessment in Child and Adolescent Psychiatry .................................................................. 78
Learning Objectives ............................................................................................................................... 78
Curriculum Links .................................................................................................................................... 78
Expert Led Session ................................................................................................................................. 78
Case Presentation .................................................................................................................................. 78
Journal Club Presentation ..................................................................................................................... 78
‘555’ Topics (1 slide on each topic with no more than 5 bullet points) ................................................ 79
MCQs ..................................................................................................................................................... 79
Additional Resources / Reading Materials ............................................................................................ 81
Child and Adolescent Psychiatry. Robert Goodman and Stephen Scott. Third Edition, Wiley-
Blackwell .................................................................................................................................. 81
Child and Adolescent Psychiatry: A Developmental Approach. 4th ed. Jeremy Turk, Philip Graham,
Frank C Verhulst 2007. Oxford University Press ............................................................................. 81

7
Session 2: Attention Deficit Hyperactivity Disorder (ADHD) ................................................................. 83
Learning Objectives ............................................................................................................................... 83
Curriculum Links .................................................................................................................................... 83
Expert Led Session ................................................................................................................................. 83
Case Presentation .................................................................................................................................. 83
Journal Club Presentation ..................................................................................................................... 83
‘555’ Topics (1 slide on each topic with no more than 5 bullet points) ................................................ 84
MCQs ..................................................................................................................................................... 84
Additional Resources / Reading Materials ............................................................................................ 86
Child and Adolescent Psychiatry. Robert Goodman and Stephen Scott. Third Edition, Wiley-
Blackwell .................................................................................................................................. 87
Session 3: Autism Spectrum Disorder (ASD) ......................................................................................... 88
Learning Objectives ............................................................................................................................... 88
Curriculum Links .................................................................................................................................... 88
Expert Led Session ................................................................................................................................. 88
Case Presentation .................................................................................................................................. 88
Journal Club Presentation ..................................................................................................................... 88
‘555’ Topics (1 slide on each topic with no more than 5 bullet points) ................................................ 89
MCQs ..................................................................................................................................................... 89
Additional Resources / Reading Materials ............................................................................................ 91
Session 4: Anxiety and Depression ........................................................................................................ 93
Learning Objectives ............................................................................................................................... 93
Curriculum Links .................................................................................................................................... 93
Expert Led Session ................................................................................................................................. 93
Case Presentation .................................................................................................................................. 93
Journal Club Presentation ..................................................................................................................... 93
‘555’ Topics (1 slide on each topic with no more than 5 bullet points) ................................................ 94
MCQs ..................................................................................................................................................... 94

8
Additional Resources / Reading Materials ............................................................................................ 97
Session 5: Attachment Disorder ............................................................................................................ 99
Learning Objectives ............................................................................................................................... 99
Curriculum Links .................................................................................................................................... 99
Expert Led Session ................................................................................................................................. 99
Case Presentation .................................................................................................................................. 99
Journal Club Presentation ..................................................................................................................... 99
‘555’ Topics (1 slide on each topic with no more than 5 bullet points) .............................................. 100
MCQs ................................................................................................................................................... 100
Additional Resources / Reading Materials .......................................................................................... 102
Session 6: Assessment of Mental Health Problems in Child & Adolescents with Intellectual Disability
(ID) ....................................................................................................................................................... 104
Learning Objectives ............................................................................................................................. 104
Curriculum Links .................................................................................................................................. 104
Expert Led Session ............................................................................................................................... 104
Case Presentation ................................................................................................................................ 104
Journal Club Presentation ................................................................................................................... 104
‘555’ Topics (1 slide on each topic with no more than 5 bullet points) .............................................. 105
MCQs ................................................................................................................................................... 105
Additional Resources / Reading Materials .......................................................................................... 107
Rutter's Child and Adolescent Psychiatry, Fifth Edition. ......................................................... 107
Child and Adolescent Psychiatry. ........................................................................................ 107
Robert Goodman and Stephen Scott. Third Edition, Wiley-Blackwell ............................................. 107
Session 7: Eating Disorders ................................................................................................................. 108
Learning Objectives ............................................................................................................................. 108
Curriculum Links .................................................................................................................................. 108
Expert Led Session ............................................................................................................................... 108
Case Presentation ................................................................................................................................ 108

9
Journal Club Presentation ................................................................................................................... 109
‘555’ Topics (1 slide on each topic with no more than 5 bullet points) .............................................. 109
MCQs ................................................................................................................................................... 109
Additional Resources / Reading Materials .......................................................................................... 111
Seminars in Child and Adolescent Psychiatry (second edition) Edited by Simon Gowers, Royal
college of Psychiatrists UK, Seminar Series ................................................................................. 111
Wiley: Handbook of Eating Disorders, 2d Edition Janet Treasure (Editor), Ulrike
Schmidt (Editor), Eric van Furth (Editor) February 2003 ISBN: 978-0-471-49768-4 ........................... 111
Psychological treatments for children and adolescents with eating disorders: In this
podcast, Professor Simon Gowers gives an overview of the different psychological therapies
available for children and adolescents with eating disorders, discussing in some detail family
therapy, interpersonal therapy and cognitive behavioural therapy ...................................... 112
http://www.psychiatrycpd.org/default.aspx?page=8284 .................................... 112
Cr189. MARSIPAN: management of really sick patients with anorexia nervosa (2nd edn) ........ 112
www.Rcpsych.ac.uk ............................................................................................................................. 112
Session 8: Legal Aspects of Child & Adolescent Psychiatry ................................................................. 112
Learning Objectives ............................................................................................................................. 112
Curriculum Links .................................................................................................................................. 112
Expert Led Session ............................................................................................................................... 112
Case Presentation ................................................................................................................................ 113
Journal Club Presentation ................................................................................................................... 113
‘555’ Topics (1 slide on each topic with no more than 5 bullet points) .............................................. 113
MCQs ................................................................................................................................................... 113
Additional Resources / Reading Materials .......................................................................................... 116
Rutter's Child and Adolescent Psychiatry, Fifth Edition. ......................................................... 116
Child and Adolescent Psychiatry. ........................................................................................ 116
Robert Goodman and Stephen Scott. Third Edition, Wiley-Blackwell ............................................. 116
Session 1: Psychiatry and the Criminal Justice System ....................................................................... 118
Learning Objectives ....................................................................................................... 118

10
Curriculum Links ............................................................................................................ 118
Expert Led Session ........................................................................................................ 118
Case Presentation ......................................................................................................... 118
Journal Club Presentation .............................................................................................. 119
‘555’ Topic (5 slides with no more than 5 bullet points) .................................................. 119
MCQs ............................................................................................................................ 119
Additional Resources / Reading Materials ...................................................................... 123
Session 2: The Link between Crime and Mental Disorder .................................................................. 124
Learning Objectives ....................................................................................................... 124
Curriculum Links ............................................................................................................ 124
Expert Led Session ........................................................................................................ 124
Case Presentation ......................................................................................................... 125
Journal Club Presentation .............................................................................................. 125
‘555’ Topic (5 slides with no more than 5 bullet points) .................................................. 125
MCQs ............................................................................................................................ 126
Additional Resources / Reading Materials ...................................................................... 129
Session 3: Too mad to murder? .......................................................................................................... 131
Learning Objectives ....................................................................................................... 131
Curriculum Links ............................................................................................................ 131
Expert Led Session ........................................................................................................ 131
Case Presentation ......................................................................................................... 132
Journal Club Presentation .............................................................................................. 132
‘555’ Topic (5 slides with no more than 5 bullet points per slide) .................................... 133
MCQs ............................................................................................................................ 133
Additional Resources / Reading Materials ...................................................................... 136
Session 4: Introduction to risk assessment and risk management ................................................... 138
Learning Objectives ....................................................................................................... 138
Expert Led Session ........................................................................................................ 138
Case Presentation ......................................................................................................... 138

11
Journal Club Presentation .............................................................................................. 138
‘555’ Topic (5 slides with no more than 5 bullet points per slide) .................................... 139
MCQs ............................................................................................................................ 139
Additional Resources / Reading Materials ...................................................................... 140
Session 1: Diagnosis and Treatment for People with Alcohol Problems ............................................ 141
Learning Objectives ............................................................................................................................. 141
Curriculum Links .................................................................................................................................. 141
Expert Led Session ............................................................................................................................... 141
Case Presentation ................................................................................................................................ 141
Journal Club Presentation ................................................................................................................... 142
‘555’ Topics (5 slides on each topic with no more than 5 bullet points) ............................................ 142
MCQs ................................................................................................................................................... 142
Additional Resources / Reading Materials .......................................................................................... 145
Session 2: Diagnosis and Treatment of People with Drug Misuse ...................................................... 147
Learning Objectives ............................................................................................................................. 147
Curriculum Links .................................................................................................................................. 147
Expert Led Session ............................................................................................................................... 148
Case Presentation ................................................................................................................................ 148
Journal Club Presentation ................................................................................................................... 148
‘555’ Topics (5 slides on each topic with no more than 5 bullet points) ............................................ 148
MCQs ................................................................................................................................................... 149
Additional Resources / Reading Materials .......................................................................................... 151
Session 3: Diagnosis and management of people with co-occurring mental health and alcohol/drug
use conditions ..................................................................................................................................... 154
Learning Objectives ............................................................................................................................. 154
Curriculum Links .................................................................................................................................. 155
Expert Led Session ............................................................................................................................... 155
Case Presentation ................................................................................................................................ 155
Journal Club Presentation ................................................................................................................... 155

12
‘555’ Topics (5 slides on each topic with no more than 5 bullet points) ............................................ 155
MCQs ................................................................................................................................................... 156
Additional Resources / Reading Materials .......................................................................................... 158
Session 4: Recovery Concepts, Psycho-social Treatments and Service Development ........................ 160
Learning Objectives ............................................................................................................................. 160
Curriculum Links .................................................................................................................................. 160
Expert Led Session ............................................................................................................................... 160
Case Presentation ................................................................................................................................ 161
Journal Club Presentation ................................................................................................................... 161
‘555’ Topics (5 slides on each topic with no more than 5 bullet points) ............................................ 161
MCQs ................................................................................................................................................... 161
Additional Resources / Reading Materials .......................................................................................... 164
Session 1: Referring to Psychotherapy Services .................................................................................. 181
Learning Objectives ............................................................................................................................. 181
Curriculum Links .................................................................................................................................. 181
Expert Led Session ............................................................................................................................... 181
Case Presentation ................................................................................................................................ 181
Journal Club Presentation ................................................................................................................... 181
‘555’ Topics (5 slides on each topic with no more than 5 bullet points) ............................................ 182
MCQs ................................................................................................................................................... 182
4. How do you define transference? .......................................................................................... 182
A. The empathy shown by the therapist to the patient. ............................................................ 182
B. Defence mechanism where attention is shifted to a less threatening / more benign target. ...... 182
C. Therapist’s response to the patient drawn from therapist’s previous life experiences. ............. 182
D. Patient’s response to the therapist based upon their earlier relationships .............................. 182
E. All of the above ................................................................................................................ 182
5. What would suggest a patient has good psychological mindedness? .......................................... 182
A. Becoming very upset when talking about the past ................................................................ 183

13
B. Finding it hard to step back and observe the situation objectively .......................................... 183
C. Needing to be talked through assessment with lots of prompts ............................................. 183
D. Reasonable sense of self esteem ........................................................................................ 183
E. None of the above ............................................................................................................ 183
Additional Resources / Reading Materials .......................................................................................... 183
Session 2: Psychological approaches to EUPD .................................................................................... 184
Learning Objectives ............................................................................................................................. 184
Curriculum Links .................................................................................................................................. 184
Expert Led Session ............................................................................................................................... 184
Case Presentation ................................................................................................................................ 184
Journal Club Presentation ................................................................................................................... 185
McMain et al (2009) “A Randomized Trial of Dialectical Behavior Therapy Versus General Psychiatric
Management for Borderline Personality Disorder” Am J Psychiatry 166:1365–1374 ........................ 185
Batement & Fonagy (2009) “Randomized Controlled Trial of Outpatient Mentalization-Based Treatment
Versus Structured Clinical Management for Borderline Personality Disorder” Am J Psychiatry 166:1355–
1364 ...................................................................................................................................... 185
‘555’ Topics (5 slides on each topic with no more than 5 bullet points) ............................................ 185
MCQs ................................................................................................................................................... 186
Additional Resources / Reading Materials .......................................................................................... 186
Session 3: Psychological approaches to Depression ........................................................................... 187
Learning Objectives ............................................................................................................................. 187
Curriculum Links .................................................................................................................................. 187
1.1, 1.2, 1.3, 1.3.4, 2.3, 2.4, 2.6, 2.8, 6.1, 7.1.1, 9, 14 ......................................................................... 187
Expert Led Session ............................................................................................................................... 187
Case Presentation ................................................................................................................................ 187
Journal Club Presentation ................................................................................................................... 187
‘555’ Topics (5 slides on each topic with no more than 5 bullet points) ............................................ 188
MCQs ................................................................................................................................................... 189
1. NICE guidance (CG90): ...................................................................................................... 189

14
B. Recommends Computerised CBT for mild-moderate depression ............................................ 189
C. Recommends Psychotherapy for severe depression ............................................................. 189
D. Advises not combining medication with psychological therapies ............................................ 189
E. Recommends Cognitive therapy for relapse prevention ........................................................ 189
F. Defines Short-term Psychodynamic Psychotherapy as 10-15 sessions over 3-4 months ............ 189
2. Cognitive Therapy: ............................................................................................................ 189
A. Is originally based on the work of Judith Beck ...................................................................... 189
B. Identifies Cognitive Errors that lead to or maintain depressive thoughts ................................. 189
C. Focuses on non-conscious thought content ......................................................................... 189
D. Is enhanced by concurrent antidepressant treatment ........................................................... 189
E. Should not be used in older patients ................................................................................... 189
3. Psychodynamic Therapies: ................................................................................................. 189
A. Have no evidence base for effectiveness ............................................................................. 189
B. Are based on the model of the mind put forward by Freud ................................................... 189
C. Seek to eradicate a patient’s defences ................................................................................ 189
D. Were among the first to link depression to loss .................................................................... 189
E. Focus on the past ............................................................................................................. 189
4. Psychological factors in the aetiology of depression include .................................................. 189
A. Parental indifference ........................................................................................................ 189
B. Social circumstance .......................................................................................................... 189
C. Maternal Depression ........................................................................................................ 189
D. Cognitive biases or distortions ........................................................................................... 189
E. Bereavement ................................................................................................................... 189
5. Evidence of effectiveness in the treatment of depression exists for: ....................................... 189
A. Psychoanalytic therapy ..................................................................................................... 189
B. Interpersonal Therapy ....................................................................................................... 189
C. ‘Low intensity’ therapy in IAPT ........................................................................................... 189
D. Mentalization based CBT ................................................................................................... 189

15
E. EMDR ........................................................................................................................................... 189
Additional Resources / Reading Materials .......................................................................................... 190
Session 4: Psychological approaches to Trauma ................................................................................. 190
Learning Objectives ............................................................................................................................. 190
Curriculum Links .................................................................................................................................. 190
Expert Led Session ............................................................................................................................... 190
Case Presentation ................................................................................................................................ 190
Journal Club Presentation ................................................................................................................... 191
‘555’ Topics (5 slides on each topic with no more than 5 bullet points) ............................................ 191
MCQs ................................................................................................................................................... 192
Additional Resources / Reading Materials .......................................................................................... 192
Session 1: Psychosis Across the Ages .................................................................................................. 193
Learning Objectives ............................................................................................................................. 193
Curriculum Links .................................................................................................................................. 193
Expert Led Session (incorporating case discussion) ............................................................................ 194
Journal Club Presentation ................................................................................................................... 194
‘555’ Topics (5 slides on each topic with no more than 5 bullet points) ............................................ 194
MCQs ................................................................................................................................................... 195
Additional Resources / Reading Materials .......................................................................................... 196
Session 2: Depression Across The Ages ............................................................................................... 197
Learning Objectives ............................................................................................................................. 197
Curriculum Links .................................................................................................................................. 197
Expert Led Session (incorporating case discussion) ............................................................................ 197
Journal Club Presentation ................................................................................................................... 198
‘555’ Topics (5 slides on each topic with no more than 5 bullet points) ............................................ 199
MCQs ................................................................................................................................................... 199
Additional Resources / Reading Materials .......................................................................................... 200
Session 3: Liaison Psychiatry Across The Ages .................................................................................... 200

16
Learning Objectives ............................................................................................................................. 200
Curriculum Links .................................................................................................................................. 201
Expert Led Session (incorporating case discussion) ............................................................................ 201
Journal Club Presentation ................................................................................................................... 202
‘555’ Topics (5 slides on each topic with no more than 5 bullet points) ............................................ 202
MCQs ................................................................................................................................................... 202
Additional Resources / Reading Materials .......................................................................................... 204
Session 4: Impact of Mental Illness on Carers and Families ............................................................... 205
Learning Objectives ............................................................................................................................. 205
Curriculum Links .................................................................................................................................. 205
Expert Led Session ............................................................................................................................... 206
Case Presentation ................................................................................................................................ 206
Journal Club Presentation ................................................................................................................... 206
‘555’ Topics (5 slides on each topic with no more than 5 bullet points) ............................................ 206
MCQs ................................................................................................................................................... 207
Additional Resources / Reading Materials .......................................................................................... 208

17
List of Contributors
Course Director
Dr Latha Hackett, Consultant in Child and Adolescent Psychiatry
Deputy Course Director
Dr Gareth Thomas, Consultant in Old Age Psychiatry
Module Leads
Across the Ages Dr Karl Coldman [email protected]
CAMHS Dr Neelo Aslam [email protected]
Forensic Dr Victoria Sullivan [email protected]
General Adult Dr Sally Wheeler [email protected]
Intellectual Disability Dr Sol Mustafa [email protected]
Old Age Dr Anthony Peter [email protected]
Psychotherapy Dr Adam Dierckx [email protected]
Substance Misuse Dr Patrick Horgan [email protected]
Trust Leads
CWP Dr Matthew Cahill [email protected]
GMMH (NMGH site) Dr Adam Dierckx [email protected]
GMMH (Prestwich site) Dr Catrin Evans [email protected]
GMMH (Prestwich site) Dr Asif Mir [email protected]
Lancashire care (Central Lancs) Dr Yousaf Iqbal [email protected]
Lancashire care (North Lancs) Dr Brijesh Desai [email protected]
Lancashire care (North Lancs) Dr Adam Joiner [email protected]
Mersey Care Dr Yenal Dundar [email protected]
NWBH Dr Naghma Malik [email protected]
Pennine Care Dr Ema Etuk [email protected]

18
Brief guidelines for case conference presentation
The objectives of case conference are:
1. To provide a forum to discuss complex/interesting cases in a learning atmosphere.
2. To develop your ability to present cases in a concise and logical manner.
3. To develop your presentation skills.
Guidelines for presenters:
1. Please use PowerPoint for the presentation (or if you are using other tools make sure that they are
compatible with your local IT facilities).
2. You have to present a case that is relevant to the theme of the day on which you are presenting.
3. Please meet with your educational/clinical supervisor at least 4-6 weeks prior to the presentation to
identify an appropriate case to present. If there is no suitable case in the team that you work in,
you may have to approach other teams/consultants to identify a case.
4. Cases can be chosen for their atypical presentation, diagnosis, complexity or for exploring
management options.
5. It would be helpful if you can identify specific clinical questions that would you would like to be
discussed/answered at the end of the presentation.
6. We would recommend the following structure for the presentation:
Introduction (include reasons for choosing the case)
Circumstances leading to admission (if appropriate)
History of presenting complaint
Past Psychiatric history
Medical History/ current medication
Personal/family History
Alcohol/Illicit drugs history
Forensic history
Premorbid personality
Social circumstances
Mental state examination
Investigations
Progress since admission (if appropriate)
A slide with questions that you would you like to be discussed
Discussion on differential diagnosis including reasons for and against them.
Management / treatment

19
7. The structure of the presentation can vary as long it is logical and concise. Please build into the
presentation some natural points to stop and discuss the case.
8. 8. Important: Please ask a senior member of your team who knows the case to attend on the day
you are presenting.
Brief guidelines for journal club presentation
The objectives of journal club presentation are:
1) To learn to perform a structured critical appraisal of a study.
2) To learn to make appropriate use of evidence in making decisions about the care of your
patients.
3) To prepare for the MRCPsych exams.
4) To develop your presentation skills.
Guidelines for presenters:
1. Please use PowerPoint for the presentation (or if you are using other tools make sure that they
are compatible with your local IT facilities).
2. Please select one of the 3 papers listed for the week from the School of Psychiatry handbook to
present.
3. Email the paper to your local co-ordinator at least a week before the presentation so that it can
be circulated in time.
4. As the presenter you are expected to both present the paper and critically review it.
5. We would recommend the following structure for the presentation: Background to study,
methods, analysis, results, conclusions, critical appraisal of the study and implications for clinical
practice
6. The most important part of the presentation is the critical appraisal. This should include aspects
such as:
Purpose of the study
Type of study
Subject selection and any bias
Power calculation (could the study ever answer the question posed)
Appropriateness of statistical tests used

20
Use of relevant outcomes
Implications of findings
Applications of findings/conclusions in your area
Directions for further research
7. Use standardized critical appraisal tools.
8. Please discuss the paper and the presentation with your educational/clinical supervisor prior to
the presentation.
Syllabus Links
MRCPsych Paper A - The Scientific and theoretical basis of Psychiatry
MRCPsych Paper B - Critical review and the clinical topics in Psychiatry
MRCPsych CASC

21
GENERAL ADULT SEMESTER 3:
Curriculum Mapping
Section Topic Covered by
LEP AP LR
7.1 Disorders in adulthood
7.1.1 Unipolar depression
7.1.2 Bipolar depression
7.1.3 Schizophrenia
7.1.4 Anxiety disorders
7.1.5 OCD
7.1.6 Hypochondriasis
7.1.7 Somatization disorder
7.1.8 Dissociative disorders
7.1.9 Personality disorders
7.1.10 Organic psychoses
7.1.11 Other psychiatric disorders
7.2 Perinatal Psychiatry
7.3 General Hospital Psychiatry
7.4 Emergency Psychiatry*
7.5 Eating Disorders
7.5.1 Anorexia nervosa
7.5.2 Bulimia nervosa
7.6 Psycho-sexual disorders
7.6.1 Non-organic sexual dysfunction, etc.
7.6.2 Gender Identity Disorders
- Mental Health Act 1983
Key- LEP – Local Education Programme;
AP- Academic Programme
LR – Learning Resources

22
Links to Critical Appraisal Checklists
Study Checklists
Randomized Controlled Trial
1. CONSORT Checklist
2. SIGN Checklist
3. CASP Checklist
Case-control Study 1. SIGN Checklist
2. CASP Checklist
Cohort Study 1. SIGN Checklist
2. CASP Checklist
Meta-analysis & Systematic Review
1. PRISMA statement
2. SIGN Checklist
3. CASP Checklist
Qualitative study 1. CASP Checklist
Economic study 1. SIGN Checklist
2. CASP Checklist
Diagnostic study 1. SIGN Checklist
2. CASP Checklist

23
Session 13: Psychosis-3
Journal theme: Meta-analysis / Systematic Review on Psychosis
Learning Objectives
To develop an understanding of the biopsychosocial management of schizophrenia
To develop an understanding of evidence based treatment
To develop an understanding of the use of antipsychotics in special cases e.g. liver and renal impairment
To develop an understanding of Meta-analysis / Systematic Review and develop skills for
critically appraising them.
Expert Led Session
Schizophrenia: Biopsychosocial management and evidence based treatment.
Case Presentation
A case of Schizophrenia (any subtype) /Schizoaffective disorder / Delusional disorder / Acute
and transient psychotic disorder / First-episode psychosis
Journal Club Presentation (Select 1 paper)
Zhanga J, Gallego JA, Robinson DG, Malhotra AK, Kane JM, et al. (2013). Efficacy and
safety of individual second-generation vs. first-generation antipsychotics in first-episode
psychosis: a systematic review and meta-analysis. The International Journal of
Neuropsychopharmacology; 16 (6), 1205-1218. DOI:
http://dx.doi.org/10.1017/S1461145712001277
Souza JS, Kayo M, Tassell I, Martins CB, & Elkisa H. (2013). Efficacy of olanzapine in
comparison with clozapine for treatment-resistant schizophrenia: evidence from a systematic
review and meta-analyses. CNS Spectrums; 18 (2), 82- 89. DOI:
http://dx.doi.org/10.1017/S1092852912000806
Leucht S, Cipriani A, Spineli L, Mavridis D, Örey D. (2013). Comparative efficacy and
tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.
The Lancet; 382 (9896), 951–962. DOI: http://dx.doi.org/10.1016/S0140-6736(13)60733-3
‘555’ Topics (Select 1 topic; 5 slides with no more than 5 bullet points)
Recommendations for antipsychotics in liver disease
Recommendations for antipsychotics in renal impairment
Antipsychotics and sexual side effects
Statistics ‘555’ topic

24
Parametric and non-parametric tests
MCQs
1. Which one of the following led a trial that proved Clozapine's effectiveness in treating resistant schizophrenia?
A. Kretschmer
B. Cade
C. Kraepelin
D. Kane
E. Bleurer
2. Choose the correct match from the following pairs:
A. Risperidone: dibenzoxapine
B. Droperidol: butyrophenones
C. Aripiprazole: benzisothiazole
D. Thioridazine: diphenyl butyl piperidine
E. Flupentixol: dihydroindole
3. Which of the following atypical agents have the shortest half-life?
A. Quetiapine
B. Aripiprazole
C. Olanzapine
D. Clozapine
E. Risperidone
4. The patients who are prescribed clozapine or olanzapine should have their serum lipids measured
every:
A. 6 days whilst on treatment
B. One year whilst on treatment
C. 3 months for the first year of treatment
D. 6 weeks for the first year of treatment
E. 6 months for the first year of treatment
5. What percentage of patients develop Tardive Dyskinesia with every year of typical antipsychotic
exposure?
A. More than 50%
B. 2-5%
C. 5-10%
D. 20-25%

25
E. 10-20%
Session 14: Depression-3
Journal theme: Qualitative study on depression
Learning Objectives
To develop an understanding of the biopsychosocial management of Depression.
To develop an understanding of evidence based treatment.
To develop an understanding of the use of antidepressant in special cases e.g. liver and renal
impairment.
To develop an understanding of Qualitative study and develop skills for critically appraising
them.
Expert Led Session
Depression- Biopsychosocial management and evidence-based treatment
Case Presentation
A case of major depressive disorder / severe depression with psychotic symptoms / dysthymia
/ recurrent depressive disorder
Journal Club Presentation (Select 1 paper)
Mamisachvili L, Ardiles P, Mancewicz G, Thompson S, Rabin K, et al. (2013). Culture and
Postpartum Mood Problems; Similarities and Differences in the Experiences of First- and
Second- Generation Canadian Women. J Transcult Nurs; DOI: 10.1177/1043659612472197
Gensichen J, Guethlin C, Sarmand N, Sivakumaran D, Jäger C, et al. (2012). Patients’
perspectives on depression case management in general practice – A qualitative study.
Patient Education and Counselling; 86 (1), 114–119. DOI:
http://dx.doi.org/10.1016/j.pec.2011.02.020
Coupe N, Anderson E, Gask L, Sykes P, Richards DA, et al. (2014). Facilitating professional
liaison in collaborative care for depression in UK primary care; a qualitative study utilising
normalisation process theory. BMC Family Practice; 15:78. DOI: 10.1186/1471-2296-15-78

26
‘555’ Topics (Select 1 topic; 5 slides with no more than 5 bullet points)
ECT – indications and contraindications
Depression – important rating scales
Treatment of refractory depression- first choice (evidence-based)
Statistics ‘555’ topic
Coding and thematic analysis
MCQs
1. Which of the following neurotransmitters does Duloxetine act on?
A. Serotonin only
B. Noradrenaline and Serotonin
C. Dopamine
D. Noradrenaline, Serotonin and Dopamine
E. GABA
2. Which of the following statements about Trazodone is FALSE?
A. It is relatively safe in overdose
B. It does not have strong antihistamine properties
C. It is not a MAO-A and MAO- B inhibitor
D. It does not block 5-HT reuptake
E. It is a 5HT2 agonist
3. Which of the following are not common side effects of Mirtazapine?
A. Sedation
B. Nausea, vomiting, abdominal pain
C. Sexual dysfunction
D. Agitation, anxiety
E. Insomnia

27
4. Laura is a depressed 61-year-old woman who has not responded to an SSRI and has urinary
incontinence. Which one of the following antidepressants is the best choice in this situation?
1. Phenelzine
2. Mirtazapine
3. Vortioxetine
4. Trazodone
5. Duloxetine
5. Hypertension is a common side effect of which of the following antidepressants?
A. Venlafaxine
B. Paroxetine
C. Escitalopram
D. Trazodone
E. Mirtazapine

28
Session 15: Bipolar Disorder-3
Journal theme: RCT on bipolar disorder
Learning Objectives
To develop an understanding of the biopsychosocial management of Bipolar disorder.
To develop an understanding of evidence based treatment.
To develop an understanding of the use of mood-stabilizers in special cases e.g. liver and renal
impairment.
To develop an understanding of Randomized Controlled trials and develop skills for critically
appraising them.
Expert Led Session
Bipolar disorder- Biopsychosocial management and evidence-based treatment.
Case Presentation
A case of type I bipolar disorder / type II bipolar disorder / cyclothymia / bipolar disorder with
psychotic symptoms / rapid cycling bipolar disorder/ unipolar mania.
Journal Club Presentation (Select 1 paper)
Kemp D, Gao K, Fein E, Chan P, Conroy C, Obral S, Ganocy S, Calabrese R (2012)
Lamotrigine as add-on treatment to lithium and divalproex: lessons learned from a double-blind,
placebo-controlled trial in rapid-cycling bipolar disorder. Bipolar Disord., 14(7):780-789.
Schoeyen HK, Kessler U, Andreassen OA, Auestad BH, Bergsholm P, et al. (2014).
Treatment-Resistant Bipolar Depression: A Randomized Controlled Trial of Electroconvulsive
Therapy Versus Algorithm-Based Pharmacological Treatment. The American Journal of
Psychiatry; 172 (1), 41-51. DOI: http://dx.doi.org/10.1176/appi.ajp.2014.13111517
Jones SH, Smith G, Mulligan LD, Lobban F, Law H, et al. (2010). Recovery-focused
cognitive–behavioural therapy for recent-onset bipolar disorder: randomised controlled pilot
trial. The British Journal of Psychiatry; 206 (1) 58-66. DOI: 10.1192/bjp.bp.113.141259

29
‘555’ Topics (Select 1 topic; 5 slides with no more than 5 bullet points)
Monitoring requirements for mood stabilizers
Treatment of acute mania
Evidence-based treatment of bipolar depression
Statistics ‘555’ topic
Intention-to-treat analysis & Last Observation Carried Forward (LOCF)
MCQs
1. Sodium valproate:
A. Is mostly renally metabolised
B. Commonly causes hypertrichosis
C. Reduces lamotrigine levels
D. Is licensed for prophylaxis of BPAD
E. Is a first line choice in acute mania
2. Which of the following drugs has a high therapeutic index:
A. Lithium
B. Carbamazepine
C. Phenytoin
D. Warfarin
E. Gabapentin
3. The risk of Ebstein’s anomaly in babies born to woman taking lithium is:
A. 1:10
B. 1:100
C. 1:500
D. 1:1000
E. 1:10000
4. Which of the following commonly causes hypercalcaemia:
A. Lithium
B. Valproate
C. Risperidone
D. Quetiapine
E. Clozapine

30
5. Lithium levels in once daily nocte dosing should be taken:
A. 4 hours post dose
B. 12 hours post dose
C. 6 hours post dose
D. Immediately before the next dose
E. 8 hours post dose

31
Session 16: Anxiety disorders-2 (GAD, panic disorder, phobic anxiety disorders)
Journal theme: case –control studies on the topic
Learning Objectives
To develop an understanding of GAD, panic disorder, phobic anxiety disorders
(aetiology, epidemiology, natural history, neurobiology, genetics, diagnostic criteria,
classification, psychopathology, clinical presentation, assessment, risks) and their
management (pharmacological, psychological, social).
To develop an understanding of Case-control studies and develop skills for critically
appraising them.
Expert Led Session
Biopsychosocial management of GAD, panic disorder and phobic anxiety disorders.
GAD, panic disorder, phobic anxiety disorders
Case Presentation
A case where either GAD, panic disorder or phobic disorder is the main diagnosis or a
differential diagnosis.
Journal Club Presentation (Select 1 paper)
Lipka J, Miltner WH, Straube T (2011) Vigilance for threat interacts with amygdala responses
to subliminal threat cues in specific phobia. Biol Psychiatry, 70(5):472-8.
Santos MA, Ceretta LB, Réus GZ, Abelaira HM, Jornada LK, Schwalm MT, Neotti
MV, Tomazzi CD, Gulbis KG, Ceretta RA, Quevedo J (2014) Anxiety disorders are associated
with quality of life impairment in patients with insulin-dependent type 2 diabetes: a case-
control study. Rev Bras Psiquiatr., 36 (4):298-304.
Kiropoulos L, Klien B, Austin D, Gilson K, Pier C, Mitchell J and Ciechomski L (2008) Is
internet-based CBT for panic disorder and agoraphobia as effective as face-to-face CBT?
Journal of anxiety disorders 22(8), 1273-1284.
‘555’ Topics (Select 1 topic; 5 slides with no more than 5 bullet points)
CBT for agoraphobia- principles

32
Principles of use of benzodiazepines for anxiety disorders
NICE recommendations for treatment of GAD- overview
Statistics ‘555’ topic
Null hypothesis, Type-1 error and type-2 error
MCQs
1. Venlafaxine is not licenced for which of the following indications?
A. Social anxiety
B. PTSD
C. Panic disorder
D. Depression +/- Anxiety
E. GAD
2. The following are TRUE of the pharmacokinetics of benzodiazepines:
A. When long-acting they have long elimination half-life.
B. When short-acting they have a small distribution volume.
C. When long-acting they have no active metabolites
D. When short-acting they have high accumulation
E. Benzodiazepines with a half-life of 12 hours tend to be used as anxiolytics.
3. Which of the following statements is FALSE about the effects of hypnotics on sleep?
A. Benzodiazepines supress stage IV sleep.
B. With chronic Benzodiazepines use suppression of REM sleep in the early part of the night
occurs
C. On withdrawal of Benzodiazepines a rebound increase above the ‘normal’ amount of REM
sleep occurs.
D. It may take up to 6 weeks to see a return to a normal sleep pattern on Benzodiazepine
withdrawal.
E. Barbiturates are more likely to suppress REM sleep than are Benzodiazepines.
4. With regards to the NICE guidelines for GAD, which of the following is FALSE?
A. SSRIs (particularly Sertraline) are the first line medications.

33
B. SNRIs are second line.
C. If the patient cannot tolerate SSRI or SNRI, offer Pregabalin.
D. Antipsychotics should be offered for the treatment of GAD in primary care.
E. Do not offer a benzodiazepine for the treatment of GAD in primary or secondary care except
as a short-term measure during crises
5. With respect to the NICE guidelines on psychological intervention for GAD, which of the following is
FALSE?
A. CBT for people with GAD should be based on the treatment manuals used in the clinical trials
of CBT for GAD.
B. CBT for GAD usually consist of 12–15 weekly sessions (fewer if the person recovers sooner;
more if clinically required), each lasting 1 hour.
C. Practitioners providing high-intensity psychological interventions for GAD need not have regular
supervision to monitor fidelity to the treatment model.
D. If a person with GAD chooses a high-intensity psychological intervention, offer either CBT or
applied relaxation.
E. Consider providing all interventions in the preferred language of the person with GAD if
possible.

34
Session 17: Suicide/self-harm-2
Journal theme: Any study method on the topic
Learning Objectives
To develop an understanding of various facets of self-harm and suicide (aetiology,
epidemiology, neurobiology, genetics, clinical presentation, risk assessment) and their
management (pharmacological, psychological, social).
Expert Led Session
Suicide & self-harm- comprehensive risk assessment
Case Presentation
Cases related to any type of clinical presentations where suicide and/ or self-harm is the
central theme
Journal Club Presentation (Select 1 paper)
Quinlivan L, Cooper J, Steeg S, Davies L, Hawton K, Gunnell D, Kapur N (2014) Scales for
predicting risk following self-harm: an observational study in 32 hospitals in England. BMJ
Open, doi: 10.1136/bmjopen-2013-004732.
Kapur N, Gunnell D, Hawton K, Nadeem S, Khalil S, Longson D, Jordan R, Donaldson I,
Emsley R, Cooper J (2013) Messages from Manchester: pilot randomised controlled trial
following self-harm. BJPsych 203: 73-74.
Hawtona K, Bergena H, Cooperb J, Turnbullb P, Watersc K, et al. (2015). Suicide following
self-harm: Findings from the Multicentre Study of self-harm in England, 2000–2012. Journal
of Affective Disorders; 175, 147–151. DOI: 10.1016/j.jad.2014.12.062
‘555’ Topics (Select 1 topic; 5 slides with no more than 5 bullet points)
National Confidential Inquiry into suicide by people with mental illness – Key findings of the
latest annual report
Purpose of a Coroner’s Inquest
Suicide in prisons
Statistics ‘555’ topic

35
Standard error and confidence intervals
MCQs
1. Which of the following are the signs and symptoms of Tricyclic antidepressant overdose?
A. Sedation, tachycardia, arrhythmia, hypotension, seizures, coma
B. Vomiting, tremor, drowsiness, tachycardia
C. Sweating, tachycardia, blood pressure changes
D. Tremor, weakness, confusion, hypertension
E. Lethargy, sedation, GI disturbance
2. Which of the following medications has high toxicity in overdose?
A. Lofepramine
B. SSRIs
C. Trazodone
D. Phenelzine
E. Ariprazole
3. There is meta-analysis evidence concluding that lithium reduced the risk of both attempted and
completed suicide in patients with bipolar illness by:
A. 10 %
B. 30%
C. 80%
D. 25%
E. There is no such evidence
4. Suicidal ideation is a known side effect of all of the following medications EXCEPT?
A. Chloroquine
B. Reserpine
C. Interferons
D. Amisulpride
E. Mefloquine

36
5. True or false: Increased rates have been reported with:
A. Renal dialysis
B. SLE
C. Epilepsy
D. Patients with high cholesterol
E. Peptic ulcer

37
Session 18: Perinatal psychiatry
Journal theme: Study with any method
Learning Objectives
To understand the impact / risks of major mental disorders on pregnancy and post-
partum period. To understand the general principles of prescribing; and the risks &
benefits of prescribing psychotropic medications in pregnancy, post-partum period and
breast feeding.
Expert Led Session
Evidence-based recommendations for psychotropic medications in pregnancy
[antipsychotics, antidepressants, mood stabilizers and anxiolytics].
Case Presentation
A case of any mental disorder in pregnancy or post-partum period.
Journal Club Presentation (Select 1 paper)
Ennis, Z. and Damkier, P. (2015). Pregnancy Exposure to Olanzapine, Quetiapine,
Risperidone, Aripiprazole and Risk of Congenital Malformations. A Systematic Review. Basic
& Clinical Pharmacology & Toxicology, 116(4), pp.315-320.
Boden, R., Lundgren, M., Brandt, L., Reutfors, J., Andersen, M. and Kieler, H. (2012). Risks
of adverse pregnancy and birth outcomes in women treated or not treated with mood
stabilisers for bipolar disorder: population based cohort study. BMJ, 345(nov07 6), pp.e7085.
Uguz, F. (2016). Second-Generation Antipsychotics During the Lactation Period: A
Comparative Systematic Review on Infant Safety. Journal of Clinical Psychopharmacology,
36(3), pp.244-252.
‘555’ Topics (Select 1 topic; 5 slides with no more than 5 bullet points)
Post-partum risks of relapse in schizophrenia, bipolar disorder and depression
Congenital malformations associated with Lithium, Valproate, Carbamazepine, Lamotrigine
and Paroxetine- salient points
Use of SSRIs in pregnancy – salient points

38
Statistics ‘555’ topic
Number Needed to Treat (NNT)
MCQs
1. During pregnancy the following physiological changes occur
A. Plasma volume markedly increases and eGFR increases
B. Plasma volume markedly decreases and eGFR increases
C. Plasma volume markedly increases and eGFR decreases
D. Plasma volume markedly decreases and eGFR decreases
E. There is no change in either plasma volume or eGFR
2. Which of the following is NOT associated with exposure to SSRIs in the Perinatal period?
A. Perinatal Death
B. Persistent Pulmonary Hypertension of the Newborn
C. Postpartum haemorrhage
D. Poor neonatal adaptation syndrome
E. Preterm birth
3. Which of the following statements is TRUE regarding NICE guidelines?
A. Benzodiazepines can be offered in pregnancy for medium term treatment of anxiety
B. Consideration of medication dose changes do not have to be made during pregnancy
C. If this is a first pregnancy a women’s previous response to medication should not influence
the choice of antidepressant (being pregnant dictates the choice)
D. Lithium can be continued if the women is at high risk of relapse and an antipsychotic is
unlikely to be effective
E. Measure prolactin levels in women planning pregnancy who are taking a prolactin raising
antipsychotic as raised prolactin increases the chances of conception
4. Which of the following statements is TRUE?
A. Valproate is associated with reduced fertility in women and men
B. Taking Folic acid 5mg with Valproate will reduce teratogenicity

39
C. Valproate monotherapy is not associated with an increased risk of Attention Deficit
Hyperactivity Disorder
D. Valproate monotherapy only affects the child in the 1st and 3rd trimester
E. Valproate passes in higher concentrations than Lamotrigine in breastmilk
5. Which of the following is TRUE regarding breastfeeding?
A. Patients with postpartum mental health disorders who require pharmacotherapy should
generally be discouraged from breastfeeding
B. All psychotropic medications are transferred to breast milk in varying amounts
C. Psychotropics should be chosen with regard to longer half life and less protein binding
D. Mothers should change their pregnancy medication for breastfeeding
E. Methadone and Nicotine Replacement Therapy are incompatible with breastfeeding
Further Reading
PSYCHOSIS
Guidelines
NICE Guidance Pathway: Psychosis and Schizophrenia Pathway - :
http://pathways.nice.org.uk/pathways/psychosis-and-schizophrenia
Nice guidelines: CG178- Psychosis and schizophrenia in adults:
http://guidance.nice.org.uk/CG178
BAP guidelines: Evidence-based guidelines for the pharmacological treatment of
schizophrenia: recommendations from the British Association for Psychopharmacology-
https://www.bap.org.uk/pdfs/BAP_Guidelines-Schizophrenia.pdf
E-Learning
RCPsych CPD Online
First episode psychosis: Part 1 -assessment, diagnosis and rationale
First episode psychosis: Part 2 -treatment approaches and service delivery
Journal Articles
Feedman, R (2003) Schizophrenia. N Engl J Med 349:1738-1749

40
Woolley, J & McGuire P (2005) Neuroimaging in schizophrenia: what does it tell the clinician?
APT 11: 195-202.
Cardno A (2014) Genetics and psychosis. APT 20: 69-70
Torrey EF (1987) Prevalence studies in schizophrenia. BJPsych 150:598-608.
Macleod J (2007) Cannabis use and psychosis: the origins and implications of an
association. APT 13:400-411.
Martindale B (2007) Psychodynamic contributions to early intervention in psychosis. APT
13:34-42.
Connolly M & Kelly C (2005) Lifestyle and physical health in schizophrenia. APT 11:125-132.
Mullen P (2006) Schizophrenia and violence: from correlations to preventive strategies. APT
12:239-248
Schleifer JJ (2011) Management of acute agitation in psychosis: an evidence-based
approach in the USA. APT 17:91-100.
DEPRESSION
Guidelines
NICE Guidance Pathway: Depression Pathway-
http://pathways.nice.org.uk/pathways/depression
Nice guidelines: CG90- Depression in adults: Recognition and management
https://www.nice.org.uk/guidance/CG90
BAP guidelines: Evidence-based guidelines for treating depressive disorders with
antidepressants: A revision of the 2008 British Association for Psychopharmacology
guidelines- https://www.bap.org.uk/pdfs/BAP_Guidelines-Antidepressants.pdf
E-Learning
RCPsych CPD Online
The pharmacological treatment of resistant depression- an overview
Dual diagnosis: the diagnosis and treatment of depression with co-existing
substance misuse
Managing depression in physically ill patients
Prescription of ECT
Antidepressants and psychosexual dysfunction: Part 1 – diagnosis
Antidepressants and psychosexual dysfunction: Part 2 – treatment
Journal Articles

41
Belmaker, RH & Agam G (2008). Major depressive disorder, N Engl J Med, 358: 55-68.
Jacob KS (2009) Major depression: revisiting the concept and diagnosis. APT 15:279-285.
Taylor D (2008) Psychoanalytic and psychodynamic therapies for depression: the evidence
base. APT 14:401-413.
Branney P & White A (2008) Big boys don’t cry: depression and men. APT 14:256-262.
Cowen P (2005) New drugs, old problems: Revisiting Pharmacological management of
treatment-resistant depression. APT 11:19-27.
Oakley C, Hynes F, Clark T (2009). Mood disorders and violence: a new focus, APT, 15:263-
270.
BIPOLAR DISORDER
Guidelines
Nice guidelines: CG185- Bipolar disorder: assessment and management
https://www.nice.org.uk/guidance/cg185
BAP guidelines: Evidence-based guidelines for treating bipolar disorder: revised third edition
https://www.bap.org.uk/pdfs/BAP_Guidelines-Bipolar.pdf
E-Learning
RCPsych CPD Online
The pharmacological management of mania
Safe Lithium Prescribing: initiation and monitoring
Journal Articles
Elanjithara T, Frangou S, McGuire P (2011) Treatment of the early stages of bipolar disorder.
APT 17:283-291.
Bouch J (2010) Bipolar disorder. APT 16:317.
Saunders KEA & Goodwin GM (2010) The course of bipolar disorder. APT 16:318-328.
ANXIETY DISORDERS
Guidelines

42
NICE Guidance Pathway for GAD and panic disorder (with or without agoraphobia):
http://pathways.nice.org.uk/pathways/generalised-anxiety-disorder
NICE guidelines on GAD and panic disorder: CG113-
https://www.nice.org.uk/Guidance/CG113
BAP guidelines: Evidence-based pharmacological treatment of anxiety disorders, post-
traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005
guidelines from the British Association for Psychopharmacology
https://www.bap.org.uk/pdfs/BAP_Guidelines-Anxiety.pdf
E-Learning
RCPsych CPD Online
The pharmacological management of anxiety disorders
Journal Articles
Kessler RC, Chiu WT, Jim R, Ruscio AM, Shear C, Walters E. (2006). The epidemiology of
panic attacks, panic disorder and agoraphobia in the national co-morbidity survey replication.
Archives of General Psychiatry (now JAMA Psychiatry), 63(4), 415-424.
Shader RJ, Greenblatt DJ. (1993). Use of benzodiazepines in anxiety disorders. N Eng J of
Med, 328, 1398-1405.
Hamilton, M. (1959) The assessment of anxiety states by rating scale. British Journal of
Medical Psychology, 32(1), 50-55.
Linden, .M. Zubraegel .D. Baer .T. et al. (2005) Efficacy of cognitive behaviour therapy in
generalised anxiety disorders. Psychotherapy and Psychosomatics 74, 36-42.
SELF-HARM & SUICIDE
E-Learning
RCPsych CPD Online
The psychosocial management of self-harm: Part 1
The psychosocial management of self-harm: Part 2
BMJ Learning Module on suicidal behaviour and self-harm
http://learning.bmj.com/learning/module-intro/cmt-self-
harm.html?moduleId=10054668&page=1&locale=en_GB
Journal Articles

43
Bouch J, Marshall JJ (2005) Suicide risk: structured professional judgement. Advances in
Psychiatric Treatment 11: 84-91.
Heeringen K, Mann JJ (2014) The neurobiology of suicide. Lancet Psychiatry 1:63-72.
O’Connor RC, Nock MK (2014) The psychology of suicidal behaviour. Lancet Psychiatry
1:73-85.
Other resources
Royal College of Psychiatrists leaflets
http://www.rcpsych.ac.uk/healthadvice/problemsdisorders.aspx
Links to the ICD10 online:
http://apps.who.int/classifications/icd10/browse/2016/en#/V
http://www.who.int/classifications/icd/en/bluebook.pdf (Bluebook)
http://www.who.int/classifications/icd/en/GRNBOOK.pdf (for research criteria)
TrOn: www.tron.rcpsych.ac.uk

44
OLD AGE SEMESTER 3:
Session 1: Cognition
Learning Objectives
The overall aim is for the trainee to gain an overview of cognition.
By the end of the session trainees should:
o Understand the link between the cognitive domains and brain regions
o Appreciate the theory of a bedside cognitive assessment
o Have an awareness of common cognitive syndromes
o Be able to reflect on the limitations of cognitive assessment tools
Curriculum Links
Old Age Section of the MRCPsych Curriculum: 8.3
Expert Led Session
A Consultant led session based on the learning objectives listed above
Case Presentation
A case to be presented which highlights the importance of a robust assessment, including some
interesting findings in the cognitive assessment process in the older person
Journal Club Presentation

45
Cecato, J.F., Martinelli, J.E., Izbicki, R., Yassuda, M.S. and Aprahamian, I., 2017. A subtest
analysis of The Montreal Cognitive Assessment (MoCA): which subtests can best discriminate
between healthy controls, mild cognitive impairment and Alzheimer's disease?. International
psychogeriatrics, 29(4), pp.701-701.
Krishnan, K., Rossetti, H., Hynan, L.S., Carter, K., Falkowski, J., Lacritz, L., Cullum, C.M. and
Weiner, M., 2017. Changes in Montreal cognitive assessment scores over time. Assessment,
24(6), pp.772-777.
Roalf, D.R., Moore, T.M., Mechanic-Hamilton, D., Wolk, D.A., Arnold, S.E., Weintraub, D.A. and
Moberg, P.J., 2017. Bridging cognitive screening tests in neurologic disorders: A crosswalk
between the short Montreal Cognitive Assessment and Mini-Mental State Examination.
Alzheimer's & dementia: the journal of the Alzheimer's Association, 13(8), pp.947-952.
‘555’ Topic (5 slides with no more than 5 bullet points per slide)
Bedside Testing of the Frontal Lobe or the Parietal Lobe
Normal age-related changes in cognitive function
MCQs
1. Which of the following is not a bedside frontal lobe test?
A. Abstract thinking
B. Go-No-Go
C. Cognitive estimates
D. Verbal fluency
E. Clock drawing
2. Which of the following is an objective rating scale for cognition?
A. MOCA
B. GDS
C. DASS21
D. Cornell
E. MUST

46
3. All are features of Gerstmann Syndrome except:
A. Right-left disorientation
B. Anosognosia
C. Finger agnosia
D. Dyscalculia
E. Dysgraphia
4. Which of the following is seen in Wernicke’s aphasia?
A. Effortful speech
B. Telegraphic speech
C. Intact repetition
D. Impaired comprehension
E. Nystagmus
5. The following brain region is associated with semantic memory:
A. Thalamus
B. Hippocampus & entorhinal cortex
C. Anterior temporal lobe
D. Dorsolateral prefrontal cortex
E. Cerebellum
6. Which of the following is not a test of executive function?
A. Luria Task
B. Wisconsin Card Sorting Test
C. Stroop Test
D. Graded naming test
E. Verbal fluency
Additional Resources / Reading Material
Websites:
Montreal Cognitive Assessment (MOCA) available at: www.mocatest.org

47
RCPsych CPD Online Modules: Bedside Assessment of Cognition.
Journal Papers:
Tang, M. and Reitz, C., 2017. Genetics of Alzheimer's disease: an update. Future Neurology, 12(4),
pp.237-247.
Kipps, CM., & Hodges, JR., 2005. Cognitive assessment for clinicians. Journal of Neurology,
Neurosurgery & Psychiatry, 76 (suppl 1), i22-i30.
Giri, M., Zhang, M., & Lü, Y. (2016). Genes associated with Alzheimer’s disease: an overview
and current status. Clinical Interventions in Aging, 11, 665–681.
http://doi.org/10.2147/CIA.S105769
Shaik, S. S., & Varma, A. R., 2012. Differentiating the dementias: a neurological approach.
Progress in Neurology and Psychiatry, 16(1), 11-18.
Takas, A., Koncz, R., Mohan, A. and Sachdev, P., 2017. Forgetfulness, stress or mild dementia?
Cognitive assessment of older patients. https://medicinetoday.com.au/2017/may/feature-
article/forgetfulness-stress-or-mild-dementia-cognitive-assessment-older-patients/
Young, J., Meagher, D., & MacLullich, A., 2011. Cognitive assessment of older people. BMJ, 343,
d5042.
Guidelines:
NICE CG42 – Dementia https://www.nice.org.uk/guidance/Cg42
Other resources:
Hodges, J.R., 2017. Cognitive assessment for clinicians. Oxford University Press.
Jacoby R, Oppenheimer C, Dening T. (eds.), 2008. The Oxford Textbook of Old Age Psychiatry.
Oxford University Press: Oxford. Chapters on psychometric assessment, biological aspect of ageing
and clinical cognitive assessment..
Larner, A.J. ed., 2017. Cognitive screening instruments. Springer.
Volkman, N., Cohen, N. and Vroman, G., 2018. Misinterpreting Cognitive Decline in the Elderly:
Blaming the Patient. In Human Error in Medicine (pp. 93-122). CRC Press.

48
Session 2: Alzheimer’s Disease
Learning Objectives
The overall aim is for the trainee to gain an overview of Alzheimer’s disease.
By the end of the session trainees should:
o Understand the epidemiology of Alzheimer’s disease.
o Understand the risk factors, genetics, neuropathology, neurotransmitters and
neuroimaging associated with Alzheimer’s Disease.
o Understand the clinical features of Alzheimer’s disease, the assessment process and the
principles of management.
o Understand the impact on carers associated with disorders like Alzheimer’s Disease.
Curriculum Links
Old Age Section of the MRCPsych Curriculum: 8.1, 8.2, 8.3, 8.4, 8.5
Expert Led Session
A Consultant led session based on the learning objectives listed above
Case Presentation
A case to be presented which highlights the diagnostic process and/or Alzheimer’s Disease and/or
BPSD (behaviour that challenges). Please consider the learning objectives above.
Journal Club Presentation
Gitlin, L.N., Arthur, P., Piersol, C., Hessels, V., Wu, S.S., Dai, Y. and Mann, W.C., 2018. Targeting
Behavioral Symptoms and Functional Decline in Dementia: A Randomized Clinical Trial. Journal
of the American Geriatrics Society, 66(2), pp.339-345
Sabia, S., Dugravot, A., Dartigues, J.F., Abell, J., Elbaz, A., Kivimäki, M. and Singh-Manoux, A., 2017.
Physical activity, cognitive decline, and risk of dementia: 28 year follow-up of Whitehall II cohort
study. Bmj, 357, p.j2709.
Sommerlad, A., Ruegger, J., Singh-Manoux, A., Lewis, G. and Livingston, G., 2017. Marriage and
risk of dementia: systematic review and meta-analysis of observational studies. J Neurol
Neurosurg Psychiatry, pp.jnnp-2017.
Tricco, A.C., Ashoor, H.M., Soobiah, C., Rios, P., Veroniki, A.A., Hamid, J.S., Ivory, J.D., Khan, P.A.,
Yazdi, F., Ghassemi, M. and Blondal, E., 2018. Comparative effectiveness and safety of cognitive

49
enhancers for treating Alzheimer's disease: systematic review and network meta-analysis.
Journal of the American Geriatrics Society, 66(1), pp.170-178.
Tampi R, Hassell C, Joshi P, Tampi D. 2018. Analgesics in the Management of Behavioral and
Psychological Symptoms of Dementia: A Systematic Review. The American Journal of Geriatric
Psychiatry. 31;26(3):S143-4.
White, N., Leurent, B., Lord, K., Scott, S., Jones, L. and Sampson, E.L., 2017. The management of
behavioural and psychological symptoms of dementia in the acute general medical hospital: a
longitudinal cohort study. International journal of geriatric psychiatry, 32(3), pp.297-305.
‘555’ Topic (5 slides with no more than 5 bullet points per slide)
The use of antipsychotic medication and the risks associated in patients with dementia
The NINCDS-ADRDA or NIA-AA criteria
MCQs
1. The prevalence of dementia in the general UK population older than 65 is approximately:
A. 1-2%
B. 2-4%
C. 7%
D. 10%
E. 15-20%
2. In Alzheimer’s Disease, the gene for Amyloid Precursor Protein (APP) is found on the long arm of
chromosome:
A. 1
B. 12
C. 21
D. 19
E. None of the above
3. Which of the following statements regarding biomarkers in Alzheimer’s disease is true:
A. The first biomarker change in Alzheimer’s disease is reflected by a decrease in CSF tau levels
B. β amyloidosis can only be detected in venous plasma samples

50
C. Amyloid-β accumulation is not sufficient to cause disease progression
D. PET imaging is estimated to be able to predict changes 25 years prior to symptoms
E. All individuals that have positive biomarker results progress at the same rate.
4. The ‘anti-dementia’ drug that blocks NMDA receptors is:
A. Rivastigmine
B. Galantamine
C. Memantine
D. Donepezil
E. All of the above
5. Which of the following combination of APOE alleles confers the highest risk of developing
Alzheimer's disease?
A. 2:2
B. 2:3
C. 3:3
D. 3:4
E. 4:4
Additional Resources / Reading Materials
Websites:
https://www.rcpsych.ac.uk/ CPD Online
capacity, empowerment and conflicts of interest
inappropriate sexual behaviour in dementia
Guidelines
https://www.nice.org.uk/guidance/Cg42
Journal papers:
Banerjee S., 2009. The Use of Antipsychotic Medication for People with Dementia: Time for
Action. DOH.

51
Cooper, S., & Greene, JDW., 2005. The clinical assessment of the patient with early dementia.
Journal of Neurology, Neurosurgery & Psychiatry, 76 (5), v15-v24.
Etters, L., Goodall, D., & Harrison, B. E., 2008. Caregiver burden among dementia patient
caregivers: a review of the literature. Journal of the American Academy of Nurse Practitioners,
20(8), 423-428.
Loy, C. T., Schofield, P. R., Turner, A. M., & Kwok, J. B., 2013. Genetics of dementia. The Lancet.
Jack, C.R., Bennett, D.A., Blennow, K., Carrillo, M.C., Dunn, B., Haeberlein, S.B., Holtzman, D.M.,
Jagust, W., Jessen, F., Karlawish, J. and Liu, E., 2018. NIA-AA Research Framework: Toward a
biological definition of Alzheimer's disease. Alzheimer's & Dementia, 14(4), pp.535-562.
Mortimer, A. M., Likeman, M., & Lewis, T. T., 2013. Neuroimaging in dementia: a practical guide.
Practical neurology, 13(2), 92-103.
Tang, M. and Reitz, C., 2017. Genetics of Alzheimer's disease: an update. Future Neurology,
12(4), pp.237-247.
Treloar, A., Crugel, M., Prasanna, A., Solomons, L., Fox, C., Paton, C., & Katona, C., 2010. Ethical
dilemmas: should antipsychotics ever be prescribed for people with dementia? The British
Journal of Psychiatry, 197(2), 88-90.
Watkin, A., Sikdar, S., Majumdar, B., & Richman, A. V., 2013. New diagnostic concepts in
Alzheimer’s disease. Advances in psychiatric treatment, 19(4), 242-249.
Other resources
Dementia UK update (2nd edition), 2007. Alzheimer’s Society.
https://www.alzheimers.org.uk/sites/default/files/migrate/downloads/dementia_uk_update.pdf
Jacoby R, Oppenheimer C, Dening T., 2008. The Oxford Textbook of Old Age Psychiatry. Oxford
University Press: Oxford. Chapters on Alzheimer’s disease, pharmacological treatment of
dementia.
Taylor, D., Barnes, T., Young, A., 2018. The Maudsley Prescribing Guidelines in Psychiatry, 13th
edition. Blackwell-Wiley.
World Health Organisation, 1992. ICD-10 : The ICD-10 Classification of Mental and Behavioural
Disorders : Clinical Descriptions and Diagnostic Guidelines. WHO.

52
Session 3: Other Neuro Degenerative Disorders
Learning Objectives
To overall aim is to gain a basic overview of common neuro-degenerative disorders including Lewy
Body Dementia, Fronto-Temporal Dementia (FTD), Creutzfeldt-Jakob disease (CJD), and Dementia
in Parkinson’s disease; vascular dementia is also incorporated into this session.
For each of the disorders listed above, by the end of the session, the trainee should understand
the basic epidemiology, aetiology, clinical presentation and basic management principles
Curriculum Links
Old Age Section of the MRCPsych Curriculum: 8.1, 8.3, 8.4, 8.5, 8.11
Expert Led Session
A Consultant led session based on the learning objectives listed above.
Case Presentation
A case to be presented which highlights one of the neurodegenerative disorders named above.
Please consider the learning objectives above.
Journal Club Presentation
Rongve, A., Soennesyn, H., Skogseth, R., Oesterhus, R., Hortobágyi, T., Ballard, C., .& Aarsland, D.
(2016). Cognitive decline in dementia with Lewy bodies: a 5-year prospective cohort study. BMJ
open, 6(2), e010357.
Schrag, A., Siddiqui, U.F., Anastasiou, Z., Weintraub, D. and Schott, J.M., 2017. Clinical variables
and biomarkers in prediction of cognitive impairment in patients with newly diagnosed
Parkinson's disease: a cohort study. The Lancet Neurology, 16(1), pp.66-75.
Connors, M.H., Quinto, L., McKeith, I., Brodaty, H., Allan, L., Bamford, C., Thomas, A., Taylor, J.P.
and O'Brien, J.T., 2017. Non-pharmacological interventions for Lewy body dementia: a
systematic review. Psychological medicine, pp.1-10.
Coleman, K.K., Coleman, B.L., MacKinley, J.D., Pasternak, S.H. and Finger, E.C., 2017. Association
between Montreal Cognitive Assessment sub-item scores and corresponding cognitive test

53
performance in patients with frontotemporal dementia and related disorders. Dementia and
geriatric cognitive disorders, 43(3-4), pp.170-179.
Sevilla, R.R., Naranjo, I.C., Cuenca, J.C.P., Rodriguez, J.M.F. and Espuela, F.L., 2018. Vascular risk
factors and white matter hyperintensities as predictors of progression to dementia in patients
with mild cognitive impairment. Current Alzheimer research
‘555’ Topic (5 slides with no more than 5 bullet points per slide)
Dementia in Huntington’s Disease
The presentation of FTD
Management of psychosis in Parkinson’s disease
MCQs
1. Which of the following feature is seen more in cortical than subcortical dementia:
A. Calculation preserved
B. Aphasia occurs early
C. Apathy
D. Slowed motor speed and control
E. Adventitious movement
2. In Progressive Supranuclear Palsy (PSP), which of the following is true?
A. A tendency to fall forwards is seen
B. Onset is in the 4th decade of life
C. Dystonia is seen
D. Cortical type of dementia is noted
E. Pupils become dilated and fixed
3. A man with Parkinson’s Disease develops psychotic symptoms. What is the first line antipsychotic
treatment?
A. Quetiapine
B. Amisulpride
C. Haloperidol

54
D. Risperidone
E. Clozapine
4. Which of the following MRI finding is seen in Huntington’s Disease?
A. Caudate atrophy
B. Cerebellar atrophy
C. Multiple white matter intensities
D. Pulvinar infarct
E. Lacunar infarct
5. A 70 year old man has a diagnosis of Lewy Body Dementia. Which of the following drugs has the
best evidence for improving delusions and hallucinations associated with LBD?
A. Donepezil
B. Mirtazapine
C. Risperidone
D. Clozapine
E. Rivastigmine
Additional Resources / Reading Material
Websites:
Trainees Online (TrON): Neuropathology: Part 1 – dementia
RCPsych, CPD Online – useful modules on:
o Neuroimaging in dementia
o Early onset dementias
o Neuropsychiatric problems in Parkinson’s disease
o Hungtington’s disease
Journal Papers:
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K., 2004. Stages in the
development of Parkinson’s disease-related pathology. Cell and tissue research, 318(1),
121-134.

55
Brooks, DJ., 2002. Diagnosis and management of atypical parkinsonian syndromes. Journal
of Neurology, Neurosurgery & Psychiatry, 72(suppl 1), i10-i16.
Craufurd, D, MacLeod, R, Frontali, M, Quarrell, O, Bijlsma, EK, Davis, M, Hjermind, LE, Lahiri,
N, Mandich, P, Martinez, A and Tibben, A., 2015. Diagnostic genetic testing for Huntington's
disease. Practical neurology, 15(1), pp.80-84.
Gore, RL., Vardy, ER., & T O'Brien, J. , 2014. Delirium and dementia with Lewy bodies:
distinct diagnoses or part of the same spectrum? Journal of Neurology, Neurosurgery &
Psychiatry, 2013.
Gupta, S., Fiertag, O., & Warner, J., 2009. Rare and unusual dementias. Advances in
psychiatric treatment, 15(5), 364-371.
Ian G. McKeith, Bradley F. Boeve, Dennis W. Dickson, et al., 2017. Diagnosis and
management of dementia with Lewy bodies: Fourth consensus report of the DLB
Consortium. Neurology published online. DOI 10.1212/WNL.0000000000004058
http://n.neurology.org/content/neurology/early/2017/06/07/WNL.0000000000004058.full.
Jauhar, S. and Ritchie, S., 2010. Psychiatric and behavioural manifestations of Huntington’s
disease. Advances in psychiatric treatment, 16(3), pp.168-175.
Latoo, J., Mistry, M., & Dunne, F. J., 2012. Diagnosis and management of psychosis in
Parkinson's disease. Progress in Neurology and Psychiatry, 16(5), 7-10.
O’Brien, J.T. and Thomas, A., 2017. Vascular Dementia. Focus, 15(1), pp.101-109.
Smith, E.E., 2017. Clinical presentations and epidemiology of vascular dementia. Clinical
Science, 131(11), pp.1059-1068.
Sullivan, V, Majumdar, B, Richman, A, & Vinjamuri, S., 2012. To scan or not to scan:
neuroimaging in mild cognitive impairment and dementia. Advances in Psychiatric
Treatment, 18(6), 457-466.
Warren, JD, Rohrer, JD, & Rossor, MN., 2013. Frontotemporal dementia. BMJ;347:f4827 doi:
10.1136/bmj.f4827

56
Other resources:
Jacoby R, Oppenheimer C, Dening T. (eds.), 2008. The Oxford Textbook of Old Age
Psychiatry. Oxford University Press: Oxford. Chapters on clinical aspects of dementia and on
the different forms of dementia.
Munoz, D.G. and Weishaupt, N., 2017. Vascular Dementia. In The Cerebral Cortex in
Neurodegenerative and Neuropsychiatric Disorders (pp. 119-139).
Taylor, D., Barnes, T., Young, A., 2018. The Maudsley Prescribing Guidelines in Psychiatry, 13th edition. Blackwell-Wiley.
World Health Organisation, 1992. ICD-10 : The ICD-10 Classification of Mental and
Behavioural Disorders : Clinical Descriptions and Diagnostic Guidelines. WHO.
Session 4: Delirium
Learning Objectives
The overall aim of the session is for the trainee to gain an overview of delirium
By the end of the sessions the trainee should:
o Understand the epidemiology, the risk factors associated and the basic physiological and
psychological changes associated with delirium
o Have an understanding of the clinical features of delirium, and have a framework for the
basic assessment process, principles of management, and prognosis.
Curriculum Links
Old Age Section of the MRCPsych Curriculum: 8.3, 8.4, 8.5.
Expert Led Session
A Consultant led session based on the learning objectives listed above.
Case Presentation
A case to be presented which highlights a patient presenting with possible or definite delirium.
Please consider the learning objectives above.
Journal Club Presentation

57
Journal papers:
Balogun, S. A., & Philbrick, J. T. 2014. Delirium, a Symptom of UTI in the Elderly: Fact or
Fable? A Systematic Review. Canadian Geriatrics Journal, 17(1), 22–26.
http://doi.org/10.5770/cgj.17.90
Bush, S.H., Marchington, K.L., Agar, M., Davis, D.H., Sikora, L. and Tsang, T.W., 2017. Quality
of clinical practice guidelines in delirium: a systematic appraisal. BMJ open, 7(3),
p.e013809.
Davis, D.H., Muniz-Terrera, G., Keage, H.A., Stephan, B.C., Fleming, J., Ince, P.G., Matthews,
F.E., Cunningham, C., Ely, E.W., MacLullich, A.M. and Brayne, C., 2017. Association of
delirium with cognitive decline in late life: a neuropathologic study of 3 population-based
cohort studies. JAMA psychiatry, 74(3), pp.244-251.
Devore, E.E., Fong, T.G., Marcantonio, E.R., Schmitt, E.M., Travison, T.G., Jones, R.N. and
Inouye, S.K., 2017. Prediction of long-term cognitive decline following postoperative
delirium in older adults. Journals of Gerontology Series A: Biomedical Sciences and Medical
Sciences, 72(12), pp.1697-1702.
Neufeld, K. J., Yue, J., Robinson, T. N., Inouye, S. K., & Needham, D. M. 2016. Antipsychotic
Medication for Prevention and Treatment of Delirium in Hospitalised Adults: A Systematic
Review and Meta‐Analysis. Journal of the American Geriatrics Society, 64(4), 705-714.
van Velthuijsen, E.L., Zwakhalen, S.M., Pijpers, E., van de Ven, L.I., Ambergen, T., Mulder,
W.J., Verhey, F.R. and Kempen, G.I., 2018. Effects of a Medication Review on Delirium in
Older Hospitalised Patients: A Comparative Retrospective Cohort Study. Drugs & aging,
35(2), pp.153-161.
Yang, Y., Zhao, X., Dong, T., Yang, Z., Zhang, Q. and Zhang, Y., 2017. Risk factors for
postoperative delirium following hip fracture repair in elderly patients: a systematic
review and meta-analysis. Aging clinical and experimental research, 29(2), pp.115-126.
‘555’ Topic (5 slides with no more than 5 bullet points per slide)
Delirium versus dementia
Delirium tremens
Detection of delirium

58
MCQs
1. Which of the following is most common in delirium?
A. Hallucinations
B. Sleep-wake cycle disturbed
C. Labile mood
D. Increased motor activity
E. Delusions
2. What % of patients with delirium go onto develop dementia:
A. 5%
B. 10-25%
C. 25-45%
D. 1%
E. 90%
3. Which of the following is not a risk factor for delirium:
A. Recent surgery
B. Poor sight
C. Terminal illness
D. Pre-existing memory problems
E. Intellectual disability
4. Which is a clinical feature common to both dementia and delirium:
A. Rapid onset
B. Global cognitive impairment
C. Clouding of consciousness
D. Clear consciousness
E. Gradual onset over 6 months
5. Which assessment rating tool does NICE recommend using to assess for delirium:
A. MOCA
B. CAM

59
C. MMSE
D. ACEIII
E. DAS21
6. Which drug is not associated with an increased risk of delirium:
A. Calcium channel blocker
B. Antihistamines
C. Benzodiazepines e.g. lorazepam
D. Antipsychotics
E. Antipsychotics
Additional Resources / Reading Materials
Websites:
CPD Online: Delirium in older people: assessment and management
http://www.europeandeliriumassociation.com/
http://www.scottishdeliriumassociation.com/
Guidelines
Delirium: prevention, diagnosis and management, NICE guidelines [CG103].
Journal Papers:
Clegg, A., & Young, J. B. 2010. Which medications to avoid in people at risk of delirium: a
systematic review. Age and ageing, afq140.
Fiedler, S.M. and Houghton, D.J., 2018. An In-depth Look into the Management and Treatment
of Delirium. In Clinical Approaches to Hospital Medicine (pp. 89-107). Springer, Cham.
MacLullich, A. M., Beaglehole, A., Hall, R. J., & Meagher, D. J. 2009. Delirium and long-term
cognitive impairment. International Review of Psychiatry, 21(1), 30-42.
Miller, C., Teale, E. and Banerjee, J., 2018. Cognitive Impairment in Older People Presenting to
ED. In Geriatric Emergency Medicine (pp. 199-207). Springer, Cham.

60
O’Connell, H., Kennelly, S. P., Cullen, W., & Meagher, D. J. 2014. Managing delirium in everyday
practice: towards cognitive-friendly hospitals. Advances in psychiatric treatment, 20(6), 380-
389.
Raju, K., & Coombe‐Jones, M. 2015. An overview of delirium for the community and hospital
clinician. Progress in Neurology and Psychiatry, 19(6), 23-27.
Young, J., & Inouye, S. K. 2007. Delirium in older people. BMJ, 842-846.
Books:
Jacoby R, Oppenheimer C, Dening T. (eds.) 2008. The Oxford Textbook of Old Age Psychiatry.
Oxford University Press: Oxford. Chapter on delirium.
Taylor, D., Barnes, T., Young, A., 2018. The Maudsley Prescribing Guidelines in Psychiatry, 13th
edition. Blackwell-Wiley. (section on delirium and delirium tremens)
World Health Organisation, 1992. ICD-10 : The ICD-10 Classification of Mental and Behavioural
Disorders : Clinical Descriptions and Diagnostic Guidelines. WHO.
Session 5: Mood Disorders in the Older Person
Learning Objectives
The overall aim of the sessions is for the trainees to gain an overview of mood disorders in later
life.
By the end of the session trainees should:
o Understand the epidemiology, aetiology and the classification of mood disorders in the
elderly.
o Understand how mood disorders present in the elderly (including psychotic features), the
assessment process including neuroimaging and the use of rating scales and the principles
of treatment including treatment resistance.
o Understand more about the risk of suicide in the elderly.
Curriculum Links
Old Age Section of the MRCPsych Curriculum: 8.3, 8.4, 8.5, 8.6, 8.7, 8.8, 8.9, 8.10.
Expert Led Session
A Consultant led session based on the learning objectives listed above.

61
Case Presentation
A case to be presented which highlights an older person presenting with a mood disorder. Please
consider the learning objectives above.
Journal Club Presentation
Andreas, S., Schulz, H., Volkert, J., Dehoust, M., Sehner, S., Suling, A., Ausín, B., Canuto, A.,
Crawford, M., Da Ronch, C. and Grassi, L., 2017. Prevalence of mental disorders in elderly
people: the European MentDis_ICF65+ study. The British Journal of Psychiatry, 210(2),
pp.125-131.
Hedna, K., Sundell, K.A., Hamidi, A., Skoog, I., Gustavsson, S. and Waern, M., 2018.
Antidepressants and suicidal behaviour in late life: A prospective population-based study
of use patterns in new users aged 75 and above. European journal of clinical pharmacology,
74(2), pp.201-208.
Orgeta, V., Brede, J. and Livingston, G., 2017. Behavioural activation for depression in older
people: systematic review and meta-analysis. The British Journal of Psychiatry, pp.bjp-bp.
Qiu, W. Q., Himali, J. J., Wolf, P. A., DeCarli, D. C., Beiser, A., and Au, R., 2017. Effects of
white matter integrity and brain volumes on late life depression in the Framingham Heart
Study. Int J Geriatr Psychiatry, 32: 214–221. doi: 10.1002/gps.4469.
Schaakxs, R., Comijs, H.C., Lamers, F., Beekman, A.T.F. and Penninx, B.W.J.H., 2017. Age-
related variability in the presentation of symptoms of major depressive disorder.
Psychological medicine, 47(3), pp.543-552.
‘555’ Topic (5 slides with no more than 5 bullet points per slide)
Abnormal Grief Reaction

62
Suicide in the elderly
MCQs
1. The features suggestive of pseudo-dementia would include all except:
A. There is a long history of memory impairment and difficult with ADLs
B. The patient complains of poor memory
C. Assessment of cognitive function often results in 'don't know answers'
D. The onset is fast
E. There is often a history of depression or an identifiable precipitant
2. An 84 year old lady presents with severe depression. She had a myocardial infarction 3 months
ago and her QTc is 490ms. Which antidepressant is the best choice?
A.Sertraline
B.Mirtazapine
C.Paroxetine
D.Citalopram
E.Duloxetine
3. An 87 year old man has lost his wife recently. Which of the following clinical features would most
suggest that this was an abnormal grief reaction?
A. Loss of sleep
B. Loss of appetite
C. Laying the dining table for the deceased at meal times
D. Anxiety
E. Suicidal ideation
4. Which is not a feature of serotonin syndrome?
A. Blurred vision
B. Confusion
C. Akathisia
D. Elevated white cells
E. Hypomimia

63
5. Which rating scale is most helpful in detecting depression in people with dementia?
A. Cornell
B. MMSE
C. GDS
D. AMTS
E. Hamilton Rating Scale
6. You have a patient on lithium with a consistently elevated blood pressure. What is your most
appropriate action?
A. Start amiloride
B. Lithium must be stopped
C. Start furosemide
D. Start lisonopril
E. Start candesartan
Additional Resources / Reading Materials
Websites:
CPD Online Modules: Quick bite: Suicide in the elderly, treating depression in later life,
bereavement
Journal Papers:
Cattell, H. 2000. Suicide in the elderly. Advances in Psychiatric Treatment, 6(2), 102-108.
Draper, B. M. 2014. Suicidal behaviour and suicide prevention in later life. Maturitas, 79(2),
179-183.
McDonald, W.M., Hermida, A., Petrides, G. and Kellner, C., 2017. Update on New Research
and the Clinical Practice of ECT in the Elderly. The American Journal of Geriatric Psychiatry,
25(3), p.S25.
Richards, F., & Curtice, M. 2011. Mania in late life. Advances in Psychiatric Treatment, 17(5),
357-364.
Rodda, J., Walker, Z., & Carter, J. 2011. Depression in older adults. BMJ, 343.

64
Books:
Jacoby R, Oppenheimer C, Dening T. (eds.) 2008. The Oxford Textbook of Old Age Psychiatry.
Oxford University Press: Oxford. Chapters on depression, suicide and manic syndromes.
Stahl, SM, 2014. Prescriber's Guide: Stahl's Essential Psychopharmacology, 6th edition
Cambridge Medicine.
Taylor, D., Barnes, T., Young, A., 2018. The Maudsley Prescribing Guidelines in Psychiatry,
13th edition. Blackwell-Wiley.(sections on mood disorders including prescribing in older
adults)
World Health Organisation, 1992. ICD-10 : The ICD-10 Classification of Mental and
Behavioural Disorders : Clinical Descriptions and Diagnostic Guidelines. WHO.

65
Session 6: Psychosis in the Older Person
Learning Objectives
The overall aim of the sessions is for the trainees to gain an overview of psychosis in later life.
By the end of the session trainees should:
o Understand the epidemiology of psychosis and psychotic disorders in the older person.
o Understand the aetiology of psychosis in the older person.
o Understand how psychosis presents in the older person, the classification of disorders,
the basic assessment process and the principles of treatment of psychosis and psychotic
disorders
Curriculum Links
Old Age Section of the MRCPsych Curriculum: 8.3, 8.4, 8.5, 8.6, 8.7, 8.8, 8.9
Expert Led Session
A Consultant led session based on the learning objectives listed above.
Case Presentation
A case to be presented which highlights an older person presenting with possible or probable
psychosis. Please consider the learning objectives above.
Journal Club Presentation
Almeida, O.P., Ford, A.H., Hankey, G.J., Yeap, B.B., Golledge, J. and Flicker, L., 2018. Risk of
dementia associated with psychotic disorders in later life: the health in men study
(HIMS). Psychological medicine, pp.1-11.
Howard, R., Cort, E., Bradley, R., Kelly, L., Bentham, P., Ritchie, C., Reeves, S., Fawzi, W.,
Livingston, G., Sommerlad, A. and Oomman, S., 2018. Antipsychotic treatment of very
late-onset schizophrenia-like psychosis: a randomised controlled double-blind trial. The
Lancet Psychiatry.
Louhija, U.M., Saarela, T., Juva, K. and Appelberg, B., 2017. Brain atrophy is a frequent
finding in elderly patients with first episode psychosis. International psychogeriatrics,
29(11), pp.1925-1929.

66
Stafford, J., Howard, R. and Kirkbride, J.B., 2017. The incidence of very late-onset
psychotic disorders: a systematic review and meta-analysis, 1960–2016. Psychological
medicine, pp.1-12.
‘555’ Topic (5 slides with no more than 5 bullet points per slide)
Factors Affecting the Choice of Antipsychotic in the Elderly
Comparison of the presentation of schizophrenia in adults vs older adults
MCQs
1. A 76 year old lady is diagnosed with ‘late paraphrenia’. Which of the following delusions is the
GP most likely to find?
A. Hypochondriachal
B. Delusions of misidentification
C. Religious delusions
D. Delusions of reference
E. Persecutory delusions
2. Very late onset schizophrenia is characterised by onset after:
A. 40 years
B. 60 years
C. 65 years
D. 70 years
E. 80 years
3. Which antipsychotic is most likely to cause postural hypotension:
A. Aripiprazole
B. Risperidone
C. Haloperidol
D. Quetiapine
E. Sulpiride

67
4. Which of the following drugs should not be used in renal failure?
A. Amisulpride
B. Aripiprazole
C. Chlorpromazine
D. Olanzapine
E. Quetiapine
5. ‘Sensitivity to antipsychotics’ is linked to which disorder?
A. Alzheimer’s Disease
B. Dementia with Lewy Bodies
C. Late onset Schizophrenia
D. Organic mood disorder
E. Huntington’s Disease
Additional Resources / Reading Material
Websites:
RCPsych. The management of hyperprolactinemia in psychiatric practice, psychotropic
medication and the heart
Journal Papers:
Bartels, S.J., Fortuna, K.L. and Naslund, J.A., 2018. Serious Mental Disorders in Older
Adults: Schizophrenia and Other Late‐Life Psychoses. Aging and Mental Health, pp.241-
280.
Howard, R., Rabins, P. V., Seeman, M. V., & Jeste, D. V. 2000. Late-onset schizophrenia
and very-late-onset schizophrenia-like psychosis: an international consensus. American
Journal of Psychiatry.
Karim, S., & Byrne, E. J. 2005. Treatment of psychosis in elderly people. Advances in
Psychiatric Treatment, 11(4), 286-296.
Kyomen, H. H., & Whitfield, T. H. 2000. Psychosis in the elderly. American Journal of
Psychiatry.

68
Van Assche, L., Morrens, M., Luyten, P., Van de Ven, L. and Vandenbulcke, M., 2017. The
neuropsychology and neurobiology of late-onset schizophrenia and very-late-onset
schizophrenia-like psychosis: A critical review. Neuroscience & Biobehavioral Reviews.
Zharkova, T. and Kyomen, H.H., 2018. Treatment Dilemmas: Managing Antipsychotic
Medication Risks in Elderly with Major Neurocognitive Disorder, Stroke and Psychosis.
The American Journal of Geriatric Psychiatry, 26(3), pp.S100-S101.
Guidelines:
Psychosis and schizophrenia in adults: prevention and management. NICE guidelines
[CG178]
Books:
Jacoby R, Oppenheimer C, Dening T. (eds.) 2008. The Oxford Textbook of Old Age
Psychiatry. Oxford University Press: Oxford. Chapter on late onset schizophrenia.
Stahl, SM, 2014. Prescriber's Guide: Stahl's Essential Psychopharmacology, 6th edition
Cambridge Medicine.
Taylor, D., Barnes, T., Young, A., 2018. The Maudsley Prescribing Guidelines in Psychiatry,
13th edition. Blackwell-Wiley.
World Health Organisation, 1992. ICD-10 : The ICD-10 Classification of Mental and
Behavioural Disorders : Clinical Descriptions and Diagnostic Guidelines. WHO.

69
Session 7: Anxiety Disorders in the Older Person
Learning Objectives
The overall aim of the sessions is for the trainees to gain an overview of anxiety in later life.
By the end of the session trainees should:
o Understand the epidemiology of anxiety and anxiety disorders in the older person.
o Understand the aetiology of anxiety and anxiety disorders.
o Understand how anxiety disorders present in the older person, their classification, the
basic assessment process and the principles of treatment of anxiety and anxiety
disorders.
Curriculum Links
Old Age Section of the MRCPsych Curriculum: 8.3, 8.4, 8.5, 8.7, 8.8, 8.9, 8.10
Expert Led Session
A Consultant led session based on the learning objectives listed above.
Case Presentation
A case to be presented which highlights an older person presenting with anxiety. Please
consider the learning objectives above.
Journal Club Presentation
Burroughs, H., Bartlam, B., Ray, M., Kingstone, T., Shepherd, T., Ogollah, R., Proctor, J.,
Waheed, W., Bower, P., Bullock, P. and Lovell, K., 2018. A feasibility study for Non-
Traditional providers to support the management of Elderly People with Anxiety and
Depression: The NOTEPAD study Protocol. Trials, 19(1), p.172.
Contrera, K.J., Betz, J., Deal, J., Choi, J.S., Ayonayon, H.N., Harris, T., Helzner, E., Martin, K.R.,
Mehta, K., Pratt, S. and Rubin, S.M., 2017. Association of hearing impairment and anxiety
in older adults. Journal of aging and health, 29(1), pp.172-184.
Crocco, E.A., Jaramillo, S., Cruz-Ortiz, C. and Camfield, K., 2017. Pharmacological
Management of Anxiety Disorders in the Elderly. Current treatment options in psychiatry,
4(1), pp.33-46.

70
Bulbena‐Cabré, A., Rojo, C., Pailhez, G., Buron Maso, E., Martín‐Lopez, L.M. and Bulbena,
A., 2018. Joint hypermobility is also associated with anxiety disorders in the elderly
population. International journal of geriatric psychiatry, 33(1), pp.e113-e119.
‘555’ Topic (5 slides with no more than 5 bullet points per slide)
The Use of Lithium in the Elderly
Reversible Medical Causes of Anxiety in the Elderly
MCQs
1. Regarding the diagnosis of anxiety:
A. MMSE is a useful tool
B. The ‘Worry Scale’ is a carer’s report tool in depression
C. HADS is a useful tool
D. Cornell is the most useful scale in the over 75s
E. None of the above are true
2. A diagnosis of Generalised Anxiety Disorder can only be made after how long?
A. 6 months
B. 3 months
C. 6 weeks
D. 3 weeks
E. 1 year
3. In the elderly, anxiety is most closely linked to which condition?
A. Schizophrenia
B. Depression
C. Alzheimer’s Disease
D. Diogenes Syndrome
E. Delusional Disorders
4. A 78 year old lady has recently been started on a new medication for anxiety but has developed
hyponatraemia. Which of the following has most likely caused this?
A. Lamotrigine

71
B. Risperidone
C. Lithium
D. Citalopram
E. Quetiapine
5. Approximately how many adults aged 65 and older experience a diagnosable anxiety disorder
A. 4%
B. 11%
C. 15%
D. 21%
E. 30%
Additional Resources / Reading Material
Website:
RCPsych CPD online: Pharmacological management of anxiety disorders
Journal Papers:
Badrakalimuthu, V. R., & Tarbuck, A. F. 2012. Anxiety: a hidden element in dementia.
Advances in psychiatric treatment, 18(2), 119-128.
Bleakley, S., & Davies, S. J. 2014. The pharmacological management of anxiety disorders.
Progress in Neurology and Psychiatry, 18(6), 27-32.
Hoge, E. A., Ivkovic, A., & Fricchione, G. L. 2012. Generalized anxiety disorder: diagnosis
and treatment. BMJ: British Medical Journal, 345(7885).
Morderkar, A., and Spence, S. (2008). Personality disorder in older people: how common
is it and what can be done? Advances in Psychiatric Treatment, 14: 71-77.
Guidelines:
Baldwin, D. S., Anderson, I. M., Nutt, D. J., Allgulander, C., Bandelow, B., den Boer, J. A., ...
& Malizia, A. 2014. Evidence-based pharmacological treatment of anxiety disorders, post-
traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005
guidelines from the British Association for Psychopharmacology. Journal of
Psychopharmacology, 28(5), 403-439.

72
NICE: Generalised anxiety disorder and panic disorder in adults: management. NICE
guidelines [CG113].
Books:
Jacoby R, Oppenheimer C, Dening T. (eds.), 2008. The Oxford Textbook of Old Age Psychiatry.
Oxford University Press: Oxford. Chapter on anxiety disorders in older people.
Stahl, SM, 2014. Prescriber's Guide: Stahl's Essential Psychopharmacology, 6th edition
Cambridge Medicine.
Taylor, D., Barnes, T., Young, A., 2018. The Maudsley Prescribing Guidelines in Psychiatry, 13th
edition. Blackwell-Wiley, section on depression & anxiety).
World Health Organisation, 1992. ICD-10 : The ICD-10 Classification of Mental and Behavioural
Disorders : Clinical Descriptions and Diagnostic Guidelines. WHO

73
Session 8: Medico Legal Issues in Old Age Psychiatry
Learning Objectives
The overall aim of the session is for students to gain an overview of key legislation relating to
the care of older adults.
By the end of the sessions trainees should:
o Understand the interface between the MCA and MHA.
o Understand the principles to apply when assessing capacity, including the 2-stage test.
o Understand the principles behind Deprivation of Liberty Safeguards (DoLS).
o Understand the applicability of Guardianship.
o Gain an understanding of a Lasting Power of Attorney (LPA).
o Understand the principles of testamentary capacity.
Curriculum Links
Old Age Section of the MRCPsych Curriculum: 8.1, 8.2, 8.3, 8.5
Expert Led Session
A Consultant led session based on the learning objectives listed above.
Case Presentation
A case to be presented which highlights an interesting medico legal issue in a patient seen.
Please consider the learning objectives above.
Journal Club Presentation
Brenkel, M., Shulman, K., Hazan, E., Herrmann, N. and Owen, A.M., 2017. Assessing
Capacity in the Elderly: Comparing the MoCA with a Novel Computerized Battery of
Executive Function. Dementia and geriatric cognitive disorders extra, 7(2), pp.249-256.
Cole, J., Kiriaev, O., Malpas, P. and Cheung, G., 2017. ‘Trust me, I’m a doctor’: a
qualitative study of the role of paternalism and older people in decision-making when
they have lost their capacity. Australasian Psychiatry, 25(6), pp.549-553.

74
De Simone, V., Kaplan, L., Patronas, N., Wassermann, E. M., & Grafman, J. 2017. Driving
abilities in frontotemporal dementia patients. Dementia and geriatric cognitive
disorders, 23(1), 1-7.
Hinsliff‐Smith, K., Feakes, R., Whitworth, G., Seymour, J., Moghaddam, N., Dening, T. and
Cox, K., 2017. What do we know about the application of the Mental Capacity Act (2005)
in healthcare practice regarding decision‐making for frail and older people? A
systematic literature review. Health & social care in the community, 25(2), pp.295-308.
‘555’ Topic (5 slides with no more than 5 bullet points per slide)
Legal aspects of covert medication
Lasting power of attorney - details of the application process.
MCQs
1. Which is of the following is not a core principle of MCA 2005
A. Everyone is assumed to have capacity
B. All Practical steps needs to be taken to help the person to make the decision
C. Any decision made on behalf of a person lacking capacity should be in their best interests
D. Person cannot make a unwise decision
E. Decision made on behalf of a person lacking capacity should be least restrictive
2. A person should be able to do the following to be able to make a decision:
A. Understanding the information relevant to the decision
B. Retain the information
C. Weighing up the pros and cons of the decision
D. Communicate the decision
E. All of the above
3. Lasting Power of Attorney (LPA) can potentially cover the following area:
A. Property
B. Finances

75
C. Health care decisions
D. Personal welfare decisions such as where a person lives
E. All of the above
4.Which of the following is false regarding the legal rights of an attorney with a LPA for healthcare
decisions:
A. Cannot consent to or refuse treatment if the donor has capacity to make the particular healthcare decision
B. Cannot make a decision relating to life-sustaining treatment if it is not explicitly specified in LPA
C. Cannot demand medical treatment that healthcare staff do not believe is necessary or appropriate
D. Cannot consent or refuse treatment if donor is detained under the Mental Health Act
E. Need not always make decisions in the donor’s best interests.
5. The following are true about Deprivation of Liberty Safeguards(DOLS) except:
A. The safeguards apply to only people who lack capacity
B. A DOLS authorisation in itself authorises specific treatment
C. A person can only be deprived of their liberty if it’s in their best interests to protect them from harm
D. DOLS can only be authorised if it is a proportionate response to the likelihood and seriousness of the harm
E. Applies only to people aged 18 and over
Additional Resources / Reading Material
Websites
RCPsych CPD modules
Competence, capacity and decision-making ability in mental disorder, mental Capacity Act
2005: Part 1, mental Capacity Act 2005: Part 2
Other resources:
39 Essex Street http://www.39essex.com/practice-area/court-of-protection-barristers/
GMC – Capacity & consent tool. http://www.gmc-uk.org/news/29321.asp
Lucy Series https://thesmallplaces.wordpress.com/author/lucyseries/ (interesting discussion and commentary on all things related to legal capacity and human rights)

76
Mental Capacity Act Code of Practice (https://www.gov.uk/government/publications/mental-capacity-act-code-of-practice).
Journal Articles:
Abdool, R., 2017. Covert medication: legal, professional, and ethical considerations. The Journal of Law, Medicine & Ethics, 45(2), pp.168-169.
Braye, S., Orr, D. and Preston-Shoot, M., 2017. Autonomy and protection in self-neglect work: the ethical complexity of decision-making. Ethics and Social Welfare, pp.1-16.
Jacoby, R., & Steer, P., 2007. How to assess capacity to make a will. British Medical Journal, 7611, 155
O'Shea, T., 2018. A civic republican analysis of mental capacity law. Legal Studies, 38(1), pp.147-163. http://eprints.whiterose.ac.uk/116359/
Royal College of Psychiatrists, 2004. College statement on Covert Administration of Medicines. Psychiatric Bulletin. 28(10), pp385-386
Wilson, S., & Pinner, G. 2013. Driving and dementia: a clinician's guide. Advances in psychiatric treatment, 19(2), 89-96.
Books and other resources:
Dalley, G., Gilhooly, M., Gilhooly, K., Harries, P. and Levi, M., 2017. Financial Abuse of People Lacking Mental Capacity: A Report to the Dawes Trust. https://bura.brunel.ac.uk/bitstream/2438/15255/1/Fulltext.pdf
Jacoby R, Oppenheimer C, Dening T. (eds.) 2000. The Oxford Textbook of Old Age
Psychiatry. Oxford University Press: Oxford. Chapters 41-44 cover capacity, legal
frameworks and driving in later life.
The Law Society. 2015. Deprivation of liberty: a practical guide. The Law Society. https://www.lawsociety.org.uk/support-services/advice/articles/deprivation-of-liberty/

77
Curriculum Mapping
Section Topic Covered by
LAP RAP LR
8.1 Demographic population changes in the UK and
Worldwide
8.2 District Service Provision
8.3 Specialist aspects of assessment of mental health in
older people
8.4 Psychological aspects of Physical Disease
8.5
Prevalence/ incidence, clinical features, differential
diagnosis, aetiology, management and prognosis of
the common disorders occurring in later life
8.6 Suicide and attempted suicide in old age
8.7 Psychiatric aspects of personality in old age
8.8 Psychotherapy with older adults
8.9 Bereavement and adjustment disorders
8.10 Sleep disorder in later life
8.11 Psychosexual disorders in old age
KEY: LAP = Local Educational Programme
RAP = Regional Academic Programme
LR = Learning Resources

78
CAMHS SEMESTER 3:
Session 1: Assessment in Child and Adolescent Psychiatry
Learning Objectives
Undertake assessments of children and young people; to communicate effectively with
children and young people across the age range; to take a developmental history; to
formulate and prepare a plan and identify appropriate interventions.
Describe how the emphasis of assessments in CAMHS may be different to that in Adult Mental
Health.
Curriculum Links
Child Psychiatry:
10.1 10.2 10.3 10.4 10.5 10.6
Expert Led Session
This should include consideration of room setting e.g. with appropriate toys and other
developmentally appropriate materials/approaches, the differences and similarities between
adult and child psychiatry, pointers on taking a developmental history, ICD 10, bio-
psychosocial formulation and risk assessment
Case Presentation
To highlight multi-disciplinary/multiagency nature of work (should include discussion of
school observation/assessment)
To highlight bio-psychosocial formulation
To highlight Multi-axial formulation in Child and Adolescent Psychiatry
Those trainees who are not currently in a CAMHS post should contact their local CAMHS team
for the suitable case for presentation.
Journal Club Presentation
Practitioner Review: Self-harm in adolescents, Ougrin D, Tranah T, Leigh E, Taylor L, Asarnow
JR. Journal of Child Psychology and Psychiatry, 2012, 53:4,337– 350, April 2012.

79
The Clinical Application of the Biopsychosocial Model in Mental Health: A Research Critique:
Álvarez, AS; Pagani, M; Meucci, P (2012) American Journal of Physical Medicine &
Rehabilitation, 2012, 91:13, S173–S180
‘555’ Topics (1 slide on each topic with no more than 5 bullet points)
Risk assessment domains and formulation
Local Safeguarding process and organisational structure
Conduct Disorder – Diagnostic Criteria /Management
MCQs
1. Patient should routinely have a neurological examination if they present with all except:
A. History of an episode of fainting
B. History of seizures
C. Developmental delay
D. Dysmorphic features
E. Abnormal gait
2. A physical risk assessment for patients with Anorexia Nervosa should include all except:
A. Assessment of BMI and weight
B. Assessment of heart rate
C. Assessment of temperature
D. Assessment of hydration status
E. Assessment of EEG abnormalities
3. During an assessment of a 14 year old patient with depression in primary care, which of the
following would prompt you to refer to tier 2 or 3 CAMHS:
A. Mild depression in those who have not responded to interventions in tier 1 after 2-3 months
B. Active suicidal plans
C. Referral requested by the young person
D. Moderate to severe depression
E. All of the above
4. Assessment of ADHD commonly include all except:
A. ADOS

80
B. School observations
C. History from parents/carers
D. Connors assessment
E. History from patient
5. Mental state examination of a 15 year old patient should include all the following except:
A. Assessment of appearance and behaviour
B. Family history
C. Assessment of speech
D. Assessment of insight
E. Assessment of cognition
6. The multi axial diagnostic formulation scheme of ICD 10 include:
A. Axis III: psychiatric disorder
B. Axis II: medical conditions
C. Axis IV: adaptive functioning
D. Axis I: psychiatric disorder
E. Axis VI: medical conditions
7. An assessment of a 3 year old with suspected Autistic Spectrum Disorder must include:
A. A home visit
B. A detailed mental state examination
C. Observation of the child interacting with others
D. All of the above A-C
E. None of the above A-C
8. CAMHS assessments in patients with speech delay should routinely include all except:
A. Family tree
B. Family history of ASD / Aspergers
C. Developmental history
D. Details of whether the patient had the combined MMR vaccine
E. Medical history
9. The presence of a disorder can be explained in terms of all except:
A. Predisposing factors
B. Precipitating factors

81
C. Perpetuating factors
D. Petulant factors
E. Protective factors
10. In regards to initial CAMHS assessment of children under 5 with speech delay:
A. You should not see them without the presence of their parent/carer in the room
B. You should aim to get the child sat down in a chair for the majority of the assessment
C. You should observe them playing and play too if appropriate
D. You should avoid difficult topics
E. You should use more directed questioning
Additional Resources / Reading Materials
Reading Resources
1. Managing Self Harm in Young People
http://www.rcpsych.ac.uk/files/pdfversion/CR192.pdf
2. Practice Parameters for the Psychiatric Assessment of Children and Adolescents. J. Am. Acad.
Child Ado/esc. Psychiatry. 1995,31:1386-1402. J. Am. Acad. Child Ado/esc. Psychiatry. 1997.36(10
Supplement):45-20S.
3. Practice Parameter for the Assessment of the Family. J. Am. Acad. Child
Adolesc. Psychiatry, 2007;46(7):922Y937
4. Wolpert, M., Ford, T., Trustam, E., Law, D.,Deighton, J., Flannery, H., and Fugard R. J. B. (2012)
Patient-reported outcomes in child and adolescent mental health services (CAMHS): Use of
idiographic and standardized measures, Journal of Mental Health, 21:2, 165-173
Books
Child and Adolescent Psychiatry. Robert Goodman and Stephen Scott. Third Edition, Wiley-
Blackwell
Child and Adolescent Psychiatry: A Developmental Approach. 4th ed. Jeremy Turk, Philip
Graham, Frank C Verhulst 2007. Oxford University Press
NICE clinical guideline 133 Self-harm: longer-term management Clinical case scenarios for
health and social care professionals

82
E-Learning
RCPsych TRon Module
1. Overview of child and adolescent psychiatry
Assessment and treatment of children and adolescents; disorders usually first diagnosed in
infancy, childhood and adolescence; developmental disabilities; effects of adult mental illness
on children and young people, including effects of maternal mental health; effect of
depression on parental functioning and interactions and impact on child development and
functioning; cultural variations in aetiology and management; short- and long-term effects of
negative life events on development and functioning e.g. maternal loss, child abuse, chronic
or life-threatening illness; interaction between psychiatric disorder and physical illness in
children and adolescents; physical presentation of psychiatric disorder and psychiatric
presentation of physical disorder.
(Syllabus: 10 – introduction, 10.1, 10.2, 10.5)
1. The neurological examination
The neurological examination is often approached with trepidation by psychiatrists but can be
done quickly and reliably with practice. The best approach is to keep doing them as often as
possible, but in order for them to be useful, and conducted without fear, it's advantageous to
have an understanding of what you are trying to achieve. In this podcast Professor Adam
Zeman, Professor of Cognitive and Behavioural Neurology at the University of Exeter Medical
School, explains to Dr Raj Persaud how to conduct a neurological examination.
http://www.psychiatrycpd.org/default.aspx?page=20900
Journal Articles
The Child and Adolescent Psychiatric Assessment (CAPA).
Angold A, Prendergast M, Cox A, Harrington R, Simonoff E, Rutter M.
Psychol Med. 1995 Jul;25(4):739-53.

83
Session 2: Attention Deficit Hyperactivity Disorder (ADHD)
Learning Objectives
Describe signs, symptoms and differential diagnosis of Attention Deficit Hyperactivity
Disorder, and treatment options.
Curriculum Links
ADHD:
10.1 10.2 10.3 10.6 10.7 10.8.3.1 10.8.3.2 10.8.3.3 10.8.3.4 10.8.3.5
Expert Led Session
This should consider aspects of assessment, formulation, evidence base, NICE guidelines of
assessment and intervention, differential diagnosis, co-morbidities, consequences of non-
treatment and impact on substance misuse.
Case Presentation
To highlight points in assessment, use of questionnaires, use of Quantified behavioural (Qb)
test, multisource information gathering, differential diagnoses and formulation.
Journal Club Presentation
Treatment of Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and Irritability:
Results From the Multimodal Treatment Study of Children With ADHD (MTA) Lorena
Fernandez de la Cruz, PhD, Emily Simonoff, MD, James J. McGough, MD, Jeffrey M. Halperin,
PhD, L. Eugene Arnold, MD, MEd, Argyris Stringaris, MD, PhD, MRCPsych J Am Acad Child
Adolesc Psychiatry 2015;54(1):62–70.
Long-Term Outcomes of ADHD: Academic Achievement and Performance L. Eugene Arnold1,
Paul Hodgkins2,3, Jennifer Kahle4, Manisha Madhoo5, and Geoff Kewley6. Journal of
Attention Disorders 1–13 © 2015 SAGE Publications
Study of user experience of an objective test (QbTest) to aid ADHD assessment and medication
management: a multi-methods approach
Charlotte L. Hall, Althea Z. Valentine, Gemma M. Walker, Harriet M. Ball, Heather Cogger,
David Daley, Madeleine J. Groom, Kapil Sayal and Chris Hollis

84
BMC PsychiatryBMC series – open, inclusive and trusted201717:66
https://doi.org/10.1186/s12888-017-1222-5© The Author(s). 2017
‘555’ Topics (1 slide on each topic with no more than 5 bullet points)
Medical treatment in ADHD, types of medication, pharmacokinetics, pharmacodynamics, side
effect profile.
Formal assessment tools in ADHD assessment; pros and cons.
NICE Guidelines for ADHD .
MCQs
1. A four year old boy is brought to clinic with his parents. They report that he is inattentive at
school, will not sit and play with his siblings at home and on one occasion let go of his mother’s hand
whilst shopping and ran out into the road. Following assessment and diagnosis, what would your
initial management step be?
A. Refer patient for individualised CBT
B. Refer family for Family Therapy
C. Refer family to parent training and education sessions
D. Commence 5mg methylphenidate daily, titrating up weekly until improvement is seen
E. None of the above
3. The parents of a 5 year old girl recently diagnosed with ADHD have cancelled their second group
parent training and education session. They tell you this is because their 11 year old son has learning
disabilities and is wheelchair bound. They have no extended family or close friends to help with child
care arrangements on the days required. What would you advise?
A. Offer to commence medication for the patient as they will not be able to attend the parent
training and education sessions
B. Offer to hold individualised parent training and education sessions on a day that would better suit
them
C. Discharge the family from your case load as they have missed two consecutive appointments
D. Ask them to contact children and family services to arrange child care whilst they attend the
training sessions
E. None of the above

85
4. You have assessed a 7 year old boy with suspected ADHD in clinic. You would like to get further
information about his behaviour in school from his teachers. Which of the following regarding
consent to discuss the case with school is correct?
A. You will need to document that you have obtained consent from the patient’s parents or carers
before you contact the school for information
B. You will need to document that you have obtained consent from the patient before you contact
school for information
C. You don’t need consent to request information with school
D. You don’t need consent to request information from school as long as you don’t discuss
treatment with them
E. You will need verbal consent from the patient’s parents or carers before you contact the school
for information
5. Following assessment of an 8 year old boy, you diagnose severe ADHD with severe impairment of
functioning in both social and academic domains. What would be your initial step in management?
A. Refer family to Family Therapy
B. Refer patient for CBT
C. Refer family to parent training and education
D. Commence the patient on medication
E. None of the above
6. You wish to complete a pre-drug treatment assessment on a 7 year old girl with diagnosed severe
ADHD. Which of the following is NOT routinely required?
A. Record of height and weight plotted on centile chart
B. ECG
C. Heart rate and blood pressure plotted on a centile chart
D. Mental health and social assessment
E. Assessment of cardiovascular symptoms
7. You have been seeing a 12 year old boy with ADHD. Parent training/education sessions proved
ineffective. With the parents’ consent you commenced the patient on low dose methylphenidate,
5mg daily. At the following review the methylphenidate is not working and the patient’s behaviour
continues to be impairing his social and academic functioning. You are happy that your diagnosis
remains correct. He does not describe any side effects on questioning. What would your next step in
treatment be?

86
A. Consider commencing low dose bupropion as an adjunct to methylphenidate
B. Consider stopping methylphenidate and commencing Atomoxetine
C. Stop medication and review diagnosis again
D. Consider stopping methylphenidate and commencing low dose dexamfetamine
E. Consider increasing the dose of methylphenidate
8. NICE guidance suggests that modified release preparations of methylphenidate should be
considered for all the following reasons, except:
A. Convenience
B. To increase adherence
C. To help in facilitating schools who cannot safely store medication
D. Patients with co-morbid tic disorder
E. Reducing stigma
9. ICD 10 diagnosis of hyperkinetic disorder includes all the following criteria, except:
A. Inattention, hyperactivity and/or impulsivity persistent for at least 3 months
B. Symptoms are pervasive across situations
C. Symptoms are not caused by other disorders such as autism or affective disorders
D. Symptoms cause impairment in social, academic or occupational functioning.
E. All of the above
10. Adverse effects of Methylphenidate can include all, except:
A. Raised blood pressure
B. Anorexia
C. Insomnia
D. Growth acceleration
E. Exaggeration of tic disorders
Additional Resources / Reading Materials
Books
Rutter's Child and Adolescent Psychiatry, Fifth Edition.
Sir Michael Rutter , Dorothy Bishop, Daniel Pine, Steven Scott , Jim S. Stevenson, Eric A.
Taylor, Anita Thapar

87
Child and Adolescent Psychiatry. Robert Goodman and Stephen Scott. Third Edition, Wiley-
Blackwell
Attention Deficit Hyperactivity Disorder” by Professor Russell Barkley.
E-Learning
Attention deficit hyperactivity disorder in children and adolescents. In this podcast Professor
Heidi Feldman, from the Stanford University School of Medicine, talks with Dr Raj Persaud on
attention deficit–hyperactivity disorder (ADHD) in children and adolescents; referring to her
recent clinical review of the disorder published in the New England Journal of Medicine.
http://www.psychiatrycpd.org/default.aspx?page=20527
Neurobiology of ADHD, by Dr Katia Rubia
http://www.psychiatrycpd.org/podcasts/neurobiologyofadhd.aspx
Guidelines
Attention deficit hyperactivity disorder (ADHD) (CG72)
http://www.nice.org.uk/guidance/index.jsp?action=byTopic&o=7281
Further Reading Resources
Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity
disorder: Update on recommendations from the British Association for Psychopharmacology Blanca
Bolea-Alamañac1, David J Nutt2, Marios Adamou3, Phillip Asherson4, Stephen Bazire5, David
Coghill6, David Heal7, Ulrich Müller8, John Nash9, Paramalah Santosh10, Kapil Sayal11, Edmund
SonugaBarke12 and Susan J Young2 for the Consensus Group
Journal of Psychopharmacology 1–25, 2014
Downloaded from jop.sagepub.com at University of Bristol Library on February 15, 2014

88
Session 3: Autism Spectrum Disorder (ASD)
Learning Objectives
Signs and Symptoms of Autism spectrum disorder including the triad of impairments
Diagnostic criteria for diagnosis of ASD including the DSM 5 and ICD 10
Causes of ASD and psychological theories of ASD including Theory of mind, Central
coherence deficit and executive function.
Interventions in ASD
Curriculum Links
Autism Spectrum Disorders:
10.8.8.1 10.8.8.2 10.8.8.3 10.8.8.4 10.8.8.5
Expert Led Session
To cover Aetiological theories of ASD, NICE guidelines in ASD, Interventions in ASD
Case Presentation
This should include detailed assessment which includes developmental history, information
from multiple sites and multiaxial formulation (ICD 10 or DSM 5 criteria used), cover signs and
symptoms, triad of impairment and interventions offered
Journal Club Presentation
Huerta, M., Bishop, S. L., Duncan, A., Hus, V., & Lord, C. (2012). Application of DSM-5 criteria
for autism spectrum disorder to three samples of children with DSM-IV diagnoses of
pervasive developmental disorders. American Journal of Psychiatry, 169(10), 1056-1064.
McPartland, J. C., Reichow, B., & Volkmar, F. R. (2012).
Risi, Lord, Gotham, Corsello, Chrysler et al. (Sept. 2006) Zwaigenbaum, L., Bryson, S., Lord,
C., Rogers, S., Carter, A., Carver, L., & Yirmiya, N. (2006). Combining Information from
Multiple Sources in the Diagnosis of Autism Spectrum Disorders. Journal of Am Academy of
Child & Adolescent Psychiatry, 45(9) 1094-1103

89
Berihun Assefa Dachew (a1), Abdullah Mamun (a2), Joemer Calderon Maravilla (a3) and
Rosa Alati Pre-eclampsia and the risk of autism-spectrum disorder in offspring: meta-analysis
(a3) Br J Psychiatry. 2018 Mar;212(3):142-147. doi: 10.1192/bjp.2017.27. Epub 2018 Jan 24.
Jonathan Green,a,d,* Tony Charman,e Helen McConachie,f Catherine Aldred,a,g Vicky
Slonims,h Pat Howlin,i Ann Le Couteur,f Kathy Leadbitter,a Kristelle Hudry,e Sarah Byford,j
Barbara Barrett,j Kathryn Temple,f Wendy Macdonald,c Andrew Pickles,b and the PACT
Consortium, Parent-mediated communication-focused treatment in children with autism
(PACT): a randomised controlled trial, Lancet. 2010 Jun 19; 375(9732): 2152–2160. doi:
10.1016/S0140-6736(10)60587-9
‘555’ Topics (1 slide on each topic with no more than 5 bullet points)
Interventions used in ASD and their evidence base to cover - One slide each for the following:
Behavioural intervention e.g. riding the rapids,
Speech and language interventions such as Early communication workshops, more than
words, talkability groups
Sleep disorders in ASD and interventions
Social Stories in ASD
MCQs
1. The M:F ratio of Childhood Autism is:
A. 1:1
B. 2:1
C. 3:1
D. 4:1
2. The prevalence of Autism Spectrum Conditions in a school based study in UK was:
A. 99 per 10,000
B. 70 per 10,000
C. 9 per 10,000
D. 1 per 10,000
3. The clinical features of Childhood Autism as described by Kanner include all the following except:
A. Autistic aloneness

90
B. Delayed or abnormal speech
C. An obsessive desire for sameness
D. Onset in the first one year of life
4. The following are true about the aetiology of Autism except:
A. Higher concordance among MZ twins.
B. Increased rate of perinatal complications.
C. Decreased brain serotonin levels
D. Condition is 50 times more frequent in the siblings of affected persons
5. Which of the following is false for Rett’s syndrome:
A. Occurs only in boys
B. Onset between the ages of 7 and 24 months
C. Often develop autistic features and stereotypies
D. X linked dominant disorder
6. The following is false for Seizures in Autism:
A. Can affect quarter of autistic individuals with generalised learning disability
B. Affects 5% of autistic individuals with normal IQ
C. In autistic individuals with normal IQ the seizure onset is usually in early childhood.
D. In autistic individuals with generalised learning disability the seizure onset is usually in early
childhood
7. The following is true about the epidemiology of Autism:
A. Prevalence is decreasing in recent years
B. Associated with high socio-economic status
C. More common in boys
D. No hereditary risk
8. All the following are first line support for a child with childhood autism except:
A. Communication skills workshop
B. Behavioural support
C. Counselling and advice to parents
D. Anti-psychotic medication.

91
9. The following can be used in the diagnosis of a child with Autism except:
A. Autism diagnostic Inventory (ADI)
B. Autism Diagnostic Observation Schedule (ADOS)
C. Social Responsiveness Scale (SRS)
D. Check list for Autism in Toddlers (CHAT)
10. Which of the following drugs can be used in short term treatment of severe aggression in Autism
under specialist supervision:
A. Risperidone
B. Diazepam
C. Lorazepam
D. Promethazine
Additional Resources / Reading Materials
Books
Rutter's Child and Adolescent Psychiatry, Fifth Edition.
Sir Michael Rutter , Dorothy Bishop, Daniel Pine, Steven Scott , Jim S. Stevenson, Eric
A. Taylor, Anita Thapar
Child and Adolescent Psychiatry. Robert Goodman and Stephen Scott. Third Edition,
Wiley-Blackwell
E-Learning
Autism, ethnicity and maternal immigration
Autism has been the subject of intense public and professional attention in recent years.
One of the biggest questions is what causes it. Like the discoveries made about
schizophrenia in the late 20th century, we are learning that autism too has genetic and
environmental determinants. Here Dr Daphne Keen discusses her paper (Keen et al, 2010)
which attempts to answer the question of whether maternal immigration and ethnicity,
together or in tandem, are implicated as being risk factors in young children who develop
autism.
http://www.psychiatrycpd.org/default.aspx?page=10591
Guidelines

92
Autism in children and young people (CG128)
http://www.nice.org.uk/guidance/index.jsp?action=byTopic&o=7281
Useful handbook
www.nas.org.uk

93
Session 4: Anxiety and Depression
Learning Objectives
Describe how anxiety and depression may present and it’s management in childhood and
adolescence and the relevance of somatisation as a communication between children and
their carers.
Curriculum Links
Anxiety disorders including OCD:
10.8.4.1 10.8.4.2 10.8.4.3 10.8.4.4 10.8.4.5
Affective Disorders:
10.8.5.1 10.8.5.2 10.8.5.3 10.8.5.4 10.8.5.5
Expert Led Session
Variable presentations (with reference to developmental age) and differential diagnosis of
anxiety and depression, treatment options, evidence base for treatment, NICE guidelines for
depression.
Case Presentation
Key diagnostic features (anxiety/depression/mixed disorder) and highlight aspects of
management (including risk assessment) with reference to NICE guidance
Journal Club Presentation
Outcomes of Childhood and Adolescent Depression Richard Harrington, Hazel Fudge,
Michael Rutter, Andrew Pickles, Jonathan Hill, Arch Gen Psychiatry. 1990;47(5):465-473.
Fluoxetine, Cognitive-Behavioral Therapy, and Their Combination for Adolescents With
Depression Treatment for Adolescents With Depression Study (TADS) Randomized Controlled
trial; Treatment for Adolescents With Depression Study (TADS) Team -
JAMA. 2004;292(7):807-820.
Walkup, J.T., Albano, A.M., Piacentini, J., Birmaher, B., Compton, S.N., Sherrill, J.T., Ginsburg,
G.S., Rynn, M.A., McCracken, J., Waslick, B. and Iyengar, S., 2008. Cognitive behavioral

94
therapy, sertraline, or a combination in childhood anxiety. New England Journal of Medicine,
359(26), pp.2753-2766.
Emslie GJ1, Mayes T, Porta G, Vitiello B, Clarke G, Wagner KD, Asarnow JR, Spirito A, Birmaher
B, Ryan N, Kennard B, DeBar L, McCracken J, Strober M, Onorato M, Zelazny J, Keller M, Iyengar
S, Brent D. Am J Psychiatry. 2010 Jul;167(7):782-91. Treatment of Resistant Depression in
Adolescents (TORDIA): week 24 outcomes.
‘555’ Topics (1 slide on each topic with no more than 5 bullet points)
Evidence based psychological interventions in the treatment of anxiety disorders and
depression in children and adolescents.
Medication treatment in Anxiety and Depression and cautions
Nice Guidance Anxiety Disorders/Depression
MCQs
Anxiety
1. Treatment of social anxiety disorder in children and young people include all except which?
A. Group CBT
B. Individualised CBT
C. Psychoeducation
D. Skills training for parents
E. Mindfulness based therapy
2. What percentage of children and adolescents in the UK have clinically significant anxiety
disorders?
A. 2-4%
B. 4-8%
C. 8-12%
D. 12-15%
E. 15-20%
3. The following regarding specific phobias are true, except:
A. Fear of animals peaks at 2-4 years of age
B. Fear of the dark peaks at 4-6 years of age
C. Fear of war is most common in adolescents

95
D. Fear of death peaks at 5-10 years of age
4. According to ICD10, separation anxiety can include all except:
A. Repeated nightmares involving separation
B. Preference to sleep away from home
C. School refusal
D. Getting up frequently at night to check on parents/carers
E. Persistent and unrealistic worry that harm will come to their parents/carers
5. The diagnosis of Generalised anxiety disorder in childhood includes all except:
A. Onset before 18 years of age
B. Multiple anxieties occurring across at least 2 situations
C. Feeling worn out and irritable
D. The anxiety must not be due to another condition or substance abuse
E. Occurring for over 12 months
Depression
1. The prevalence of depression in 11 – 15 year olds in the UK is:
A. 0.1% - 1%
B. 2% - 8%
C. 11% - 15%
D. 16% - 20%
E. 21 – 30%
2. A 12 year old girl is referred to the CAMHs team with symptoms of moderate – severe depression.
What is your first-line treatment?
A. Commence citalopram
B. Commence fluoxetine
C. Offer a specific psychological therapy
D. Admit to an inpatient unit
E. Refer back to GP for management of symptoms
3. The below are all risk factors for completed suicide except:
A. Previous suicide attempt

96
B. Presence of substance/alcohol abuse
C. Presence of psychiatric disorder
D. Strong religious beliefs
E. Lack of social support
4. The use of medication in adolescents who self-harm:
A. SSRIs is recommended for reducing self-harming behaviour
B. Flupentixol is recommended for reducing self-harming behaviour
C. Is always indicated when it occurs in the context of mental illness
D. There is no evidence that medication reduces self-harming behaviour
E. Risperidone is indicated in the presence of self-harming behaviour
5. Select the correct statement from the below regarding self-harming behaviour amongst
adolescents:
A. Is common under 10 years of age
B. In community surveys, it is described by 80% of the adolescent population
C. Is more common in girls than boys
D. The majority of adolescents who self-harm wish to kill themselves
E. Only around 75% of adolescents who self-harm seek help
6. Among adolescents who self-harm, risk factors for later suicide include all except:
A. Depression
B. Unclear reason for act of deliberate self-harm
C. Psychosis
D. Female gender
E. Male gender
7. Depression in children and adolescents can present in different ways. Please match the incorrect
statement:
A. Adults – change of appetite with associated weight loss or weight gain. Children – similar to adults
B. Adults – loss of confidence, self esteem. Children – similar to adults
C. Adults – somatic syndrome may or may not be present. Children – somatic complaints are
frequent in children
D. Adults – depressive mood for most of the day. Children – mood irritable or depressed

97
E. Adults – disproportionate self blame and feelings of excessive guilt or inadequacy. Children –
excessive or inappropriate guilt not usually present.
8. Please select the correct statement regarding suicide amongst children and adolescents in the UK:
A. Suicide is common under the age of 12 and gets progressively rarer after
B. There are roughly five suicides per million children aged 5 – 14 per year
C. Since the mid 1990’s suicide rates have increased by around 20% in both males and females
D. More female children than male children commit suicide
E. Most adolescent suicide are carefully planned in advance
9. You assess a 14 year old male who has self-harmed in the A&E department. All of the following
suggest serious suicidal intent except:
A. Extensive premeditation
B. Other people informed beforehand of his intention
C. Suicide note left
D. Carried out in isolation
E. He informed someone of his actions soon after the event
10. An 8 year old girl is referred to you. For the past month she has been performing poorly in
school, complains of being bored for most of the time, has run away from home on 3 occasions, and
has been taken to the GP by her mother due to generalised abdominal pain, for which no cause can
be found. She has a younger sibling who is 3 years old. Suggest the most likely diagnosis:
A. Factitious disorder
B. ADHD
C. Depression
D. Sibling rivalry disorder
E. Atypical autism
Additional Resources / Reading Materials
Books
Rutter's Child and Adolescent Psychiatry, Fifth Edition.
Sir Michael Rutter , Dorothy Bishop, Daniel Pine, Steven Scott , Jim S. Stevenson, Eric
A. Taylor, Anita Thapar
Child and Adolescent Psychiatry.
Robert Goodman and Stephen Scott. Third Edition, Wiley-Blackwell

98
E-Learning
Anxiety disorders in children
Approximately one in ten children suffer from anxiety disorders, and in this podcast
Professor Ronald Rapee gives a broad overview of the different kinds of anxiety disorders
common in children. He also discusses how anxiety disorders in children compare with those
in adults, and highlights the nature of findings from epidemiological studies. He talks about
some of the steps in diagnosis, and the aetiology behind anxiety disorders, including genetic
and behavioural factors. Treatment is also touched on as well as some of the pitfalls to
beware of when diagnosing and treating anxiety in children.
http://www.psychiatrycpd.org/default.aspx?page=4873
Guidelines
Depression in children and young people (CG28)
Self-harm (CG16)
Post-traumatic stress disorder (PTSD) (CG26)
Obsessive compulsive disorder (OCD) and body dysmorphic disorder (BDD) (CG31)
Social anxiety disorder: recognition, assessment and treatment01 [CG159]
http://www.nice.org.uk/guidance/index.jsp?action=byTopic&o=7281

99
Session 5: Attachment Disorder
Learning Objectives
Describe the concept of attachment and its relevance for the mental health of children and
young people.
To understand the relevance of attachment theory to emotional development, affect
regulation and relationships across the lifespan.
To understand the different classifications of attachment, the conditions that promote
healthy attachment or otherwise and the clinical relevance of failure to develop selective
attachments.
Curriculum Links
Attachment disorders:
10.8.1.1 10.8.1.2 10.8.1.3 10.8.1.4 10.8.1.5
Expert Led Session
Should cover assessment, diagnostic challenges and MDT approach in managing attachment
disorder. Can also discuss the role of specialist LAC services.
Case Presentation
To discuss key features in history and presentation and discuss overlap with intrinsic disorders,
such as ASD/ADHD.
Journal Club Presentation
Quasi-autistic patterns following severe early global privation. English and Romanian
Adoptees (ERA) Study Team. Rutter M1, Andersen-Wood L, Beckett C, Bredenkamp D, Castle
J, Groothues C, Kreppner J, Keaveney L, Lord C, O'Connor TG. J Child Psychol Psychiatry. 1999
May; 40(4): 537-49.
Specificity and heterogeneity in children's responses to profound institutional privation.
Rutter ML1, Kreppner JM, O'Connor TG; English and Romanian Adoptees (ERA) study team. Br
J Psychiatry. 2001 Aug; 179:97-103.
Genetic, environmental and gender influences on attachment disorder behaviours.Minnis H1,
Reekie J, Young D, O'Connor T, Ronald A, Gray A, Plomin R. Br J Psychiatry. 2007 Jun; 190:490-
5.
Annotation: Attachment disorganisation and psychopathology: new findings in attachment
research and their potential implications for developmental psychopathology in childhood

100
Green and Goldwyn Journal of Child Psychology and Psychiatry Volume 43, Issue 7, pages
835–846, October 2002
‘555’ Topics (1 slide on each topic with no more than 5 bullet points)
Evidence based interventions in attachment disorder
Risk factors for attachment disorder
Comorbid diagnosis in attachment disorder
MCQs
1. The biological basis of attachment behaviour is:
A. The child developing relationships with other children
B. The mother wanting to protect her child from any harm
C. The child seeking proximity to the attachment figure
D. The mother’s instinct to rear children
E. All of the above
2. Attachment theory has been developed by:
A. Freud
B. Bowlby
C. Skinner
D. Piaget
E. Klein
3. Fearfulness and “frozen watchfulness” are part of which ICD 10 diagnosis:
A. Generalised anxiety disorder
B. Phobic anxiety disorder
C. PTSD
D. Reactive attachment disorder
E. Paranoid personality disorder
4. Select a feature that does NOT form part of Reactive Attachment Disorder (ICD 10) but points
towards Pervasive Developmental Disorders:
A. Abnormal pattern of social responsiveness that improves if child is placed in normal rearing
environment

101
B. Aggressive responses towards their own or other’s distress
C. Restricted, repetitive interests and behaviours
D. Strongly contradictory social responses
E. None of the above
5. Reactive Attachment Disorder of early infancy and childhood (DSM V) and Reactive Attachment
Disorder of Childhood (ICD 10) share common diagnostic criteria. Which of the following is NOT a
diagnostic feature in ICD 10:
A. Developed before age of 5 years
B. Abnormal pattern of social responsiveness
C. Other emotional disturbances such as fearfulness, sadness
D. Pathogenic care
E. None of the above
6. Which of the following features is NOT part of Disinhibited Attachment Disorder of Childhood (ICD
10):
A. At age of 2 years it is usually manifest by clinging and diffuse, non-selectively focused attachment
behaviour
B. Early onset of diffuse attachments, continuing poor social interactions and lack of situation
specificity
C. Attention seeking behaviour often persists into middle and late childhood
D. Usually there is difficulty in forming close, confiding relationships with peers
E. Abnormal speech development including echolalia
7. Which of the following cognitive age ranges must a child reach to develop an attachment
relationship:
A. 2-5 months
B. 7-9 months
C. 2 years
D. 5 years
E. 7 years
8. What is the procedure called that assesses a child’s attachment behaviour:
A. Novel Situation Test
B. Attachment Assessment Procedure

102
C. Strange Situation Procedure
D. Mother - Infant Attachment Battery
E. None of the above
9. Symptoms of Reactive Attachment Disorder have to be present before which age:
A. 3 years
B. 9 months
C. 18 months
D. 8 years
E. 5 years
10. The current hypothesis is that Attachment Disorders develop as a result of:
A. Children having been brought up by a single parent
B. Children having had limited opportunities to form selected attachments
C. Children having received a vegetarian diet
D. Children having intrinsic difficulties in forming secure attachments
E. Children having a specific gene mutation
Additional Resources / Reading Materials
Books
Rutter's Child and Adolescent Psychiatry, Fifth Edition.
Sir Michael Rutter , Dorothy Bishop, Daniel Pine, Steven Scott , Jim S. Stevenson, Eric
A. Taylor, Anita Thapar
Child and Adolescent Psychiatry.
Robert Goodman and Stephen Scott. Third Edition, Wiley-Blackwell
E-Learning
Attachment and how it relates to psychiatry
Dr Helen Minnis discusses the issue of attachment in psychiatry and the importance of
attunement in the caregiving relationship, taking a look at the current controversies over
child care and giving guidance for psychiatrists on how to work with attachment difficulties.
http://www.psychiatrycpd.org/default.aspx?page=3301
Growing an Emotional brain: www.youtube.com/watch?v=fzn9OuBqKYs

103
Journal Articles
A review of interventions in the parent-child relationship informed by attachment theory.
Broberg AG. Acta Paediatr Suppl. 2000 Sep;89(434):37-42.
‘Making and Breaking of Affectional Bonds Bowlby BJPsych 1977 130: 201-10 and 421-431 –
classic paper.
Attachment theory and Psychiatric Disorder: in John Bowlby and Attachment theory: Jeremy
Holmes
Why Love Matters – Sue Gerhardt

104
Session 6: Assessment of Mental Health Problems in Child & Adolescents with Intellectual Disability (ID)
Learning Objectives
To understand the influence of developmental factors on the presentation and treatment of
psychiatric disorders.
To understand the principles and practice of assessment, diagnosis and treatment, including
therapeutic modalities, psychoactive medication and environmental manipulations of
patients presenting with intellectual disability
Curriculum Links
Intellectual Disability:
13.1 13.2.1 13.2.2 13.3
Expert Led Session
Should cover assessment and the role of other professionals (OT, LD nurses, LD psychologist)
and specialist schools. Evidence based management strategies.
Case Presentation
To cover presentation and assessment of mental health problems of a child or young person
with ID; including how these differ from the non ID population and management strategies
(environmental, psychological and medical).
Those trainees who are not currently in a CAMHS post should contact their local CAMHS team
for the suitable case for presentation. Specifically you should identify which Consultants see
Children with Learning Disabilities, so an appropriate case can be identified well in advance
Journal Club Presentation
Einfeld SL, Ellis LA, Emerson E (2011) Comorbidity of intellectual disability and mental
disorder in children and adolescents: A systematic review. Journal of Intellectual and
Developmental Disability 36 (2) pp137-143.
Chadwick et al, (2008). Factors associated with the risk of behaviour problems in adolescents
with severe intellectual disabilities. Journal of Intellectual Disability research 52, (10),864-
876.

105
‘555’ Topics (1 slide on each topic with no more than 5 bullet points)
Cognitive assessment tools in ID (child)
Child Development assessment tools in paediatrics
Approaches to assessment in children and young people with limited communication
MCQs
1. People with intellectual disability have previously been classified as:
A. Mentally retarded
B. Learning disabled
C. Sub-normals
D. Imbeciles
E. All of the above
2. Intellectual disabilities are defined by which 3 core criteria?
A. Lower intellectual ability
B. Onset during childhood
C. Onset before the age of 8
D. Significant impairment of social or adaptive functioning
E. IQ scores are not fixed throughout life
3. Which of the following are generally accepted ranges (ICD-10, DSM-IV) for severity of ID (choose
4)?
A. Mild (IQ 50-70)
B. Mild (IQ 70-90)
C. Moderate (IQ 50-70)
D. Moderate (IQ 35-50)
E. Severe (IQ 20-35)
F. Severe (IQ 25-50)
G. Profound (IQ below 25)
H. Profound (IQ below 20)
4. Which of the following 2 statements are true?
A. Mild ID accounts for approximately 80% of children with ID.
B. Approximately 50% of children with ID have moderate severity.

106
C. Severe ID accounts for approximately 7% of the ID group.
D. Profound ID affects 10% of children with ID.
5. The prevalence and incidence of ID varies according to gender, age, ethnicity and socioeconomic
circumstances. Which statement is false?
A. Studies generally report a female predominance in LD
B. Increased maternal age is likely to lead to an increase in incidence of LD
C. Ethnicity influences prevalence and incidence levels in ID due to the associated links with poverty,
access to healthcare, and communications barriers amongst other factors
D. Lower socioeconomic position is associated with higher prevalence of mild and moderate LD, but
not severe LD.
6. Psychiatric illnesses frequently exist comorbidly with ID. Which of the following statements is
false?
A. Prevalence of psychiatric co-morbidity ranges from 30-70%
B. There is often over diagnosis of co-morbid psychiatric conditions
C. Practically all categories of mental illness are represented in the ID population
D. Co-morbid psychiatric problems can vary and change with age
7. Match the following co-morbid problems with the age group they are most likely to present in:
1. Eating and sleep disorders A. Adolescents
2. Self-injury B. Very young children
3. ADHD C. School age children
8. Which one of the following psychiatric conditions is not generally associated with LD?
A. Attention deficit hyperactivity disorder
B. Mood disorders
C. Anxiety disorders
D. Psychotic illness
E. Obsessive compulsive disorder
F. Anorexia nervosa
G. Autistic spectrum disorder
9. Behavioural analysis involves which ABC?
A. Antecedents

107
B. Awareness
C. Boundaries
D. Behaviour
E. Consequences
F. Circumstances
10. Which statement about management of ID is inaccurate?
A. Medications are commonly under-prescribed when managing challenging behaviour associated
with ID.
B. Behavioural techniques are useful in managing ID
C. Families provide the majority of support for most people with ID
D. Social services provide the majority of support for people with ID outside of families
Additional Resources / Reading Materials
Books
Rutter's Child and Adolescent Psychiatry, Fifth Edition.
Sir Michael Rutter , Dorothy Bishop, Daniel Pine, Steven Scott , Jim S. Stevenson, Eric A. Taylor,
Anita Thapar
Child and Adolescent Psychiatry.
Robert Goodman and Stephen Scott. Third Edition, Wiley-Blackwell
Cerebra resources
http://w3.cerebra.org.uk/research/research-papers/self-injurious-behaviour-in-children-with-
intellectual-disability/
Journal Articles
Developing mental health services for Children and Adolescents with Learning Disability: A
toolkit for clinicians
http://www.rcpsych.ac.uk/pdf/devmhservcaldbk.pdf
Mental health of children with learning disabilities. Pru AllingtonSmith, Advances in
Psychiatric Treatment, 2006, vol. 12, 130–140.
Nice Guidelines

108
Challenging behaviour and learning disabilities: prevention and interventions for people with learning
disabilities whose behaviour challenges
https://www.nice.org.uk/guidance/ng11
Session 7: Eating Disorders
Learning Objectives
To understand the principles and practice of assessment (including psychiatric comorbidity),
diagnosis (including classification) and treatment, (therapeutic modalities, use of psychoactive
medication) in patients presenting with Eating disorders in childhood and adolescence
To understand the physical sequelae of Eating Disorders, medical management and paediatric
liaison
To understand the role of other key professional (e.g. dietician, therapists)
To understand how services are configured for the management of Eating disorders
Curriculum Links
Eating disorders:
10.8.7.1 10.8.7.2 10.8.7.3 10.8.7.4 10.8.7.5
Expert Led Session
To discuss assessment, including physical examination and management with reference to
NICE and Junior MARSIPAN Guidance and MDT management.
Case Presentation
To cover the key diagnostic features, with reference to ICD10/DSMV – including physical
examination – calculation of BMI, %weight/height ratio and plotting on centile charts.

109
Journal Club Presentation
Gowers SG1, Clark A, Roberts C, Griffiths A, Edwards V, Bryan C, Smethurst N, Byford S,
Barrett B.
Clinical effectiveness of treatments for anorexia nervosa in adolescents: randomised
controlled trial. Br J Psychiatry. 2007 Nov;191:427-35.
Loeb, Katharine L, and Daniel le Grange Family-Based Treatment for Adolescent Eating
Disorders: Current Status, New Applications and Future Directions. International journal of
child and adolescent health 2.2 (2009): 243–254.
‘555’ Topics (1 slide on each topic with no more than 5 bullet points)
Signs, symptoms and prevention of re-feeding syndrome.
Therapeutic interventions for eating disorders in children and young people
MARSIPAN Guidelines physical risk assessment in eating disorders
MCQs
1. When a child with anorexia nervosa refuses treatment that is deemed essential what do the
National Institute of Clinical Excellence recommend?
A. The Mental Health Act should not be used where parents give their consent
B. Parental consent should be relied upon in cases of persistent refusal
C. A second opinion from an eating disorders specialist should be considered only as a last resort
D. If parents also refuse the treatment, the Mental Health Act should be applied
E. The Children’s Act should be considered under circumstances where parents also refuse
treatment
2. What is the approximate ratio of girls to boys with a diagnosis of any Eating Disorder in the UK?
A. 5:1
B.10:1
C.15:1
D.20:1
E. 25:1
3. Which of the following is true?
A. In children, BMI is a stable measure of severity of Anorexia Nervosa

110
B. Children with Anorexia Nervosa can present with healthy weight
C. NICE recommend low dose fluoxetine for the treatment of BN
D. During treatment patients with Anorexia nervosa should be aiming for weight gain of more than 2
kg per week
E. Oestrogen administration should not be used to treat bone density problems in children
4. What medication do NICE recommend for Bulimia Nervosa?
A. Fluoxetine
B. Olanzapine
C. Venlafaxine
D. Methylphenidate
E. Mirtazepine
5. Which of the following is not a criterion for diagnosis of Anorexia Nervosa according to ICD10?
A. Endocrine dysfunction
B. Fear of fatness
C. Over-exercise
D. Food restriction
E. Weight more than 15% below expected weight for age and height
6. All of the following are often present in both Bulimia Nervosa and Anorexia Nervosa except:
A. Food restriction
B. Self induced vomiting
C. Low weight
D. Purging
E. Episodes of overeating
7. Which of the following is a necessary early treatment for life threatening low weight in a young
person with an eating disorder?
A. Feeding high calorie meals
B. Thiamine replacement
C. NG tube feeding
D. CBT
E. Psychotropic medication

111
8. Which of the following are features of anorexia nervosa (1 or more)?
A. Low FSH, LH an Oestradiol
B. Shortened QT
C. Delayed gastric emptying
D. Reduced Growth Hormone
E. Low T3, normal TSH
F. Normocytic, normochromic anaemia
9. Which of the following are true about the long term complications of Anorexia Nervosa?
A. Pubertal delay is common
B. Osteopenia and osteoporosis are less frequent in children and adolescents than in adults
C. Catch up growth can occur with nutritional restoration
D. Hormone replacement is recommended for teenagers with Anorexia
E. Weight gain and the establishment of healthy eating habits usually results in restoration of
menstruation
10. Which of the following are true regarding the prognosis of Eating Disorders:
A. Bulimia has a worse prognosis than anorexia nervosa
B. Vomiting in Anorexia Nervosa is a predictor if poor prognosis
C. The 30 year mortality rate in women with Eating Disorders has been found to be 20%
D. The mortality rate for Eating Disorders is greater than for psychiatric in patients
E. Some bone loss experienced in Anorexia Nervosa is irreversible
Additional Resources / Reading Materials
Books
Clinical topics in Child and Adolescent Psychiatry, Sarah Huline-Dickens RCPsych 2014
Seminars in Child and Adolescent Psychiatry (second edition) Edited by Simon Gowers, Royal
college of Psychiatrists UK, Seminar Series
Wiley: Handbook of Eating Disorders, 2d Edition Janet Treasure (Editor), Ulrike
Schmidt (Editor), Eric van Furth (Editor) February 2003 ISBN: 978-0-471-49768-4

112
E-Learning
Psychological treatments for children and adolescents with eating disorders: In this
podcast, Professor Simon Gowers gives an overview of the different psychological
therapies available for children and adolescents with eating disorders, discussing in some
detail family therapy, interpersonal therapy and cognitive behavioural therapy
http://www.psychiatrycpd.org/default.aspx?page=8284
Additional resources
Cr189. MARSIPAN: management of really sick patients with anorexia nervosa (2nd edn)
www.Rcpsych.ac.uk
Eating disorders (CG9)
http://www.nice.org.uk/guidance/index.jsp?action=byTopic&o=7281
Session 8: Legal Aspects of Child & Adolescent Psychiatry
Learning Objectives
Have an understanding of broad legal frameworks and more specific aspects of the Mental Health Act,
Mental Capacity Act, Children Act with respect to children and how the law interacts with children
including issues relating to confidentiality, consent, care and treatment and safeguarding
Curriculum Links
This session overlaps with aspects of the following Individual Learning Objectives as outlined
in the competency based Curriculum for Core Training (2013):
ILO 1b, 3c, 4b,4c,4d,6a,17a,17b,17c,18a
Expert Led Session
To cover: informed consent; assessment of competence; Mental Health Act; Mental Capacity
Act; Children and Families Act.

113
Case Presentation
To cover: parental responsibility; consent; assessment of competence; and consideration of
legal frameworks in Child and Adolescent Psychiatry
Examples:
15 year old presents following overdose and refuses investigation and/or treatment
Use of The Mental Health Act in Anorexia Nervosa
“Zone of parental control” – treatment of young person under 16, with parental
agreement.
Challenges in treatment of young person over 16, at risk of deliberate self-harm,
refusing any disclosure to carers (parents)
Safeguarding aspects of a clinical case: actions taken in response to
disclosures/raising concerns.
Journal Club Presentation
Competence and consent to treatment in children and adolescents. Mike Shaw, Advances in
Psychiatric Treatment. 2001, vol. 7, pp. 150–159
Seeking clarity in the twilight zone: Commentary on Adolescent decision-Making and the zone
of parental control. Aaron K. Vallance Advances in Psychiatric Treatment, 2014 20:151-152
Decision-making about children’s mental health care: ethical challenges. Moli Paul, Advances
in Psychiatric Treatment, 2004, vol 10, 301-311
‘555’ Topics (1 slide on each topic with no more than 5 bullet points)
Parental responsibility and Children Act relevant to Looked After Children
Mental Capacity Act – Key Principles and relevance to care of Young people (under 18)
Capacity Assessment and Gillick Competence – Key principles.
Safeguarding: How to raise concerns
Safeguarding: Organisational Structures (National/Local);(Trust Procedures/Regional
Procedures)
What are Serious Case Reviews: What are these?
MCQs
1. The Mental Health Act (1983, amended 2007) applies to which of the following age groups:

114
A. 16 and over
B. 18 and over
C. 16 – 65
D. 18 – 65
E. All age groups
2. A 15 year old boy, with a full understanding of the risks/benefits of treatment, consents to
treatment for ADHD. This can be offered under the framework of:
A. The Mental Health Act
B. The Children’ Act
C. Gillick competence
D. The Mental Capacity Act
E. The Family Reform Act
3. What is the definition of a child in UK child protection guidance?
A. Anyone under the age of 18
B. Anyone under the age of 16
C. Anyone under the age of 14
D. Anyone under the age of 18 in full-time education
E. Anyone under the age of 16 in full-time education
4. Which of these groups of people would not automatically qualify for Parental Responsibility (PR)
under The Children Act (1989)?
A. Mothers
B. Fathers
C. Adoptive parents
D. People with special guardianship
E. An individual with an order from a Family Court
5. A 14 year old girl has delirium secondary to a urinary tract infection, and has refused IV antibiotics
although has allowed nurses to site a cannula. She does not have capacity to make decisions
regarding this treatment, with her delirium interfering with her ability to understand information.
What would be the most likely legal framework used to treat her in this situation?
A. The Mental Capacity Act
B. The Mental Health Act

115
C. Gillick competence
D. The Family Reform Act
E. Consent from an individual with Parental Responsibility
6. Which of the following difficulties experienced by young people does NOT count as a mental
disorder under the terms of the Mental Health Act?
A. Anorexia Nervosa
B. Learning Disability
C. Autism Spectrum Disorder
D. Alcohol dependence
E. Personality Disorder
7. What age group can be treated under the Mental Capacity Act:
A. Any age group
B. Any age group if the person with Parental Responsibility is unavailable
C. 14 and over
D. 16 and over
E. 18 and over
8. Which of the following is NOT relevant when considering the compulsory treatment of 16-18 year
olds?
A. Deprivation of liberty
B. The zone of parental control
C. Consent of the person with parental responsibility
D. Gillick competence
E. The Mental Health Act
9. Which of the following would NOT be used when considering IV rehydration for a 14 year old with
Anorexia Nervosa?
A. The Mental Health Act
B. Treatment with consent from the person with Parental Responsibility
C. Consent from a child with Gillick competence
D. The Mental Capacity Act
E. Emergency treatment under common law

116
10. There are circumstances in which the confidentiality young people can expect may have to be
breached, to the extent of informing those with parental responsibility.
Which of the following is NOT an important factor in making this decision?
A. The young person’s age and developmental level
B. The severity of any mental disorder
C. The closeness of the relationship with the parents
D. The presence of an Autism Spectrum Disorder
E. The degree of care and protection required
Additional Resources / Reading Materials
Books
Rutter's Child and Adolescent Psychiatry, Fifth Edition.
Sir Michael Rutter , Dorothy Bishop, Daniel Pine, Steven Scott , Jim S. Stevenson, Eric A. Taylor,
Anita Thapar
Child and Adolescent Psychiatry.
Robert Goodman and Stephen Scott. Third Edition, Wiley-Blackwell
Clinical topics in Child and Adolescent Psychiatry, Sarah Huline-Dickens RCPsych 2011
E-Learning
Seclusion
In this telephone interview, Dr Stephen Elsom talks from Australia on the topical issue of
seclusion as an intervention for containing uncontrolled, disturbed behaviour of psychiatric
patients. He discusses the research evidence regarding the use of seclusion and current
thinking surrounding this practice. He also talks about methods that can be helpful to reduce
the rate of seclusion used as an intervention.
http://www.psychiatrycpd.org/default.aspx?page=4302
Guidelines
Mental Health Law Online
http://www.mentalhealthlaw.co.uk/Children_and_mental_health_law
Antisocial behaviour and conduct disorders in children and young people (QS59)

117
http://www.nice.org.uk/guidance/index.jsp?action=byTopic&o=7281
A Positive and Proactive Workforce: Guidance on reducing restrictive practice in clinical and
other settings. DOH
http://www.skillsforcare.org.uk/Documents/Topics/Restrictive-practices/A-positive-
and-proactive-workforce.pdf
RCPsych CPD online
http://www.psychiatrycpd.co.uk/learningmodules/ethicalandlegalchallenges-1.aspx

118
FORENSIC SEMESTER 3:
Session 1: Psychiatry and the Criminal Justice System
Learning Objectives
To develop an understanding of the structure and organisation of the criminal justice
system
To develop an understanding of the mental health of prisoners and understand the
complexities of their treatment
To develop an understanding of the structure and organisation of secure psychiatric
services and the different levels of security
To develop an understanding of the framework around the management of mentally-
disordered offenders
Curriculum Links
12.2 Psychiatry and the criminal Justice System
12.2.1 The role of the psychiatrist in the assessment of mentally disordered offenders:
during arrest, prior to conviction; prior to sentencing
12.3 Practising psychiatry in a secure setting
12.3.1 The role of security in a therapeutic environment
12.3.2 The essential components of a forensic service
12.3.3 Knowledge of the prevalence of psychiatric disorder in prison populations,
suicide in prisoners and psychiatric treatment in prison settings
12.3.4 Risk management planning in forensic psychiatric practice
12.3.5 Managing mentally disordered offenders discharged into the community
Expert Led Session
An introduction to the criminal justice system. To include:
Police detention and diversion
Prison structure and organisation and prison categories
Mental health care in prison
Pathways into secure settings
MAPPA
Case Presentation
Case presentation on ‘progression through the criminal justice system to hospital’.

119
If trainee has a suitable case of a mentally-disordered offender then they may present
this.
The trainee can come to the Edenfield Centre where a suitable case can be found for
them – to access case notes and / or meet patient (if appropriate)
Journal Club Presentation
Please select one of the following papers:
Fazel S, Fiminska Z, Cocks C & Coid J, Patient outcomes following discharge from
secure psychiatric hospitals: a systematic review and meta-analysis, BJPsych 2016,
208: 17 – 25
http://www.ncbi.nlm.nih.gov/pubmed/26729842
Fazel S & Baillargeon J, The health of prisoners, Lancet 2011 377: 956 – 65
http://www.ncbi.nlm.nih.gov/pubmed/21093904
Shaw J, Baker D, Hunt IM et al, Suicide by prisoners: national clinical survey, BJPsych
2004, 184: 263 – 7 http://www.ncbi.nlm.nih.gov/pubmed/14990526
Bhui K, Ullrich S, Kallis C & Coid J, Criminal justice pathways to psychiatric care for
psychosis, BJPsych 2015, 1 – 7
http://bjp.rcpsych.org/content/early/2015/11/09/bjp.bp.114.153882
‘555’ Topic (5 slides with no more than 5 bullet points)
Please select one topic:
Relational security
Procedural security
Structural security
Levels of security – high / medium / low
Mental health in reach teams
MCQs
1. What is the relative risk of psychosis in prisons compared to the general population?
A. 5
B. 10

120
C. 20
D. 100
E. 2
2. How many homicide offenders have active psychiatric symptoms at the time of
committing the homicide?
A. 1 in 10
B. 1 in 5
C. 1 in 3
D. 1 in 2
E. 1 in 4
3. The rate of suicide is highest in:
A. Service users in the community
B. Sentenced prisoners
C. Service users in general psychiatric wards
D. Older prisoners facing long sentences
E. Remand prisoners
4. Which is the most common psychiatric condition in prisoners?
A. Depression
B. Personality disorder
C. Psychopathy
D. Psychosis
E. Neurosis
5. What is the prevalence of major depression in male prisoners?
A. 10%
B. 12%
C. 25%
D. 3.7%
E. 50%
EMI Questions
Mental Health Act:

121
A. Section 35
B. Section 36
C. Section 37
D. Section 38
E. Section 45A
F. Section 47 / 49
G. Section 48 / 49
H. Section 41
Match the description to the correct section under part III Mental Health Act 1983:
1. Interim Hospital Order
2. Removal to hospital of a sentenced prisoner
3. Remand to hospital for a report
4. Hospital direction and limitation direction
5. Removal to hospital of an un-sentenced prisoner
6. Hospital order
7. Restriction Order
8. Remand to hospital for treatment
Mental Health Act:
A. Section 35
B. Section 36
C. Section 37 +/- 41
D. Section 38
E. Section 45A
F. Section 47 / 49
G. Section 48 / 49
For each of the following scenarios, which section of the Mental Health Act 1983
would be most appropriate to admit the patient under?
1. Bob is 2 years into a 17 year sentence for armed robbery. Whilst in prison he becomes
unwell – he worries that the prison officers are poisoning his food, believes there are

122
cameras in his cell and has become aggressive and violent. He refuses to accept
treatment because he believes it is part of the conspiracy to poison him.
2. Sharon has been found guilty of burglary and is in HMP anywhere. She reports
experiencing distressing command hallucinations to harm herself and others. She is being
cared for on the hospital wing and has attempted to hang herself. Treatment is ineffective.
3. Peter kills his next door neighbour because he believes that he is the devil and was
planning to harm his children. He experienced command hallucinations from God
instructing him to do so. He goes to Court, where it is accepted that Peter suffers from
paranoid schizophrenia and psychiatrists recommend admission to hospital. However he
is found guilty of murder.
4. Annabelle has a known history of bipolar affective disorder. She stopped taking her
medication and during a manic episode set fire to her flat. This is her fourth fire-setting
episode when she has been manic. She frequently disengages from her CMHT and stops
taking her medication. You are of the opinion that she requires admission to hospital to
stabilise her mental state and complete some work around her fire-setting and
compliance. Which section would you recommend to the Court?
5. Simon is a member of the Jelly Baby Street gang. He has an extensive criminal record
with offences for violence, theft, carrying weapons and possession of illicit substances. He
is not known to mental health services. He has been convicted of a section 18 wounding
with intent (GBH) after he stabbed a rival gang member in the face for giving him a funny
look. Whilst on remand he develops an acute psychotic illness during which he becomes
aggressive as he believes that the dentist has planted a monitoring device in his teeth. He
has removed several teeth looking for this. You believe he should be admitted to hospital
and are asked to prepare a court report for sentencing. Which section would you
recommend?
6. Sandeep has appeared in court charged with assault, for which she is on bail. She has
a known history of schizoaffective disorder and is showing signs of relapse. She does not
engage with the community team when unwell and will not accept treatment voluntarily.
She won’t engage in assessments as to whether her offence was related to her mental
disorder. You are of the opinion that she requires admission to hospital urgently.

123
Additional Resources / Reading Materials
Books
Chapters 3, 5 & 24 in ‘Forensic Psychiatry: Clinical and ethical issues’ Gunn J & Taylor P,
(2013) CRC Press
Chapters 1, 2, 3, 17 & 18 in ‘Practical Forensic Psychiatry,’ Clark T & Rooprai DS (2011) Hodder
Arnold
Chapters 8 & 17 in ‘Oxford Specialist Handbook: Forensic Psychiatry,’ Eastman N, Adshead G,
Fox S et al (2012) Oxford Medical Publishing
E-Learning
RCPsych CPD online: ‘Suicides in prison’
Journal Articles
Birmingham L (2001) Diversion from custody. Advances in Psychiatric Treatment 7: 198 – 207
Birmingham L, Gray J, Mason D et al (2000) Mental illness at reception into prison. Criminal
Behaviour and Mental Health 10(2); 77 - 87
Coid JW (1998) Socio-economic deprivation and admission rates to secure forensic services.
Psychiatric Bulletin 22: 294 – 297
Coid JW, Hickey N, Kahtan N et al (2007) Patients discharged from medium secure forensic
psychiatry services: reconvictions and risk factors. British Journal of Psychiatry 190: 223 - 229
Department of Health (2009) The Bradley Report: Lord Bradley’s review of people with mental
health problems or learning disabilities in the Criminal Justice System. London: Department of
Health
Hassan L, Birmingham L, Harty M et al (2011) Prospective cohort study of mental health
during imprisonment. British Journal of Psychiatry 198: 37 – 42
Liebling A (1995) Vulnerability and prison suicide. British Journal of Criminology 35: 173 – 187
Lyall M & Bartlett A (2010) Decision making in medium security: can he have leave? Journal of
Forensic Psychiatry and Psychology 21 (6): 887 – 901
Royal College of Psychiatrists (2004) Psychiatrists & Multi-Agency Public Protection
Arrangements: Guidelines on representation, participation, confidentiality & information
exchange. London: Royal college of Psychiatrists
Shaw J, Hunt IM, Flynn S et al (2006) Rates of mental disorder in people convicted of
homicide. National clinical survey. British Journal of Psychiatry 188: 143 – 147

124
Session 2: The Link between Crime and Mental Disorder
Learning Objectives
To develop an understanding of the types of offences committed by mentally
disordered offenders
To develop an understanding of the aetiology of certain crimes including violent
offences, sex offences, criminal damage and fire-setting
To develop an understanding of the ranges of offences committed by offenders with
schizophrenia, affective disorder and personality disorder.
To develop an understanding of genetic and gender-specific factors in offending
Curriculum Links
12.1 Relationship between crime and mental disorder
12.1.1 Knowledge of the range of offences committed by mentally disordered
offenders. Specific crimes and their psychiatric relevance particularly:
homicide; other crimes of violence (including infanticide); sex offences; arson;
and criminal damage.
12.1.2 The relationship between specific mental disorders and crime: substance
misuse; epilepsy; schizophrenia; bipolar affective disorder; neuro-
developmental disorders; personality disorders
12.1.4 Mental disorders and offending in special groups: young offenders; female
offenders; offenders from ethnic minorities; offenders who are deaf or have
other physical disabilities
Expert Led Session
‘Offences committed by mentally-disordered offenders’ To cover topics including:
Sexual offending
Fire-setting
Violence
Offences against the property

125
Case Presentation
Case presentation on ‘A mentally-disordered offender’ Options for case presentation:
If trainee has a suitable case of a mentally-disordered offender then they may present
this.
The trainee can come to the Edenfield Centre where a suitable case can be found for
them – to access case notes and / or meet patient (if appropriate)
To use ‘The report of the inquiry into the care and treatment of Christopher Clunis’ as the
basis of the case presentation.
Journal Club Presentation
Key points to be summarised from the following three papers:
Keers R, Ullrich S, DeStavola B & Coid J. (2014) Association of violence with emergence
of persecutory delusions in untreated schizophrenia. Am J Psychiatry 171:3: 332 – 339
Sarkar J & Di Lustro M (2011) Evolution of secure services for women in England.
Advances in Psychiatric Treatment 17, 323 – 31
http://apt.rcpsych.org/content/17/5/323.abstract
Chang Z, Larsson H, Lichtenstein P & Fazel S, Psychiatric disorders and violent
reoffending: a national cohort study of convicted prisoners in Sweden, Lancet Psychiatry
2015, 2: 891 – 908
http://www.ncbi.nlm.nih.gov/pubmed/26342957
‘555’ Topic (5 slides with no more than 5 bullet points)
The biology of crime including:
Genetics
Gender
Young offenders
Special group – either deaf patients / ethnic minorities / older adults / physical disabilities

126
MCQs
1. Which is the most prevalent personality disorder in prisoners?
A. Borderline
B. Anankastic
C. Narcissistic
D. Paranoid
E. Antisocial
2. Which of the following is true for female offenders?
A. Less likely to have a psychiatric disposal
B. Higher rate of reoffending than men
C. Less likely to self-harm than men
D. Violent offences are more common than crimes of passion
E. More likely to offend against family
3. Which is the most common mental disorder found in arsonists?
A. Learning disability
B. Personality disorder
C. Psychosis
D. Alcohol misuse
E. Depressive disorder
4. What percentage of violence is attributable to psychosis
A. 1%
B. 5%
C. 10%
D. 25%
E. 50%
5. Which of these genes is not linked to violence?
A. Dopamine transporter gene
B. Serotonin transporter gene
C. Monoamine-oxidase A (MAO-A) gene
D. Monoamine-oxidase B (MAO-B) gene
E. Catechol-O-methyltransferase (COMT) gene

127
EMI Questions
Stalking:
A. Rejected
B. Public-Figure
C. Intimacy-Seeking
D. Incompetent-Suitor
E. Psychotic
F. Resentful
G. Predatory
H. Psychopathic
I. Private Stranger
J. Acquaintance
Which of the above subtypes of stalking, is demonstrated in the following scenarios?
1. James is a 22 year old man who has recently started working stacking shelves in the
local supermarket. One Sunday he saw Jenny, who was doing her regular weekly shopping
and she smiled at him warmly. Over the following weeks he changes his shift patterns to that
he always works on Sundays. He follows her home to ensure that she gets there safely and
starts to leave her flowers and presents by her car in the car-park. He takes pictures of her
without her knowing and puts them on Facebook as his new girlfriend.
2. Steven lives in a block of flats and notices a new tenant (Sally) has moved into the
flat beneath him. He starts to take her post from the communal mailbox so that he can find
out more information about her such as her phone number. He starts to make anonymous
phone calls during which he makes sexual and violent comments. He follows her to work so
that he can best determine when she is alone.
3. David is a 32 year old stock-broker who lives in a penthouse apartment. He was in a
9-month relationship with Jasmine, who broke up with him 12 months ago as she was
frustrated that she rarely saw him. David was angry that had the gall to break up with him
and since then has rung her several times each day; sometimes he asks her to re-consider
but often he leaves abusive messages or silence on her answerphone. He has gone around

128
to her flat in the middle of the night with flowers, although he broke her window on one
occasion. He was angry that she didn’t come to his brother’s wedding as his guest 2 months
ago. He has posted private pictures of her on the internet.
4. Sandra is a 40 year old single woman. 3 years ago she met Olly Murs backstage at a
concert. Since then she has become “his biggest fan.” She buys any magazines or
newspapers that he is in, has several copies of all his CDs and DVDs and goes to as many
concerts as she can. She lost her job because she took so much time off pursuing this
interest. She recently found out where he lives and spends all of her time at his house so
that she can see him when he leaves and follow him. She looks through his rubbish, where
she found some lipstick and she saw a female leave his house. She has sent threats to this
woman that Olly is ‘hers’ and to leave him alone.
5. Aimee is an aspiring model. 6 months ago at a casting she met Sarah and leant her
some makeup. Sarah was given the job and signed up to an agency. Aimee believes that
Sarah must have got the job for reasons other than merit. She is angry that Sarah stole the
job from her. Since then she has anonymously posted death threats on Twitter and
Facebook. She waited outside Sarah’s house for her to come out and threw a tin of paint on
her. She phoned Sarah’s model agency pretending to be Sarah and cancelled jobs. She
hacked into her email and sent abusive messages to the boss of the model agency.
Sex Offender Treatment:
A. Selective Serotonin Reuptake Inhibitor (SSRI)
B. Anti-androgen
C. Luteinising Hormone Releasing Hormone (LHRH) agonist / Long-acting
Gonadotropin Releasing Hormone (GnRH) agonist
D. Oestrogens
Match the anti-libidinal medication used in the treatment of sex offenders to the
mechanism of action:
1. Medroxyprogesterone acetate
2. Fluvoxamine
3. Cyproterone Acetate
4. Goserelin
5. Leuprolide
6. Premarin

129
Additional Resources / Reading Materials
Books
Chapters 8, 9, 10, 11, 12, 19, 20 & 21 in ‘Forensic Psychiatry: Clinical and ethical issues’ Gunn J &
Taylor P, (2013) CRC Press
Chapters 10, 11, 12 & 13 in ‘Practical Forensic Psychiatry,’ Clark T & Rooprai DS (2011) Hodder
Arnold
Chapter 15 in ‘Oxford Specialist Handbook: Forensic Psychiatry,’ Eastman N, Adshead G, Fox S et
al (2012) Oxford Medical Publishing
E-Learning
RCPsych CPD online: ‘Genetics for psychiatrists’
RCPsych CPD online: ‘Neurodevelopmental model of schizophrenia’
RCPsych CPD online: ‘Psychiatric aspects of homicide’
Journal Articles
Bennett D, Ogloff J, Mullen P et al (2012) A study of psychotic disorders among female homicide
offenders Psychology, Crime and Law 18(3), 231 – 243
Chitsabesan P, Kroll L, Bailey S et al (2006) Mental health needs of young offenders in custody
and in the community. British Journal of Psychiatry 188: 534 – 540
Dein K, Woodbury-Smith M (2010) Asperger syndrome and criminal behaviour. Advances in
Psychiatric Treatment 16: 37 – 43
Devapriam J, Raju LB, Singh N et al (2007) Arson: characteristics and predisposing factors in
offenders with intellectual disabilities. British Journal of Forensic Practice 9(4): 23 – 27
Eronen M (1995) Mental disorders and homicidal behavior in female subjects. American Journal
of Psychiatry 152: 1216 – 1218
Fazel S & Benning R (2009) Suicides in female prisoners in England and Wales. British Journal of
Psychiatry 194: 183 – 184
Fazel S, Sjostedt, Langstrom N et al (2007) Severe mental illness and risk of sexual offending in
men: a case-control study based on Swedish national registers. Journal of clinical psychiatry
68(4), 588 – 596

130
Ferguson CJ & Beaver KM (2009) Natural born killers: the genetic origins of extreme violence.
Aggression and Violent Behaviour 14, 286 – 94
Gannon TA (2010 Female arsonists: key features, psychopathologies and treatment needs.
Psychiatry 73(2): 173 – 189
Gordon H & Grubin D (2004) Psychiatric aspects of the assessment and treatment of sex
offenders. Advances in psychiatric treatment 10: 73 – 80
Gudjonsson GH & Henry L (2003) Child and adult witnesses with intellectual disability: the
importance of suggestibility. Legal and Criminological Psychology 8(2): 241 – 252
Holland T, Clare CH & Mukhopadhyay (2002) Prevalence of criminal offending by men and
women with intellectual disability and the characteristics of offenders: implications for research
and service development. Journal of Intellectual Disability Research 46(S1): 6 – 20
Kolko DJ & Kazdin AE (1991) Motives of childhood firesetters: firesetting characteristics and
psychological correlates. Journal of child psychology and psychiatry 32: 535 – 550
Long C, Hall L, Craig L et al (2010) Women referred for medium secure inpatient care: a
population study over a six-year period. Journal of Psychiatric Intensive Care 7(1): 17 – 26
Mohandie K, Meloy J R, McGowan MG et al (2006) The RECON typology of stalking: reliability and
validity based upon a large sample of North American Stalkers Journal of Forensic Science 51(1),
147 – 155
Monahan J, Steadman HJ, Silver E et al (2001) Rethinking risk assessment: The MacArthur study
of risk assessment and violence. Oxford: Oxford University Press.
Mullen P, Pathe M & Purcell P (2001) The management of stalkers. Advances in psychiatric
treatment 7: 335 – 342
Talbot J (2008) No One Knows: Experiences of the criminal justice system by prisoners with
learning disabilities and difficulties. London: Prison reform trust

131
Session 3: Too mad to murder?
Learning Objectives
To develop an understanding of the role of mental disorder in offending
To develop an understanding of the frequency of and types of offences committed by
those with serious mental illness
To understand the role of special syndromes in offences
To develop an understanding of vulnerability and suggestibility in mentally disordered
offenders
Curriculum Links
12.1 Relationship between crime and mental disorder
12.1.2 The relationship between specific mental disorders and crime: substance misuse;
epilepsy; schizophrenia; bipolar affective disorder; neuro-developmental
disorders; personality disorders
12.1.3 Special syndromes: morbid jealousy, erotomania, Munchausen and Munchausen by
proxy
12.1.5 Effect of victimisation and vulnerability: anxiety states including post-traumatic stress
disorder; suggestibility; anger and aggressive behaviour. Effect of compensation on
presentation
Expert Led Session
‘Too mad to murder?’ to include:
Substance Misuse
Epilepsy
Schizophrenia

132
Bipolar affective disorder
Neuro-developmental disorders
Personality disorders
Case Presentation
Case presentation on ‘a special syndrome in relation to forensic psychiatry’. To include either
morbid jealousy, erotomania, Munchausen or Munchausen by proxy.
Options for case presentation:
If trainee has a suitable case of a special syndrome then they may present this.
The trainee can come to the Edenfield Centre where a suitable case can be found for
them – to access case notes and / or meet patient (if appropriate)
To use ‘The Allitt inquiry’ as the basis of the case presentation. (Munchausen by proxy)
Journal Club Presentation
Key points to be summarised from the following three papers:
Rose J, Cutler C, Tresize K et al (2008) Individuals with an intellectual disability who
offend, British Journal of Developmental Disabilities 106, 19 – 30
http://www.google.co.uk/url?sa=t&rct=j&q=&esrc=s&frm=1&source=web&cd=1&cad=rja&
uact=8&sqi=2&ved=0CCUQFjAA&url=http%3A%2F%2Fwww.researchgate.net%2Fpublic
ation%2F228505583_Individuals_with_an_intellectual_disability_who_offend%2Flinks%2
F0deec51817f57baef7000000&ei=3YngU_PiI-
nb7Aazh4DABg&usg=AFQjCNEg9xYeimpgqJchT70fngkh2vkPTA&sig2=KXDBJ1CC_DT
2OPQG6mr2KA
Fazel S, Wolf A, Chang Z et al (2015). Depression and violence: a Swedish population
study. Lancet Psychiatry 2: 224 – 32

133
Elbogen EB & Johnson SC (2009) The intricate link between violence and mental
disorder: results from the national epidemiological survey on alcohol and related
conditions. Archives of General Psychiatry 66(2): 152 – 161
http://www.ncbi.nlm.nih.gov/pubmed/19188537
‘555’ Topic (5 slides with no more than 5 bullet points per slide)
Human rights legislation – articles 5 / 6 / 8
Ethics
MCQs
1. Which is the biggest risk factor for violence in psychosis?
A. Non-compliance with medication
B. Co-morbid personality disorder
C. Homelessness
D. Unemployment
E. Co-morbid substance misuse
2. With respect to Munchausen’s by Proxy, which of the following is incorrect?
A. More common in mothers
B. The annual incidence of fabricated or induced illness in children under 16 is 0.5 per
100,000
C. There is no clear relationship with any specific mental disorder
D. 50% perpetrators had a personality disorder
E. 21% have a history of alcohol and / or drug misuse
3. Which of the following regarding mood disorder and violence is incorrect?
A. The prevalence of depression in male prisoners is 10%

134
B. The prevalence of depression in female prisoners is 25%
C. Manic patients are likely to show aggression and violence associated with admission to
hospital
D. 7% homicide perpetrators have a lifetime diagnosis of mood disorder
E. Most perpetrators of homicide-suicide are male
4. Which is the correct statement relating to substance use and the MacArthur Violence
Study?
A. Substance use increases the rate of violence among both those with and without mental
illness
B. The rate of violence for those with a mental disorder and no substance use is 25%
C. The rate of violence for those with a mental disorder and substance use is 50%
D. Substance use is a protective factor for violence
E. The highest rate of violence was for those with mood disorder and substance use
5. Which is the incorrect statement about epilepsy and offending?
A. Ictal violence is more likely in complex partial seizures
B. Most offending occurs in post-ictal or inter-ictal period
C. Violence in epilepsy is usually a feature of the disease
D. The prevalence of epilepsy in prisoners is 1 – 2%
E. The prevalence of epilepsy in the general population is 0.5 – 1%
EMI Questions
Fire Setting:
A. Crime concealment
B. Financial compensation
C. Suicidal
D. Extremism
E. Vandalism

135
F. Psychosis
H. Pyromania
Match the most-likely motivation for fire-setting with the clinical scenario below.
1. Wayne is a 14 year old who whilst truanting from school with a gang of boys sets fire to an
abandoned warehouse. He waits around for the fire service to arrive and watches from a
safe distance as they put the fire out.
2. Vincent is a 48 year old man with Asperger’s Disorder. He has a history of setting fires
when he is angry. He enjoys looking at how things burn. He is upset by another resident
shouting at him and so set a fire. He feels an inner tension that is relieved when he has set
the fire. He calls the fire brigade and becomes excited when they arrive.
3. Stephanie sets fire to a university research laboratory, where she believes the researchers
are carrying out experiments on elephants. Two weeks ago she suddenly realised that the
University were dissecting elephant trunks in order to test the effects of snorting cocaine so
that the Government could develop a synthetic drug to distribute in the community.
4. Alison is a 50 year old woman who has recently separated from her husband after he left
her for another woman. Divorce proceedings have begun and she is concerned that she may
have to leave the family home because she can’t afford to pay the mortgage. She is
depressed with low mood, poor sleep, anhedonia and poor concentration. She feels that if
she loses her home she won’t have anything to live for. She sets fire to her house using
petrol in 3 seats in the living room, hallway and upstairs bedroom. She calls the fire brigade
from her mobile phone in the garden.
Human Rights:
A. Article 2
B. Article 3
C. Article 5

136
D. Article 6
E. Article 8
F. Article 9
G. Article 12
These Articles of the European Convention of Human Rights (ECHR) are important in the
detention of mentally-disordered offenders. Match the correct Article with the freedom or right
it describes.
1. Right to respect for private and family life
2. Prohibition of torture
3. Right to marry
4. Right to life
5. Right to liberty and security
6. Freedom of thought, conscience and religion
7. Right to a fair trial
Additional Resources / Reading Materials
Books
Chapters 14, 16, 17, 18, & 26 in ‘Forensic Psychiatry: Clinical and ethical issues’ Gunn J
& Taylor P, (2013) CRC Press
Chapters 7, 8 & 9 in ‘Practical Forensic Psychiatry,’ Clark T & Rooprai DS (2011) Hodder
Arnold
Chapter 3 in ‘Oxford Specialist Handbook: Forensic Psychiatry,’ Eastman N, Adshead G,
Fox S et al (2012) Oxford Medical Publishing
E-Learning
RCPsych CPD online: ‘FREDA – a human rights-based approach to clinical practice’
RCPsych CPD online: ‘Morbid jealousy’
RCPsych CPD online: ‘Understanding and safely managing paranoid personality
disorder’

137
Journal Articles
Arsenault L, Moffit T, Caspi A et al (2000) Mental disorders and violence: results from the
Dunedin study. Archives of General Psychiatry 57: 979 – 986
Barrowcliff AL & Haddock G (2006) The relationship between command hallucinations
and factors of compliance: a critical review of the literature. Journal of forensic psychiatry
and psychology 17(2): 266 – 298
Booles CN, Neale BA, Meadow SR (1994) Munchausen syndrome by proxy: a study of
psychopathology. Child abuse and neglect G 18: 773 – 788
Fazel S, Langstrom N, Hjern A et al (2009) Schizophrenia, substance abuse, and violent
crime. Journal of the American Medical Association 301(19): 2016 – 2023
Gudjonsson GH & Henry L. (2003) Child and adult witnesses with intellectual disability:
the importance of suggestibility Legal and Criminological Psychology 8(2), 241 – 252
Large M, Smith G, Swinson N et al (2008) Homicide due to mental disorder in England
and Wales over 50 years. British Journal of Psychiatry 193: 130 – 133
Newhill CE, Eack SM & Mulvey EP (2009) Violent behavior in borderline personality
disorder. Journal of Personality Disorders 23: 541 – 554
Nielson O & Large M (2010) Rates of homicide during the first episode of psychosis and
after treatment: a systematic review and meta-analysis Schizophrenia Bulletin 36(4): 702
– 712
Roberts ADL & Coid JW (2010) Personality disorder and offending behaviour: findings
from the national survey of male prisoners in England and Wales. Journal of forensic
psychiatry and psychology 21: 221 – 237
Shaw J, Amos T, Hunt IM et al (2004) Mental illness in people who kill strangers:
longitudinal study and national clinical survey. British Medical Journal 328: 734 – 737
Shaw J, Amos T, Hunt IM et al (2006) Rates of mental disorder in people convicted of
homicide. British Journal of Psychiatry 188: 143 - 147
Swanson JW, Holzer CE, Ganju VK, Jono R (1990) Violence and psychiatric disorder in
the community: evidence from the epidemiological catchment area survey Hospital and
Community Psychiatry 41, 761 – 70

138
Tihonen J, Isohanni M, Rasanen P et al (1997) Specific major mental disorders and
criminality: a 26 year prospective study of the 1966 northern Finland birth cohort.
American Journal of Psychiatry 154: 840 – 845
Session 4: Introduction to risk assessment and risk management
Learning Objectives
To develop an understanding of what clinical risk is
To understand different risk assessment tools
To develop skills in planning how to undertake a risk assessment
To develop skills in risk formulation
To develop an understanding of risk management
Expert Led Session
• An introduction to risk
• Risk assessment tools
• Forensic clinical interview
• Risk assessment
• Risk formulation
• Risk management
Case Presentation
Case presentation to include a risk assessment.
Journal Club Presentation

139
Bonta J, Blais J & Wilson H (2014). A theoretically informed meta-analysis of the risk for general and violent recidivism for mentally disordered offenders. Aggression and violent behaviour 19(3): 278- 287 https://www.sciencedirect.com/science/article/pii/S1359178914000408
Klepfisz G, Daffern M & Day A. (2016) Understanding dynamic risk factors for violence. Journal of psychology, crime and law. 22 (1), 124 – 137
https://www.tandfonline.com/doi/abs/10.1080/1068316X.2015.1109091
Brown B & Rakow T. (2015) Understanding clinicians’ cues when assessing the future risk of violence: a clinical judgement analysis in the psychiatric setting. Clinical psychology & psychotherapy 23(2): 125 – 141
‘555’ Topic (5 slides with no more than 5 bullet points per slide)
Arson risk assessment
Suicide risk assessment
MAPPA
DVLA, driving and mental health
MCQs
MCQ Questions
1. Which of the following is not an actuarial risk assessment tool?
A. VRAG
B. SAVRY
C. Static 99
D. SORAG
E. PCL-R
2. Which is not a static risk factor?
A. Previous violence
B. Parental criminality
C. Age
D. Substance misuse
E. Sex

140
3. Which of the following are principles of risk management?
A. Victim-safety planning
B. Supervision
C. Scenario-planning
D. Treatment
E. All of the above
4. Which is not a feature of a truthful narrative?
A. Able to give basic details only
B. Able to give context
C. Able to reproduce conversations
D. Able to make comments about another’s mental state
E. Able to manage unexpected complications
5. Which is incorrect with regards to the HCR 20?
A. Most commonly used risk assessment tool in the UK
B. 10 Historical items
C. 10 Clinical items
D. It is a form of SPJ risk assessment tool
E. It includes risk formulation
Additional Resources / Reading Materials
Royal College of Psychiatrists -
https://www.rcpsych.ac.uk/pdf/Camden%20risk%20assessment%20and%20managemen
t.pdf
British Psychological Society -
https://www1.bps.org.uk/system/files/Public%20files/DCP/cat-381.pdf
RCPsych CPD online – Risk assessment and management of violence in general adult
psychiatry
Undrill G. (2007) The risks of risk assessment. Advances psychiatric treatment 13(4): 291
- 297

141
SUBSTANCE MISUSE SEMESTER 3:
Session 1: Diagnosis and Treatment for People with Alcohol Problems
Learning Objectives
Assessment, diagnosis and treatment of people with alcohol problems
To develop awareness of complications associated with alcohol use
To understand some of the practical aspects of managing people with alcohol problems
To gain awareness of local provisions and guidelines
Curriculum Links
11.1 Basic pharmacology and epidemiology
11.3 Problem drinking; alcohol dependence; alcohol-related disabilities. In-patient
and out-patient detoxification
11.4 Biological, psychological and socio-cultural explanations of drug and alcohol
dependence
11.7 The assessment and management of alcohol misusers
11.8 Culturally appropriate strategies for the prevention of drug and alcohol abuse
Expert Led Session
Concepts of harmful use/dependence
Management of alcohol withdrawals with reference to local guidelines
Case Presentation
Exploration of alternatives to admission for person with alcohol withdrawals – why
admission would be needed
Highlight assessment and management of comorbid physical symptoms in person with
alcohol problems
Liaison with local alcohol services for follow up

142
Journal Club Presentation
Van den Brink, W., Aubin H.J., Bladström A., Torup L., Gual A., Mann K. (2013) Efficacy of as-
needed nalmefene in alcohol-dependent patients with at least a high drinking risk level:
results from a subgroup analysis of two randomized controlled 6-month studies. Alcohol and
alcoholism, 48(5), 570-8.
Schwarzinger, M., Pollock, B., Hasan, O., Dufouil, C., Rehm, J., Baillot, S. Luchini, S. (2018).
Contribution of alcohol use disorders to the burden of dementia in France 2008–13: a
nationwide retrospective cohort study. The Lancet Public Health, 3(3):e124-e132.
Wood, A., Kaptoge, S., Butterworth, A., Willeit, P., Warnakula, S., Bolton, T., Danesh, J.
(2018). Risk thresholds for alcohol consumption: combined analysis of individual-participant
data for 599 912 current drinkers in 83 prospective studies. The Lancet, 391(10129), 1513-
1523.
‘555’ Topics (5 slides on each topic with no more than 5 bullet points)
Alcohol Related Brain Damage
Screening for alcohol use
Foetal alcohol syndrome
Long term physical complications from alcohol use
MCQs
1. Which of the following statements about Disulfiram is false:
A. Previous history of CVA is a contraindication
B. Disulfiram use will result in an decrease in accumulation of acetaldehyde in the blood stream
C. A loading dose can be used for initiation
D. Disulfiram may have a role in the treatment of cocaine dependence
E. Hepatic cell damage is a recognised adverse effect of Disulfiram
2. The following are true of Wernicke Encephalopathy except:
A. Classic triad is ocular motor abnormalities, cerebellar dysfunction, and altered mental state
B. Only 20% of patients present with the full triad
C. Altered mental state occurs in 40%

143
D. Altered mental state symptoms include: mental sluggishness, apathy, impaired awareness of an
immediate situation, an inability to concentrate, confusion or agitation
E. Ocular motor abnormalities occur in 30%
3. Which of the following is not a reason to consider inpatient setting for alcohol detoxification based
on NICE guidelines:
A. Previous detoxification was inpatient setting
B. Have a score of more than 30 on the Severity of Alcohol Dependence Questionnaire
C. Have a history of epilepsy, or experience of withdrawal-related seizures or delirium tremens during
previous assisted withdrawal programmes
D. Need concurrent withdrawal from alcohol and benzodiazepines
E. Consider a lower threshold for inpatient or residential assisted withdrawal in vulnerable groups, for
example, homeless and older people
4. Features required for a diagnosis of dependence within ICD 10 include the following except:
A. A strong desire or sense of compulsion to take the substance
B. Difficulties in controlling substance-taking behaviour in terms of its onset, termination, or levels of
use
C. A physiological withdrawal state when substance use has ceased or have been reduced, as
evidenced by: the characteristic withdrawal syndrome for the substance; or use of the same (or closely
related) substance with the intention of relieving or avoiding withdrawal symptoms;
D. Evidence of tolerance, such that increased doses of the psychoactive substance are required in order
to achieve effects originally produced by lower doses
E. Returning to substance use after a period of abstinence leads to more rapid reappearance of
features of dependence than with non-dependent individuals
5. The following are correct calculation of units of alcohol (percentages are in vol/vol) corrected to
nearest whole number:
A. 750 mls of 11% wine is 8 units
B. 6 Litres of 4.5% cider is 18 units
C. 5 cans of 330 mls of 4.8% lager is 8 units
D. 3 cans of 440 mls of 7.5% strong lager is 10 units
E. 2 bottles of 700 mls of 17% fortified wine is 24 units

144
EMI Questions
Drugs used in Alcohol Dependence:
A. Disulfiram
B. Acamprosate
C. Naltrexone
D. Nalmefene
E. Diazepam
F. Oxazepam
G. Lorazepam
H. Vitamin B compound strong
I. Thiamine
J. Baclofen
1a. Which medication should not be given if serum creatinine >120 micromol/L)
1b. Which medication used for detoxification should be avoided in patients with impaired liver
function
1c. Which medication acts as a partial agonist on Kappa opioid receptors
Investigations for people with alcohol use:
A. Gamma-glutamyl transferase (GGT)
B. Mean corpuscular volume
C. Carbohydrate-deficient transferrin (CDT)
D. Total bilirubin
E. Albumin
F. INR
G. Magnesium
H. Globulin
I. Alkaline phosphatase
J. Platelet Count
2a. This marker has Sensitivity of 50 to 70% in the detection of high levels of alcohol consumption in
the last 1 to 2 months but false positive with hepatitis, cirrhosis, cholestatic jaundice, metastatic
carcinoma, treatment with simvastatin and obesity.
2b. This is used in the calculation of the Maddrey's Discriminant Function for Alcoholic Hepatitis.

145
2c. A reduction in this can lead to increased risk of seizures and can be related to use of proton pump
inhibitors.
Additional Resources / Reading Materials
Books
Chapter 17 in Cowen, P., Harrison, P. J., Burns, T., & Gelder, M. G. (2012). Shorter Oxford
textbook of psychiatry (6th ed.). Oxford: Oxford University Press
Edwards, G. Alcohol: The World's Favorite Drug. Institute of Psychiatry London
McGrath, P. Back from the Brink: The Autobiography
Sigman, A. Alcohol Nation: How to protect our children from today's drinking culture
E-Learning
Blue Light Project: A manual for 'Working with Change Resistant Drinkers
https://www.alcoholconcern.org.uk/Handlers/Download.ashx?IDMF=8ec66a11-104f-4f02-
aed8-892e23522c14
E-learning for Healthcare (e-LfH)
http://portal.e-lfh.org.uk/Registration
o Alcohol Identification and Brief Advice
Epidemiological data on Drug and Alcohol Treatment in England
https://www.ndtms.net/default.aspx
Epidemiological Public Health Data England (Alcohol given as example)
https://fingertips.phe.org.uk/profile/local-alcohol-
profiles/data#page/1/gid/1938132984/pat/6/par/E12000002/ati/101/are/E08000003
GP learning resource centre
http://www.smmgp.org.uk/
http://www.smmgp.org.uk/html/featured-videos.php
Royal College of General Practitioners learning resource
http://elearning.rcgp.org.uk/course/index.php
Alcohol: Identification and Brief Advice
Alcohol: Management in Primary Care
Royal College of Psychiatrists CPD Online
Alcohol and the brain
Alcohol-related brain damage
Driving and mental disorders
Royal College of Psychiatrists Faculty of Addictions Psychiatry

146
http://www.rcpsych.ac.uk/workinpsychiatry/faculties/addictions.aspx
Journal Articles
Anton, R. F., O'Malley, S. S., Ciraulo, D. A., Cisler, R. A., Couper, D., Donovan, D. M., et al.
(2006). Combined pharmacotherapies and behavioral interventions for alcohol
dependence: the COMBINE study: a randomized controlled trial. JAMA, 295(17), 2003-
2017.
Group, P. (1998). Matching alcoholism treatments to client heterogeneity: treatment
main effects and matching effects on drinking during treatment. Project MATCH
Research Group. Journal of Studies on Alcohol, 58(1), 7- 29.
Home Office. Great Britain. (2012). The Government's alcohol strategy. Norwich: TSO.
Ijaz, S., Jackson, J., Thorley, H., Porter, K., Fleming, C., Richards, A., Savović, J. (2017).
Nutritional deficiencies in homeless persons with problematic drinking: A systematic
review. International Journal for Equity in Health, 16(1), 71.
Lifestyle Statistics Health and Social Care Information Centre. (2008). Statistics on alcohol
: England, 2013. London: Department of Health.
Mann, K., Lemenager, T., Hoffmann, S., Reinhard, I., Hermann, D., Batra, A., et al. (2013).
Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism
conducted in Germany and comparison with the US COMBINE study. Addiction Biology,
18(6), 937-946.
Miller, W., & Wilbourne, P. (2002). Mesa Grande: A methodological analysis of clinical
trials of treatments for alcohol use disorders. Addiction, 93(3), 265-277.
National Institute for Health and Care Excellence. (2010). Alcohol use disorders:
diagnosis and clinical management of alcohol related physical complications CG 100.
London: National Institute for Health and Care Excellence.
National Institute for Health and Care Excellence. (2011). Alcohol use disorders:
diagnosis, assessment and management of harmful drinking and alcohol dependence CG
115. London: National Institute for Health and Care Excellence.
National Institute for Health and Care Excellence. (2014). Alcohol use disorders:
preventing harmful drinking PH24. London.
Office of National Statistics. (2017). Alcohol-specific deaths in the UK: registered in 2016.
In Office of National Statistics.
https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/causesof
death/bulletins/alcoholrelateddeathsintheunitedkingdom/registeredin2016

147
Office of National Statistics. (2017) Statistics on Alcohol England, 2017.
https://www.gov.uk/government/statistics/statistics-on-alcohol-england-2017
Palmer, R. H., McGeary, J. E., Francazio, S., Raphael, B. J., Lander, A. D., Heath, A. C., et al.
(2012). The genetics of alcohol dependence: advancing towards systems-based
approaches. Drug and alcohol dependence, 125(3), 179-191.
Riley, E. P., Infante, M. A., & Warren, K. R. (2011). Fetal Alcohol Spectrum Disorders: An
Overview. Neuropsychology Review, 21(2), 73-80.
Palpacuer, C., Duprez, R., Huneau, A., Locher, C., Boussageon, R., Laviolle, B., & Naudet,
F. (2018). Pharmacologically controlled drinking in the treatment of alcohol dependence
or alcohol use disorders: a systematic review with direct and network meta-analyses on
nalmefene, naltrexone, acamprosate, baclofen and topiramate. Addiction. 113(2), 220-
237.
Pryce, R., Buykx, P., Gray, L., Stone, T., Drummond, C., & Brennan, A. (2017). Estimates of
Alcohol Dependence in England based on APMS 2014, including Estimates of Children
Living in a Household with an Adult with Alcohol Dependence Prevalence, Trends, and
Amenability to Treatment.
https://www.sheffield.ac.uk/polopoly_fs/1.693546!/file/Estimates_of_Alcohol_Depende
nce_in_England_based_on_APMS_2014.pdf
Session 2: Diagnosis and Treatment of People with Drug Misuse
Learning Objectives
Assessment, diagnosis and treatment of people with Drug Misuse
To develop working knowledge of principles of opioid substitution treatment
To increase awareness of other substances commonly misused
To develop awareness of complications associated with Drug Misuse
Curriculum Links
11.1 Basic pharmacology and epidemiology
11.2 Considerations for prescribing and treatment modalities; Legal restrictions on
prescribing

148
11.4 Biological, psychological and socio-cultural explanations of drug and alcohol
dependence ; Cultural factors in the use and abuse of drugs
11.5 Impact of drug and alcohol use on Public Health
11.6 The assessment and management of drug misusers
11.8 Culturally appropriate strategies for the prevention of drug and alcohol abuse
Expert Led Session
Diagnosis and treatment of people with problems with opioid dependence
Rationale for using opioid substitution
Changing patterns of opioid use in recent years
Principle of initiation with methadone and buprenorphine
Case Presentation
A case of someone with polysubstance misuse
Highlight physical complications of injecting substances
Journal Club Presentation
Mattick RP, Breen C, Kimber J, Davoli M (2014) Cochrane Database Syst Rev. Buprenorphine
maintenance versus placebo or methadone maintenance for opioid dependence.
2:CD002207.
Abrahamsson, T., Berge, J., Öjehagen, A., & Håkansson, A. (2017). Benzodiazepine, z-drug
and pregabalin prescriptions and mortality among patients in opioid maintenance
treatment—A nation-wide register-based open cohort study. Drug and Alcohol Dependence,
174, 58- 64.
Ledberg, A. (2017). Mortality related to methadone maintenance treatment in Stockholm,
Sweden, during 2006–2013. Journal of Substance Abuse Treatment, 75, 35-41.
‘555’ Topics (5 slides on each topic with no more than 5 bullet points)
Novel psychoactive substances
Pain management in people with opioid dependence

149
Substance misuse problems in young people
Ethics of opiate substitution treatment
MCQs
1. Common term for illicit diazepam:
A. Plant food
B. Blues
C. Spice
D. Horse
E. Whizz
2. The following are true of Novel psychoactive substances except for:
A. GHB (gammahydroxybutrate) and GBL (gammabutyrolactone) act similarly to hallucinogens such
as LSD
B. Mephedrone is part of the cathinone family of drugs
C. Piperazines substances have stimulant effects
D. Paramethoxyamphetamine (PMA) is an methylenedioxymetamphetamine (MDMA) like substance
but associated with higher risks of death than MDMA
E. Ketamine use can results in haemorrhagic cystitis
3. The following are true of methadone except for:
A. Cases of QT interval prolongation and torsade de pointes have been reported during treatment with
methadone, particularly at high doses (>100mg).
B. Typical starting doses are in the range of 10 to 30 mgs
C. Methadone tablets are the preferred formulation for commencing treatment in opioid dependence
D. Use of Cimetidine may lead to potentiation of opioid activity due to displacement of methadone
from protein binding sites
E. Peak plasma levels occur 1-5 hours after a single dose of Methadone Mixture 1mg/1ml
4. The following are true about opioid substitution treatment except for:
A. Reduces the risk of death among heroin users
B. Suppresses illicit use of heroin
C. Reduces involvement in crime among heroin users participating in treatment
D. Reduces the risk of Blood Bourne Virus transmission, including in prisons
E. Promotes abstinence from all drugs

150
5. For long term treatment of pain using opioids, the following dose of oral morphine or equivalent
should not be exceeded:
A. 10 mg
B. 40 mg
C. 80 mg
D. 120 mg
E. 240 mg
EMI Questions
Medication used in treatment of opioid dependence:
A. Hyoscine butylbromide
B. Naloxone
C. Codeine phosphate
D. Clonidine
E. Lofexidine
F. Suboxone
G. Loperamide
H. Oxycodeine
I. Fentanyl
J. MXL morphine capsules
1a. This medication is a selective adrenergic alpha-2-receptor agonist
1b. This medication can be used to reduce risk of injecting behaviour
1c. This medication is frequently used for symptomatic relief of abdominal cramps during opioid
detoxification
Analgesics of misuse:
A. Fentanyl
B. Diacetlymorphine
C. Dihydrocodeine
D. MXL
E. Diconal

151
F. Buprenorphine
G. MST Continus
H. Tramadol
I. Methadone
J. MXL morphine capsules
2a. This compound is a combination of an antiemetic and a opioid
2b. This compound has effects on serotonin reuptake as well as effects on opioid receptors
2c. This compound is approximately 80 times more potent than morphine and is available as lozenges
and transdermal formulation
Additional Resources / Reading Materials
Books
Burroughs, W. Naked Lunch.
Chapter 17 in Cowen, P., Harrison, P. J., Burns, T., & Gelder, M. G. (2012). Shorter Oxford
textbook of psychiatry (6th ed.). Oxford: Oxford University Press.
Nestler, E. J., Hyman, S. E., & Malenka, R. C. (2009). Molecular neuropharmacology : a
foundation for clinical neuroscience (2nd ed. ed.). New York ; London: McGraw-Hill Medical.
Welsh, I. Trainspotting.
E-Learning
Drug Alerts
https://findings.org.uk/
http://michaellinnell.org.uk/drugwatch.html
https://wearetheloop.org/drug-alerts/
E-learning for Healthcare (e-LfH)
http://portal.e-lfh.org.uk/Registration
o Sexual Health & HIV
o Pain
European reports on substance misuse

152
http://www.emcdda.europa.eu/
Epidemiological data on Drug and Alcohol Treatment in England
https://www.ndtms.net/default.aspx
Government information - Guidance for healthcare professionals on drug driving
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_
data/file/325275/healthcare-profs-drug-driving.pdf
GP learning resource centre
http://www.smmgp.org.uk/
http://www.smmgp.org.uk/html/featured-videos.php
Neptune ( Novel Psychoactive Treatment: UK Network) E-learning modules
http://neptune-clinical-guidance.co.uk/e-learning/
Pain resources
Action on Addiction
o https://idhdp.com/mediaimport/38281/130607_pain_management_report__final_e
mbargoed_13_june.pdf
Opioid Aware:
o https://www.rcoa.ac.uk/faculty-of-pain-medicine/opioids-aware
Living well with pain:
o http://livewellwithpain.co.uk/
Public Health England Information
https://www.gov.uk/government/organisations/public-health-england
Resource for drug advice
http://www.talktofrank.com/
Royal College of General Practitioners learning resource
http://elearning.rcgp.org.uk/course/index.php
o Drugs: Identification and Harm Reduction
o Drugs: Management of Drug Misuse (Level 1)
o Hepatitis B & C
Royal College of Psychiatrists CPD Online
Buprenorphine in opiate dependence
GHB: what psychiatrists need to know
Helping the addicted doctor
Hepatitis C and mental illness
Safe and effective opiate replacement therapy

153
Stimulants: epidemiology and impact on mental health
Stimulants: treatment approaches and organising services
Substance misuse in older people
Royal College of Psychiatrists information
Drugs and alcohol: information for young people
o https://www.rcpsych.ac.uk/healthadvice/parentsandyouthinfo/youngpeople/drugsa
ndalcohol.aspx
Substance misuse in older people: an information guide
o https://www.rcpsych.ac.uk/usefulresources/publications/collegereports/cr/cr211.as
px
Society for the Study of Addiction
http://www.addiction-ssa.org/
US National institute on Drug Misuse
https://www.drugabuse.gov/drugs-abuse
Journal Articles
Action on Addiction. (2013). The Management Of Pain In People With A Past Or Current
History Of Addiction.
Baldwin, D. S., Aitchison, K., Bateson, A., Curran, H. V., Davies, S., Leonard, B., et al. (2013).
Benzodiazepines: risks and benefits. A reconsideration. Journal of Psychopharmacology,
27(11), 967-971.
Clinical Guidelines on Drug Misuse and Dependence Update 2017 Independent Expert
Working Group (2017). Drug misuse and dependence: UK guidelines on clinical management.
London: Department of Health.
DTB. (2016). QT interval and drug therapy. BMJ, 353, i2732.
EMCDDA. (2013). Drug prevention interventions targeting minority ethnic populations: issues
raised by 33 case studies: Publications Office of the European Union, Luxembourg.
EMCDDA. (2018). European Drug Report: Trends and Developments: Publications Office of
the European Union, Luxembourg http://www.emcdda.europa.eu/publications/edr/trends-
developments/2018.
Gossop, M., Marsden, J., Stewart, D., & Kidd, T. (2003). The National Treatment Outcome
Research Study (NTORS), 4-5 year follow-up results. Addiction, 98(3), 291-303.
Mujtaba, S., Romero, J., & Taub, C. C. (2013). Methadone, QTc prolongation and torsades de
pointes: Current concepts, management and a hidden twist in the tale Journal of
cardiovascular disease research, 4(4), 229-235.

154
National Institute for Health and Care Excellence. (2007). Drug misuse – opioid detoxification
CG52. London: National Institute for Health and Care Excellence.
National Institute for Health and Care Excellence. (2012). Opioids in palliative care: safe and
effective prescribing of strong opioids for pain in palliative care of adults CG140. London:
National Institute for Health and Care Excellence.
Office of National Statistics. (2017). Deaths Related to Drug Poisoning in England and Wales,
2016 Registrations.
https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/death
s/bulletins/deathsrelatedtodrugpoisoninginenglandandwales/2016registrations
Office of National Statistics. (2014). Number of deaths related to drug poisoning where
buprenorphine and/or methadone was mentioned on the death certificate by underlying
cause, England and Wales, deaths registered between 2007-2012.
The Royal College of Psychiatrists. (2018). Our Invisible Addicts, 2nd edition. College Report
CR211.
Royal College of Psychiatrists (2012). Practice standards for young people with substance
misuse problems.
Strang, J., Metrebian, N., Lintzeris, N., Potts, L., Carnwath, T., Mayet, S., et al. (2010).
Supervised injectable heroin or injectable methadone versus optimised oral methadone as
treatment for chronic heroin addicts in England after persistent failure in orthodox
treatment (RIOTT), a randomised trial. Lancet, 375(9729), 1885-1895.
Trescot, A. M., Datta, S., Lee, M., & Hansen, H. (2008). Opioid pharmacology. Pain Physician,
11(2 Suppl), S133-153.
United Kingdom Focal Point at Public Health England. (2013). United Kingdom Drug Situation
2013 Edition.
Session 3: Diagnosis and management of people with co-occurring mental health and alcohol/drug use conditions
Learning Objectives
To develop understanding of key aspects in the diagnosis and treatment of patients with co-
occurring mental health and alcohol/drug use conditions
To increase awareness of complications with pharmacological treatment in patients with co-
occurring mental health and alcohol/drug use conditions

155
To develop knowledge of risk issues in people with co-occurring mental health and
alcohol/drug use conditions
To understand how local services are implemented to manage people with co-occurring
mental health and alcohol/drug use conditions
Curriculum Links
11.1 Basic pharmacology and epidemiology
11.5 Effect of drug and alcohol use on psychiatric illness
Expert Led Session
Diagnosis and treatment of people with psychosis and substance misuse
ICD 10/ICD 11 concepts relating to people with co-occurring mental health and alcohol/drug
use conditions)
Biological explanations of substances affecting psychosis
Case Presentation
Examine risk aspects of people with co-occurring mental health and alcohol/drug use
conditions
Relationship of the substance use to development of the symptoms
Journal Club Presentation
Asher CJ, Gask L. (2010) Reasons for illicit drug use in people with schizophrenia: Qualitative
study. BMC Psychiatry, 10:94
Chitty, K., Dobbins, T., Dawson, A., Isbister, G., & Buckley, N. (2017). Relationship
between prescribed psychotropic medications and co-ingested alcohol in intentional
self-poisonings. British Journal of Psychiatry, 210: 203-208 .
Newton-Howes, G., Foulds, J., Guy, N., Boden, J., & Mulder, R. (2017). Personality
disorder and alcohol treatment outcome: systematic review and meta-analysis. The
British Journal of Psychiatry, 211:22-30.
‘555’ Topics (5 slides on each topic with no more than 5 bullet points)

156
Personality disorder and substance misuse
Depression and alcohol
Psychotropic drug interactions with opioid substitution medications
Public health concerns of Chemsex
MCQs
1. Comparing antidepressants to placebo in people with alcohol and depression, improvements in the
following measures have recently been identified in a Cochrane Systematic Review except :
A. Reduced interview based depression score
B. Response to antidepressive medication
C. Full remission of depression
D. Increased number of abstinent patients
E. Fewer drinks per drinking day
2. Approximate percentage of people with psychosis who misuse substances at some point in their
lifetime:
A. 5
B. 20
C. 40
D. 60
E. 80
3. Using NICE guidance for people with alcohol-use disorders the following abstinence length is
suggested before treating the anxiety or depression condition:
A. 1-2 weeks
B. 3-4 weeks
C. 6-8 weeks
D. 10 -12 weeks
E. No time period specified – length of time based on clinical judgement.
4. Percentage of patients attending Community Mental Health Teams reporting past-year problem
drug use and/or harmful alcohol use has been found to be approximately:
A. 25
B. 35
C. 45

157
D. 55
E. 65
5. The following are true statements about Cannabis and psychosis except:
A. The onset of psychosis is about 3 years younger in cannabis users than in non-users
B. The relative risk of developing schizophrenia after any cannabis exposure is about 2.5
C. The specificity of the association between cannabis and psychotic disorders is low.
D. Certain genes such as COMT gene have been shown to moderate the risk of psychotic disorder with
adolescent cannabis exposure
E. Synthetic forms of cannabis such as spice do not contain cannabidiol
EMI Questions
Drugs that may induce psychiatric symptoms:
A. Gamma-Hydroxybutyric acid (GHB)
B. Lysergic acid diethylamide (LSD)
C. Ketamine
D. Phencyclidine (PCP)
E. Diazepam
F. Amphetamine
G. Cocaine
H. Alcohol
I. Cannabis
J. Butane
1a. This psychoactive component of this drug acts through the type 1 form of the receptors which
are found in high concentrations throughout the cerebellum, hippocampus, basal ganglia, cortex,
brainstem, thalamus and hypothalamus
1b. This compound acts as an agonist at 5HT2A receptor
1c. One of the main mechanisms of action of this drug is by reverse transfer of the neurotransmitter
dopamine
Psychotropic medications used in people with co-occurring mental health and alcohol/drug use
conditions:
A. Diazepam

158
B. Quetiapine
C. Risperidone
D. Citalopram
E. Amisulpride
F. Sertraline
G. Baclofen
H. Olanzapine
I. Aripipazole
J. Fluoxetine
2a. Disulfiram can inhibit the metabolism of this compound
2b. This antipsychotic should be considered in patients with impaired liver function
2c. This agent may have a role in promoting maintenance of alcohol abstinence and can be safely used
in patients with impaired liver function
Additional Resources / Reading Materials
E-Learning
Royal College of Psychiatrists CPD Online
Dual diagnosis: the diagnosis and treatment of depression with co-existing substance
misuse.
Journal Articles
Agabio, R., Trogu, E., & Pani, P. (2018, 4). Antidepressants for the treatment of people with
co-occurring depression and alcohol dependence. The Cochrane database of systematic
reviews, 4, CD008581.
Bebbington, P., & McManus, S. (2009). Adult psychiatric morbidity in England, 2007: results
of a household survey. London: National Centre for Social Research
Caton, C., Hasin, D., Shrout, P., Drake, R., Dominguez, B., Samet, S., & Schanzer,
B. (2006). Predictors of psychosis remission in psychotic disorders that co-occur with
substance use. Schizophrenia Bulletin, 32(4), 618-25.
Colizzi, M., & Murray, R. (2018, 4 20). Cannabis and psychosis: what do we know and what
should we do? The British Journal of Psychiatry, 212(04), 195-196.
Conner, K. R., Pinquart, M., & Duberstein, P. R. (2008). Meta-analysis of depression and
substance use and impairment among intravenous drug users (IDUs). Addiction, 103(4), 524-
534

159
Conner, K. R., Pinquart, M., & Gamble, S. A. (2009). Meta-analysis of depression and
substance use among individuals with alcohol use disorders. Journal of Substance Abuse
Treatment, 37(2), 127-137
Conner, K. R., Pinquart, M., & Holbrook, A. P. (2008). Meta-analysis of depression and
substance use and impairment among cocaine users. Drug and Alcohol Dependence, 98(1-2),
13-23
Davis, L. L., Pilkinton, P., Wisniewski, S. R., Trivedi, M. H., Gaynes, B. N., Howland, R. H., et al.
(2012). Effect of concurrent substance use disorder on the effectiveness of single and
combination antidepressant medications for the treatment of major depression: an
exploratory analysis of a single-blind randomized trial. Depression and anxiety, 29(2), 111-
122.
Delgadillo, J. G., C. Gilbody, S. Payne, S. (2013). Depression, anxiety and comorbid substance
use: association patterns in outpatient addictions treatment. Mental Health and Substance
Use, 6(1), 59-75
Foulds, J., Adamson, S., Boden, J., Williman, J., & Mulder, R. (2015). Depression in patients
with alcohol use disorders: Systematic review and meta-analysis of outcomes for
independent and substance-induced disorders. Journal of Affective Disorders, 185:47-59.
Healthcare Quality Improvement Partnership. (2018). National Confidential Inquiry into
Suicide and Homicide: Report 2018.
Iovieno, N., Tedeschini, E., Bentley, K., Evins, a., & Papakostas, G. (2011). Antidepressants for
major depressive disorder and dysthymic disorder in patients with comorbid alcohol use
disorders: a meta-analysis of placebo-controlled randomized trials. The Journal of clinical
psychiatry, 72 (8), 1144-51.
Maremmani, A. G., Rovai, L., Rugani, F., Bacciardi, S., Dell'osso, L., & Maremmani, I. (2014).
Substance abuse and psychosis. The strange case of opioids. Eur Rev Med Pharmacol Sci,
18(3), 287-302
National Institute for Health and Care Excellence. (2011). Psychosis with coexisting
substance misuse CG120. London: National Institute for Health and Care Excellence
Niemi-Pynttäri, J., Sund, R., Putkonen, H., Vorma, H., Wahlbeck, K., & Pirkola, S.
(2013). Substance-induced psychoses converting into schizophrenia: A register-
based study of 18,478 finnish inpatient cases. Journal of Clinical Psychiatry, 74(1),
e94-9.
Nunes E V, Levin F R. (2004) Treatment of depression in patients with alcohol or other drug
dependence: a meta-analysis. JAMA, 291(15), 1887-1896

160
Pettinati, H., O'Brien, C., & Dundon, W. (2013). Current status of co-occurring mood and
substance use disorders: A new therapeutic target. American Journal of Psychiatry, 170(1),
23–30
PHE. (2017). Better care for people with co-occurring mental health, and alcohol and drug
use conditions.
Radhakrishnan, R., Wilkinson, S. T., & D'Souza, D. C. (2014). Gone to Pot - A Review of the
Association between Cannabis and Psychosis. Front Psychiatry, 5, 54
Riper, H., Andersson, G., Hunter, S., de Wit, J., Berking, M., & Cuijpers, P. (2014). Treatment
of comorbid alcohol use disorders and depression with cognitive-behavioural therapy and
motivational interviewing: A meta-analysis. Addiction, 109(3), 394-406
Starzer, M., Nordentoft, M., & Hjorthøj, C. (2018). Rates and predictors of conversion to
schizophrenia or bipolar disorder following substance-induced psychosis. American Journal
of Psychiatry, 175(4), 343-350.
Weaver, T., Madden, P., Charles, V., Stimson, G., Renton, A., Tyrer, P., et al. (2003).
Comorbidity of substance misuse and mental illness in community mental health and
substance misuse services. The British Journal of Psychiatry, 183, 304-313
Session 4: Recovery Concepts, Psycho-social Treatments and Service Development
Learning Objectives
To understand principle of recovery and how this is implemented with drug and alcohol
services
To gain knowledge of some of the basic concepts of motivation interviewing
To gain knowledge about how services for drug and alcohol are developed
To understand what ancillary services are frequently used with alcohol and drug services
Curriculum Links
11.5 Impact of drug and alcohol use on Public Health
11.10 Motivational Interviewing
Expert Led Session

161
Psychosocial treatments for people with substance misuse problems
Overview of various interventions that are offered in substance misuse: brief interventions,
mapping techniques (e.g. ITEP), motivational interviewing overview
Useful to use youtube clips below for teaching session
Case Presentation
Presentation of a person who had significant substance misuse problem +/- comorbid
mental illness who has recovered and resources employed to effect and maintain this
recovery
Journal Club Presentation
Heather, N. (2017). Q: Is Addiction a Brain Disease or a Moral Failing? A: Neither.
Neuroethics, 10(1), 115-124.
Hibbert, L., & Best, D. (2011). Assessing recovery and functioning in former problem drinkers
at different stages of their recovery journeys. Drug and Alcohol Review, 30( 1), 12-20
Humphreys K, Blodgett JC, Wagner TH.(2014) Estimating the efficacy of Alcoholics
Anonymous without self-selection bias: An instrumental variables re-analysis of randomized
clinical trials. Alcoholism: Clinical and Experimental Research, 38(11), 2688-94
.
‘555’ Topics (5 slides on each topic with no more than 5 bullet points)
Overview of non-statutory services ( e.g. AA, NA, SMART)
Risks associated with substance misuse in prisoners
Harm minimisation approaches in substance misuse services
Gambling disorder – diagnosis and treatment
MCQs
1. Which of the following is not an example of change talk:
A. Desire: I would like to stop using alcohol
B. Ability: I could stop alcohol use
C. Reason: Alcohol worsens my psoriasis
D. Accomplishment: I finally stopped alcohol

162
E. Need: I have got to stop alcohol
2. Prochaska and DiClemente’s stages of change include the following except:
A. Contemplation
B. Preparation
C. Maintenance
D. Relapse
E. Persistence
3. Who of the following is most closely linked with Motivational Interviewing:
A. Carl Jung
B. Carl Rogers
C. David Winnicott
D. Aaron Beck
E. Melanie Klein
4. All of the following are key principles of Motivational Interviewing except:
A. Roll with resistance
B. Express empathy
C. Develop discrepancy
D. Support self efficacy
E. Strengthen safety behaviour
5. Which of the following is true of needle exchange programmes in the UK
A. Pharmacies are unable to provide this service
B. It is only available to people prescribed opioid substitute medications
C. It is only available in urban centres with populations greater than 50000
D. Only qualified nursing staff can dispense equipment
E. It reduces injection risk behaviours among people who inject drugs, in particular self- reported
sharing of needles and syringes, and frequency of injection
EMI Questions
Potential mechanisms to manage resistance:

163
A. Simple reflection
B. Amplified reflection
C. Double sided reflection
D. Shifting focus
E. Reframing
F. Agreement with a twist
G. Emphasising personal control
H. Coming alongside
I. Reaction
J. Summarizing
1a. This approach enables the validity of the client’s raw observation to be regarded but tries to
interpret the observation in a new way.
1b. This may be considered when someone says “I am my own man, I do not need you to tell me what
to do”
1c. The following exchange highlights this approach:
Client: “I have been able to use more heroin than other people in my town”
Therapist: “Perhaps you are simply immune to the effects of heroin”.
Mutual aid groups:
A. Alcoholics Anonymous (AA)
B. SMART Recovery
C. GamCare
D. TalkToFrank
E. Teen Challenge UK
F. British Doctors’ and Dentists' Group
G. Narcotics Anonymous (NA)
H. Breaking free
I. Kaleidoscope
J. Discover
2a. This is a global, community-based organization with a multi-lingual and multicultural membership.
It was founded in 1953.
2b. This is a science-based programme to help people manage their recovery from any type of
addictive behaviour. It began in 1994.

164
2c. This is a free drug advice service that is aimed at parents and children in particular. It is available
24 hours a day and online and by text message.
Additional Resources / Reading Materials
Books
Miller, W. R., & Rollnick, S. (2012). Motivational interviewing : helping people change (3rd
ed.). New York, NY: Guilford Press. (any edition reasonable)
Rodgers, N. Le Freak: An Upside Down Story of Family, Disco, and Destiny
E-Learning
Drink and Drug News- local update on substance misuse with recovery focus
https://drinkanddrugsnews.com/
Harm minimisation
http://www.prenoxadinjection.com/
https://www.harmreduction.co.uk/resources
Motivation interviewing
http://www.youtube.com/watch?v=80XyNE89eCs
http://www.youtube.com/watch?v=URiKA7CKtfc
http://www.youtube.com/watch?v=s3MCJZ7OGRk
http://www.youtube.com/watch?v=_KNIPGV7Xyg
Journal Articles
Best, D., Albertson, K., Irving, J., Lightowlers, C., Mama-Rudd, A., & Chaggar, A. (2015). The
UK Life in Recovery Survey 2015 : the first national UK survey of addiction recovery
experiences. Project Report. Sheffield. Helena Kennedy Centre for International Justice.
Sheffield Hallam University.
Faculty of Addictions Psychiatry, R. C. o. P. (2014). Gambling: the hidden addiction. Faculty
report FR/AP/01. Future trends in addictions – discussion paper 1.
Degenhardt, L., Larney, S., Kimber, J., Gisev, N., Farrell, M., Dobbins, T., et al. The impact of
opioid substitution therapy on mortality post-release from prison: retrospective data linkage
study. Addiction. 109(8), 1306-1317.
Gossop, M., Trakada, K., Stewart, D., & Witton, J. (2005). Reductions in criminal convictions
after addiction treatment: 5-year follow-up. Drug and alcohol dependence, 79(3), 295-302.

165
Hall, W., Carter, A., & Forlini, C. (2015). The brain disease model of addiction: Is it supported
by the evidence and has it delivered on its promises? The Lancet Psychiatry, 2, 105–110.
Heather, N., Best, D., Kawalek, A., Field, M., Lewis, M., Rotgers, F., Heim, D. (2017).
Challenging the brain disease model of addiction: European launch of the addiction theory
network. Addiction Research and Theory, 26(4), 249-255.
Larney, S., Gisev, N., Farrell, M., Dobbins, T., Burns, L., Gibson, A., et al. Opioid substitution
therapy as a strategy to reduce deaths in prison: retrospective cohort study. BMJ Open, 4(4),
e004666.
National Institute for Health and Care Excellence. (2014). Needle and syringe programmes
PH52. London: National Institute for Health and Care Excellence.
Strang, J. (2012). Medications in recovery re-orientating drug dependence treatment:
National Treatment Agency.
Volkow, N., & Koob, G. (2015). Brain disease model of addiction: Why is it so controversial?
The Lancet Psychiatry, 2(8), 677-679.
INTELLECTUAL DISABILITIES SEMESTER 3:
Session 1: History Taking and Communication in Patients with an
Intellectual Disability
Learning Objectives
Awareness of the difficulties encountered in assessing patients with an intellectual disability
Use of other forms of communication rather than just verbal
The importance and role of the developmental history
To develop an understanding of how patients with an intellectual disability can present
with conditions such as a mental disorder
Curriculum Links

166
13.3 Clinical
13.3.1 Assessment and communication with people with intellectual disability.
13.3.2 The presentation and diagnosis of psychiatric illness and behavioral disorder in people
with intellectual disability, including the concept of diagnostic overshadowing
13.2.2 Aetiology. The influence of psychological and social factors on intellectual and
emotional development in people with intellectual disability, including the concept of
secondary handicap.
Expert Led Session
Assessment, interviewing & gathering information in adults with Intellectual disability
Case Presentation
Case presentation of local patient with intellectual disability, identified by tutor or
specialist in post. (This does not have to be an inpatient and discussion with the local ID
team may be appropriate in advance to identify such a case). Brief discussion on aetiology
as applicable to the case in a formulation type summary
Journal Club Presentation
Assessment of mental health problems in people with autism Xenitidis K., Paliokosta E.,
Maltezos S. and Pappas V. (2007). Advances in Mental Health and Learning Disabilities 1, 4,
15-22.
A guide to intellectual disability psychiatry assessments in the community. Advances in
psychiatry Treatment November 1, 2013 19:429-436
Learning disability in the accident and emergency department. Advances in Psychiatric
Treatment January 2005 11:45-57

167
‘555’ Topics (5 slides on each topic with no more than 5 bullet points)
Please select one of the following:
Assessment of the agitated patient in the emergency room setting (focus on
environment, style of communication, getting informant history etc)
How to assess for a mental illness in a patient with a Intellectual disability (Focus on
depressed mood or psychosis depending on confidence of chair- possible mute patient,
signs and how they differ, role of biological symptoms and effect on routine)
How to perform a full Developmental History (Focus on all aspects of development and issues
of schooling, statement of educational needs, support and current functional ability etc)
MCQs
1. With regard to people with intellectual disabilities, which of the following is false:
A. Diagnosis of intellectual disability is dependent on significantly sub-average IQ and associated
deficits in adaptive behaviour with onset occurring before 18 years of age
B. The prevalence of intellectual disability in the general population is 3%
C. Mental health problems are more common than in the general population
D. Mental health problems always present as challenging behaviour
E. The philosophy of normalisation supports people with intellectual disabilities accessing generic
health services.
2. According to ICD-10, the following is not a degree of mental retardation:
A. Borderline
B. Moderate
C. Profound
D. Severe
E. Mild
3. Disruptive and dissocial behaviour occurs more commonly in which of the following category?
A. Mild intellectual disability
B. Moderate intellectual disability
C. Severe intellectual disability
D. Profound intellectual disability
E. Equally common across all categories
4. The prevalence of epilepsy in the intellectual disability population is approximately:
A. 1-2%
B. 5-10%
C. 10-15%
D. 20-25%

168
E. 50%
5. The communication style that does not interfere with assessment in the intellectual disability
population is:
A. Denial
B. Fabrication
C. Engagement
D. Digression
E. Suggestibility
Additional Resources / Reading Materials
Books
Intellectual Disability Psychiatry: A Practical Handbook. Edited by Angela
Hassiotis, Diana Andrea Barron and Ian Hall.(2010) Wiley Publications.
The Psychiatry of Intellectual Disability. Edited by Meera Roy, Ashok Roy &
David Clark. 2006 Radcliffe Publishing Ltd.
Royal College of Psychiatrists. DC-LD: Diagnostic Criteria for Psychiatric Disorders
for Use with Adults with Learning Disabilities/mental Retardation (Occasional paper)
http://www.rcpsych.ac.uk/publications/collegereports/op/op48.aspx
E-Learning
http://www.gmc-uk.org/learningdisabilities/
Journal Articles
Cooper, A., Simpson, N. (2006). Assessment and classification of psychiatric
disorders in adults with learning disabilities. Psychiatry, 5: 306-11.
Cooper, S.-A., van der Speck, R. (2009) Epidemiology of mental ill health in adults
with intellectual disabilities. Current Opinion in Psychiatry. 22: 431-436.

169
Session 2: Mental Disorders in Intellectual Disability
Learning Objectives
Recognising and identifying how the presentation of mental disorders differs in ID population
Importance of collateral information from various sources
Role of medication/ doses/side effects
Curriculum Links
13.1 Services
13.1.2 The provision of specialist psychiatric services for people with intellectual disability
13.2.1 The factors which might account for the observed high rates of psychiatric behavioral
disorders in this group.
13.3.2 The presentation and diagnosis of psychiatric illness and behavioral disorder in people
with intellectual disability, including the concept of diagnostic overshadowing
13.3.4 The application of psychiatric methods of treatment in intellectual disability including
drug treatments. The application of a multidisciplinary approach to the management of
mental health problems in people with intellectual disability
Expert Led Session
Dr Patel’s presentation - Mental disorders
Case Presentation
Case presentation of a local patient with intellectual disability, identified by tutor or
specialist in post. If there is neither a specialist consultant nor tutor in post discussion with
the local ID team may be appropriate in advance to identify such a case. Brief discussion
on aetiology as applicable to the case in a formulation type summary
Journal Club Presentation
Please select one of the following papers:
Cooper S.A., Smiley E., Morrison J., Williamson A. and Allan L. (2007) Mental ill-health
in adults with intellectual disabilities: prevalence and associated factors. British Journal
of Psychiatry 190, 1, 27-35.

170
Hurley A.D. (2006) Mood disorders in intellectual disability. Current Opinion in Psychiatry
19, 5, 465-469.
Cooper S.A. Melville C.A. and Enfield S.L. (2003) Psychiatric diagnosis, intellectual
disabilities and Diagnostic Criteria for Psychiatric Disorders for Use with Adults with
Learning Disabilities/Mental Retardation (DC-LD). Journal of Intellectual Disability Research
47, supplement one, 3-15.
‘555’ Topics (5 slides on each topic with no more than 5 bullet points)
Please select one of the following:
Assessment of the Psychotic patient in the community setting (focus on environment, style
of communication, getting informant history etc.)
Perform a risk assessment in a patient with a moderate Learning disability who is
presenting with self-injurious behaviour (Focus on nature of behaviours, communication
ability of the patient, issues of any change.)
What are the roles of a community ID nurse, speech and Language therapist and an
Occupational therapist in the ID team?(You can discuss this with your local ID team to
guide with the task)
MCQs
1. In individuals with severe learning disability, self-injurious behaviour has a peak
occurrence between the ages of:
A. 10-15 yrs
B. 15-20
C. 20-25
D. 25-30
E. 35-40
2. Self-injurious behaviour is common in which of the following:
A. Cri du chat syndrome
B. Angelman syndrome
C. Downs Syndrome
D. Cornelia de Lange syndrome
E. Lesch Nyhan syndrome

171
3. Prevalence of depression in ID is around:
A. 1%
B. 2-4%
C. 5-15%
D. 16-25%
E. 26 -35%
4. Which of the following apply to the PAS-ADD:
A. Was developed from the SCID
B. Focuses exclusively to Axis II Disorders
C. Designed for completion by carers with knowledge of psychopathology
D. Each item is rated on a 6 point scale
E. It comprises a life events and a problems section
5. In patients with ID and schizophrenia compared with patients with ID alone, the following
were noted:
A. Impaired mobility
B. High birth weight
C. Gestation beyond 38 weeks
D. Impaired hearing
E. Low rates of obstetric complications
Additional Resources / Reading Materials
Books
Seminars in the psychiatry of learning disabilities – second edition (2003), The Royal college of Psychiatrists, Gaskell
Psychiatric and behavioural disorders in developmental disabilities and mental retardation (2001), Edited by Nick Bouras, Cambridge University Press, 1999. Reprinted 2001.
Practice guidelines for the assessment and diagnosis of mental health problems in adults with intellectual disability (2001) Deb, S., Matthews, T., Holt, G., & Bouras, N. published by Pavillion for the European Association for mental Health in Mental Retardation.
Sturmey, P. (1995) DSM-III-R and persons with dual diagnoses: conceptual issues and strategies for future research, Journal of intellectual Disability Research, 39, 357-364
Corbett, J. A. (1979) Psychiatric morbidity and mental retardation. In: F. E. James and R. P. Snaith (Eds.) Psychiatric illness and Mental Handicap, London: Gaskell.
Lund, J. (1985) The prevalence of psychiatric morbidity in mentally retarded adults, Acta Psychiatrica Scandinavica, 72, 563-570

172
Reiss, S. (1988) The Reiss Screen for Maladaptive Behaviour. Ohio: IDS Publishing Corporation.
Matson JL and Bamburg J (1998) Reliability of the assessment of dual diagnosis (ADD), research in Developmental Disabilities 20, 89-95
Moss S (2002) The mini PAS-ADD interview pack, Brighton: Pavilion Publishing
Roy A, Matthew H, Martin D and fowler V (2002) HoNOS-LD: Health of the Nation Outcome scale for people with Learning Disabilities, Kidderminster: British Institute of Learning Disabilities
Journal Articles
Bouras, N. and Drummond, C. (1992) Behaviour and psychiatric disorders of people with mental handicaps living in the community. Journal of Intellectual Disability Research, 36, 349-357.
Patel, P., Goldberg, D., and Moss, S. (1993) Psychiatric Morbidity in older people with moderate and severe learning disability: The Prevalence Study, British Journal of Psychiatry, 163, 481-491.
Diagnostic Criteria for Psychiatric Disorders for adults with learning disabilities (DC-LD) (2003) Journal of Intellectual Disability Research, 47, supplement 1.

173
Session 3: Behavioural Issues in Intellectual Disability
Learning Objectives
Understanding challenging behaviour and awareness of methods of recording/ assessing
Aetiology of challenging behaviours
Management options
Curriculum Links
13.1 Services
13.1.2 The provision of specialist psychiatric services for people with intellectual disability
13.2.1 The factors which might account to the observed high rates of psychiatric behavioural disorders in this group
13.3.2 The presentation and diagnosis of psychiatric illness and behavioural disorder in people with intellectual disability, including the concept of diagnostic overshadowing
Expert Led Session
Challenging Behaviour Talk
Case Presentation
Case presentation of local patient with intellectual disability presenting with behavioural
problems, identified by tutor or specialist in post (this does not have to be an inpatient
and discussion with the local ID team may be appropriate in advance to identify such a
case). Brief discussion on aetiology as applicable to the case in a formulation type
summary
Journal Club Presentation
Please select one of the following papers:
Unwin G.L. and Deb S. (2008) A multi-centre audit of the use of medication for the
management of behavioural problems in adults with intellectual disabilities. British Journal
of Learning Disabilities, 36, 2, 140-143
Cooper S.A. Melville C.A. and Enfield S.L. (2003) Psychiatric diagnosis, intellectual
disabilities and Diagnostic Criteria for Psychiatric Disorders for Use with Adults with
Learning Disabilities/Mental Retardation (DC-LD). Journal of Intellectual Disability Research
47, supplement one, 3-15.

174
Group-based cognitive-behavioural anger management for people with mild to moderate
intellectual disabilities: cluster randomised controlled trial BJP October 2013 203:288-296;
‘555’ Topics (5 slides on each topic with no more than 5 bullet points)
Please select one of the following:
Review of Frith Guidelines on management of Patients with ID that present with Aggressive
or Self Injurious behaviours. (Read the Guidelines in particular the flow charts)
Describe challenging behaviour and the various phases of the cycle of challenging behaviour
(Focus on nature of behaviours, communication ability of the patient, issues of any change.)
Formal Assessment of a behavioural problem with a view to intervention. (You can discuss
this with your local ID team to guide with the task). Steps involved, would include ABC
charts or functional assessments and basic behavioural interventions
MCQs
1. Causes of challenging behaviour in a person with learning disability:
A. Pain
B. Overstimulation
C. Under stimulation
D. Wanting attention
E. All of the above
2. The following statements are true of factors increasing challenging behaviours in a person
with learning disability except which option?
A. Undetected physical illness
B. Communication problems
C. Underlying mental illness
D. Environmental issues
E. Problem solving ability
3. Inappropriate behaviours may be maintained by re-enforcement from others. Which of
the following is a process that helps to identify factors maintaining that behaviour?
A. Functional analysis
B. Statistical analysis
C. Procedural analysis
D. Behavioural analysis

175
EMI Questions
Match each of the following psychological strategies to their possible effects:
A. Proactive Strategies
B. Positive Programming
C. Focused Support
D. Reactive Strategies
1. Systematic instructions given for greater skills and competence development which improves
social integration
2. To produce rapid results and reduce reactive strategies
3. Designed to manage the behaviours at the time they occur
4. To produce change over time
Additional Resources / Reading Materials
E-Learning
www.LD-Medication.bham.ac.uk
British Psychological Society and Royal College of Psychiatrists (BPS & RCPsych, 2006). Challenging behaviour: a unified approach. Available:
http://www.rcpsych.ac.uk/pdf/23%2009%202011%20LD%20PSYCH%20READING%20LIST.pdf

176
Session 4: Offenders in Intellectual Disability
Learning Objectives
Awareness of differences in offending behaviours in ID population
Outcome following Offence
Treatment options for offenders with ID
Curriculum Links
13.1 Services
13.1.2 The provision of specialist psychiatric services for people with intellectual disability *Forensic ID
13.2.1 The factors which might account to the observed high rates of psychiatric behavioural
disorders in this group.
13.2.2 The influence of psychological and social factors on intellectual and emotional development
in people with intellectual disability, including the
13.3.2 The presentation and diagnosis of psychiatric illness and behavioural disorder in people
with intellectual disability, including the concept of diagnostic overshadowing
13.2.1 The factors which might account to the observed high rates of psychiatric behavioural
disorders in this group
13.3.7 The assessment, management and treatment of offenders with intellectual disability
Expert Led Session
Dr. Razzaque Lecture (and Dr Burke and Dr Gupta) + optional case vignettes
Case Presentation
Case presentation of local patient with intellectual disability presenting with offending behaviour
problems. , identified by tutor or specialist in post (this does not have to be an inpatient and discussion
with the local ID team may be appropriate in advance to identify such a case). Brief discussion on
aetiology as applicable to the case in a formulation type chair to pose question if patient has an IQ of
55 how will this alter i.e. pathway/management.

177
Journal Club Presentation
Please select one of the following papers:
Mentally disordered detainees in the police station: the role of the psychiatrist APT March 2010 16:115-123; doi:10.1192/apt.bp.107.004507
Ian Hall Young offenders with a learning disability APT July 2000 6:278-
285; doi:10.1192/apt.6.4.278
S. Halstead Forensic Psychiatry for People with Learning Disability APT March 1996 2:76-85;
doi:10.1192/apt.2.2.76
Arrest patterns among mentally disordered offenders. BJP September 1988 153:313-6 ‘555’ Topics (5 slides on each topic with no more than 5 bullet points)
Please select one of the following:
Describe the pathway of a person with intellectual disability following a recent fire
setting incident
Describe Disability Discrimination Act and its impact on patients and clinicians. (Focus
on nature of behaviours, communication ability of the patient, issues of any change.)
Safe Guarding Formal Assessment of a behavioural problem with a view to intervention.
(You can discuss this with your local ID team to guide with the task)
MCQs
1. Offenders with ID compared to other offenders:
A. Start offending at a later age
B. Frequently are convicted of single offences
C. Arson offences are over represented
D. More in severe and profound disability
E. Less likely to be convicted
2. Mentally ill offenders with ID were found to be:
A. Younger at first conviction
B. Had less admissions to psychiatric hospitals
C. Showed a high frequency of violence
D. Tended to be females
E. Committed more serious offences during the follow-up period

178
3. In patients with ID referred for evaluation for a report, the percentage felt not competent to stand
trial is (approximately):
A. Up to 10%
B. 11 - 20%
C. 21 - 30%
D. 31 - 40%
E. 41 - 50%
4. In offenders with ID the following is the most commonly used form of psychological input/ therapy:
A. Psychodynamic Psychotherapy
B. Gestalt Therapy
C. Cognitive Behavioural Therapy
D. Response and stimulus prevention
E. Dialectical Behavioural Therapy
5. Regarding the PCL-R;
A. Low scores are related to recidivism
B. Relate to Cluster A personality disorders
C. Those in medium security have higher scores than those in high security
D. Scoring patterns in ID population are significantly different compared to the general population
E. High scores relate to aggression
Additional Resources / Reading Materials
**William Fraser & Michael Kerr (eds) Seminars in the psychiatry of learning disability Gaskell
Press 2003 ISBN 1-901242-93-5
Chapter 16: Forensic psychiatry and learning disability by Susan Johnston
Wm Lindsay et al (Eds) Offenders with developmental disabilities 2004. Willey ISBN: 0-471-
48635-3
Ian Hall Young offenders with a learning disability APT July 2000 6:278-
285; doi:10.1192/apt.6.4.278
S. Halstead Forensic Psychiatry for People with Learning Disability APT March 1996 2:76-85;
doi:10.1192/apt.2.2.76
Mentally disordered detainees in the police station: the role of the psychiatrist APT March
2010 16:115-123; doi:10.1192/apt.bp.107.004507
Kalpana Dein and Marc Woodbury-Smith Asperger syndrome and criminal behaviour APT
January 2010 16:37-43; doi:10.1192/apt.bp.107.005082
David Murphy Understanding offenders with autism-spectrum disorders: what can forensic
services do?: commentary on... asperger syndrome and criminal behaviour APT January 2010

179

180
16:44-46; doi:10.1192/apt.bp.109.006775
Michael A. Ventress, Keith J. B. Rix, and John H. Kent: Keeping PACE: fitness to be
interviewed by the police APT September 2008 14:369-381; doi:10.1192/apt.bp.107.004093
Legal aspects in Psychiatry of Learning Disability:
This module does not currently include a specific lecture on legal aspects. You should be familiar
with the Mental Health Act 1983 and Mental Capacity Act 2005 from other modules on this course.
Some supplementary reading is included here:
Asit B. Biswas and Avinash Hiremath: Mental capacity assessment and ‘best interests’
decision-making in clinical practice: a case illustration APT November 2010 16:440-447;
doi:10.1192/apt.bp.108.006494

PSYCHOTHERAPY SEMESTER 3:
Session 1: Referring to Psychotherapy Services
Learning Objectives
Identify relevance to psychotherapy of particular aspects of the psychiatric history. Account for psychiatric presentation in psychological terms. Know when to refer patients appropriately to specialist services Understand that psychotherapies have an empirical evidence base underpinning referral for treatment
Curriculum Links
6 – Organization & Delivery of Psychiatric Services 7.1.x.4 – Psychological aspects of treatment 9.0 – Psychotherapy 9.1.1 – Dynamic Psychotherapy or 9.3 CBT or 9.4 other modalities * *Depending on case material and therapy described.
Expert Led Session
What happens in a specialist psychotherapy assessment and why? What therapies are indicated for which common conditions? – To include reference to the current evidence base. NICE Guidance and its limits / omissions.
Case Presentation
Case presentation of a local patient referred for psychotherapy. Case to be identified by tutor/chair/specialist in post. To highlight aspects of psychiatric history that indicate referral to psychotherapy. To highlight aspects of history that would be relevant for specialist psychotherapy assessment. To highlight factors that suggest good or bad prognostic signs for therapy outcome.
Journal Club Presentation
The paper should preferably be selected in discussion with the chair / presenter of the expert led session
• Schöttke H. et al (2017) “Predicting psychotherapy outcome based on therapist interpersonal skills: A five-year longitudinal study of a therapist assessment protocol” Psychotherapy Research 27(6): 642–652
• Clarke et al (2013) “Cognitive analytic therapy for personality disorder: randomised controlled trial” BJP 202:129-134 (with accompanying Editorial) Mulder & Chanen (2013) “Effectiveness of cognitive analytic therapy for personality disorders” BJP 202:89-90
• Lorentzen et al (2013) “Comparison of short- and long-term dynamic group psychotherapy: randomised clinical trial” BJP 203:280-287

182
• Leichsenring & Rabung (2008) “Effectiveness of Long-Term Psychodynamic Psychotherapy: A Meta-Analysis” JAMA 300(13): 1551-1565
‘555’ Topics (5 slides on each topic with no more than 5 bullet points)
Select one of the following:
• Important aspects of psychiatric history to include in referral
• Positive predictors of engagement with therapy
• Relative contraindications to therapy
• Potential adverse effects of therapy
MCQs
1. The following theorists are correctly matched with the concepts that they introduced: A. Sigmund Freud The Subconscious B. Melanie Klein The Paranoid-Schizoid Position C. David Malan The Two Triangle technique D. Herbert Rosenfeld Containment E. Anna Freud The Ego 2. Defences: A. Are always pathological. B. Reduce anxiety. C. Enhance conscious insight. D. Are universal. E. Develop later in childhood. 3. A psychotherapy formulation: A. Leads to a diagnosis. B. Ignores the past. C. Is only applicable in psychotherapy. D. Is theory neutral. E. Makes predictions.
4. How do you define transference?
A. The empathy shown by the therapist to the patient.
B. Defence mechanism where attention is shifted to a less threatening / more benign target.
C. Therapist’s response to the patient drawn from therapist’s previous life experiences.
D. Patient’s response to the therapist based upon their earlier relationships
E. All of the above
5. What would suggest a patient has good psychological mindedness?

183
A. Becoming very upset when talking about the past
B. Finding it hard to step back and observe the situation objectively
C. Needing to be talked through assessment with lots of prompts
D. Reasonable sense of self esteem
E. None of the above
Additional Resources / Reading Materials
Jessica Yakeley (2014)“Psychodynamic psychotherapy: developing the evidence base” APT 20:269-279 Chess Denman (2011) “The place of psychotherapy in modern psychiatric practice” APT 17:243-249

184
Session 2: Psychological approaches to EUPD
Learning Objectives
The overall aim of the session is to understand emotionally unstable personality disorder from a psychological /psychotherapy perspective.
By the end of the session the trainee should have an understanding of the psychological aspects of this diagnosis.
By the end of the session the trainee should have a more detailed understanding of at least one of the newer therapy approaches to EUPD.
Curriculum Links
2.x – Human Development 6 – Organization & Delivery of Psychiatric Services 7.1.9.1-5 – Psychological aspects of treatment 9.0 – Psychotherapy 9.1.1 – Dynamic Psychotherapy or 9.3 CBT or 9.4 other modalities * *Depending on case material and therapy described.
Expert Led Session
Developments in the psychological understanding of EUPD: aetiology and presentation What therapies are indicated for EUPD? – To include reference to the current evidence base. NICE Guidance and its limits / omissions. Learning points for general mental health work
Case Presentation
Case Presentation of patient with Emotionally Unstable Personality Disorder
Preferably a patient who has had / is having psychological therapy for this.
Good level of detail about background history essential

185
Journal Club Presentation
Please select one of the following papers: Clarke et al (2013) “Cognitive analytic therapy for personality disorder: randomised controlled trial” BJPsych 202:129-134
(with accompanying Editorial) Mulder & Chanen (2013) “Effectiveness of cognitive analytic therapy for personality disorders” BJPsych 202:89-90
McMain et al (2009) “A Randomized Trial of Dialectical Behavior Therapy Versus General Psychiatric Management for Borderline Personality Disorder” Am J Psychiatry 166:1365–1374 Batement & Fonagy (2009) “Randomized Controlled Trial of Outpatient Mentalization-Based Treatment Versus Structured Clinical Management for Borderline Personality Disorder” Am J Psychiatry 166:1355–1364 Doering et al (2010) “Transference-focused psychotherapy v. treatment by community psychotherapists for borderline personality disorder: randomised controlled trial” BJPsych 196:389-395 Bamelis et al (2014) Results of a Multicenter Randomized Controlled Trial of the Clinical Effectiveness of Schema Therapy for Personality Disorders Am J Psychiatry 171: 305 – 322
‘555’ Topics (5 slides on each topic with no more than 5 bullet points)
Select one of the following:
• Signs & Symptoms of Emotionally Unstable Personality Disorder
• Biological aetiology of EUPD
• Drug treatments in EUPD

186
MCQs
1. The following are symptoms of Emotionally Unstable Personality Disorder (EUPD): a. Unstable or unclear self-image b. Callous unconcern for others c. Increased impulsivity d. Intense anger and aggression e. Unstable and intense relationships
2. EUPD is group in ‘Cluster B’ of DSM-IV along with:
a. Antisocial PD b. Schizotypal PD c. Narcissistic PD d. Dependent PD e. Histrionic PD
3. The following have been recommended by NICE in the treatment of EUPD:
a. Brief Dynamic Psychotherapy b. Mentalization Based Treatment c. Mindfulness Based Therapy d. Olanzepine e. Dialectical Behaviour Therapy
4. The following statements about EUPD are true:
a. EUPD is more commonly diagnosed in women b. EUPD is a lifelong condition if untreated c. Psychoanalysis is an effective treatment for EUPD d. EUPD is easily distinguished from mood disorder e. Almost all patients with EUPD have a history of abuse f. Patients with EUPD have a lower risk of death by suicide compared to those with mood
disorder g. Admissions to hospital lasting more than six months adversely affect prognosis. h. Prescribing antidepressants for unstable mood symptoms can be helpful i. EUPD can be co-morbid with mood disorder j. Severity of symptoms can be rated with the Zanarini scale
Additional Resources / Reading Materials
NICE on Borderline Personality Disorder – Clinical Guideline 78 & Quality Standards
Borderline Personality Disorder: An evidence based guide for generalist mental health professionals
by Anthony Bateman & Roy Krawitz Oxford (2013)
Choi-Kane et al “What works in the treatment of Borderline Personality Disorder" Curr Behav
Neurosci Rep (2017) 4:21–30

187
Session 3: Psychological approaches to Depression
Learning Objectives
To increase awareness of the psychological aspects of Depressive Disorder.
To have an introductory knowledge of the main psychological models for depression.
To have an overview of psychological treatments for Depression
Curriculum Links
1.1, 1.2, 1.3, 1.3.4, 2.3, 2.4, 2.6, 2.8, 6.1, 7.1.1, 9, 14
Expert Led Session
An overview of psychological therapies for Depressive Disorder
Case Presentation
This should be of a patient with depression, not necessarily one who is in / has had therapy. There
should be sufficient background history to generate a discussion about the psycho-social factors in
aetiology
Journal Club Presentation
The paper should preferably be selected in discussion with the chair / presenter of the expert led
session
Driessen et al (2015) The efficacy of short-term psychodynamic psychotherapy for
depression: A meta-analysis update Clinical Psychology Review 42: 1-15
Gottems Bastos et al (2015) The efficacy of long-term psychodynamic psychotherapy,
fluoxetine and their combination in the outpatient treatment of depression Psychotherapy
Research 25(5): 612-624
(Other paper suggested by expert if applicable)

188
‘555’ Topics (5 slides on each topic with no more than 5 bullet points)
Select one of the following:
Psychological factors in the aetiology of depression
Psychological symptoms of depression
Current psychological treatments for depression recommended by NICE

189
MCQs
1. NICE guidance (CG90):
B. Recommends Computerised CBT for mild-moderate depression
C. Recommends Psychotherapy for severe depression
D. Advises not combining medication with psychological therapies
E. Recommends Cognitive therapy for relapse prevention
F. Defines Short-term Psychodynamic Psychotherapy as 10-15 sessions over 3-4 months
2. Cognitive Therapy:
A. Is originally based on the work of Judith Beck
B. Identifies Cognitive Errors that lead to or maintain depressive thoughts
C. Focuses on non-conscious thought content
D. Is enhanced by concurrent antidepressant treatment
E. Should not be used in older patients
3. Psychodynamic Therapies:
A. Have no evidence base for effectiveness
B. Are based on the model of the mind put forward by Freud
C. Seek to eradicate a patient’s defences
D. Were among the first to link depression to loss
E. Focus on the past
4. Psychological factors in the aetiology of depression include
A. Parental indifference
B. Social circumstance
C. Maternal Depression
D. Cognitive biases or distortions
E. Bereavement
5. Evidence of effectiveness in the treatment of depression exists for:
A. Psychoanalytic therapy
B. Interpersonal Therapy
C. ‘Low intensity’ therapy in IAPT
D. Mentalization based CBT
E. EMDR

190
Additional Resources / Reading Materials
Sigmund Freud “Mourning and Melancholia” (1917 [1915]) Standard Edition 14: 237-258
Aaron Beck “Cognitive Therapy and the Emotional Disorders” 1976
Session 4: Psychological approaches to Trauma
Learning Objectives
Recognised clinical presentation of PTSD and Complex Trauma
Increase awareness of psychological treatments for PTSD and Complex Trauma
Curriculum Links
6 – Organization & Delivery of Psychiatric Services
7.1 – Psychological aspects of treatment
9.0 – Psychotherapy
9.1.1 – Dynamic Psychotherapy
or 9.3 CBT or 9.4 other modalities *
*Depending on case material and therapy described.
Expert Led Session
Background review of PTSD presentation
Psychological treatments for PTSD including NICE Guidance
Introduction to Complex Trauma
Case Presentation
Case presentation of a patient with PTSD or Complex Trauma.
To highlight aspects of psychiatric history that indicate diagnosis.
To highlight aspects of history that would be relevant for specialist psychotherapy
assessment.
To highlight factors that suggest good or bad prognostic signs for therapy outcome.

191
Journal Club Presentation
The paper should preferably be selected in discussion with the chair / presenter of the expert led session
• Bradley R. et al (2005) ‘A Multidimensional Meta-Analysis of Psychotherapy for PTSD’ Am J Psychiatry 162:214–227
• Santiago PN, Ursano RJ, Gray CL, Pynoos RS, Spiegel D, et al. (2013) ‘A Systematic Review of PTSD Prevalence and Trajectories in DSM-5 Defined Trauma Exposed Populations: Intentional and Non-Intentional Traumatic Events’. PLoS ONE 8(4): e59236. doi:10.1371/journal.pone.0059236
• Shalev A. Y. et al (2012) ’Prevention of Posttraumatic Stress Disorder by Early Treatment’ Arch Gen Psychiatry. 69(2):166-176
‘555’ Topics (5 slides on each topic with no more than 5 bullet points)
Select one of the following:
• Important aspects of psychiatric history to include in referral
• Evidence for and against ‘post-event debriefing’ or single interview
• Aetiology of PTSD

192
MCQs
1. The following treatments are indicated in PTSD:
A. EMDR B. Debriefing C. Psychoanalysis D. Schema Focused CBT E. Psychodynamic Psychotherapy
2. The following are risk factors for an increased likelihood of PTSD:
A. Male gender. B. Introverted character. C. Family history of Narcissistic Personality Disorder. D. Bereavement. E. Low educational attainment.
3. The following are part of the six diagnostic criteria for PTSD in ICD-10:
A. Exposure to any sort of trauma. B. Occasional memories of the traumatic event. C. Avoidance of situations that remind the person of the trauma. D. Normal social functioning. E. Symptoms of at least one week duration.
4. The following have been used in military circles as terms for what we now would call PTSD:
A. Shell Shock B. Lack of Moral Fibre C. Vietnam War Syndrome D. Old Soldier’s Syndrome E. Battle Paralysis
5. The following statements are true of PTSD:
A. Comorbidity is unusual B. There are detectable effects on the hypothalamo-pituitary axis C. “flashbacks’ or intrusive memories of the trauma are characteristic D. Endogenous opioids function is affected in PTSD E. Soldiers are at less risk of PTSD than rape victims
Additional Resources / Reading Materials
PTSD NICE Guidance CG26 (2005): to be reviewed 2018
Understanding Trauma: A Psychoanalytic Approach by Caroline Garland (1998) Karnac Books

193
ACROSS THE AGES SEMESTER 3:
Session 1: Psychosis Across the Ages
Learning Objectives
The overall aim is for the trainee to gain an overview into the similarities and differences
of psychosis across the different age ranges.
By the end of the session, trainees should understand the commonality and differences
in presentation of psychosis in different age groups.
By the end of the session, trainees should understand the aetiology of psychosis in different
age groups.
By the end of the session, trainees should understand the assessment and treatment process
for psychosis in the different age groups.
Curriculum Links
1b: Recognise how the stage of cognitive and emotional development may influence the aetiology, presentation and management of mental health problems
2a: Be familiar with contemporary ICD or DSM diagnostic systems with the ability to discuss the advantages and limitations of each
2a: State the typical signs and symptoms of psychiatric disorders as they manifest across the age range, including affective disorder; anxiety disorders; disorders of cognitive impairment; psychotic disorders; personality disorders; substance misuse disorders; organic disorders; developmental disorders; and common disorders in childhood
2a: Use the diagnostic system accurately in identifying specific signs and symptoms that comprise syndromes and disorders across the age range
2b: Describe the various biological, psychological and social factors involved in the predisposition to, the onset of and the maintenance of psychiatric disorders across the age range, including trauma
3a: Develop an individualised assessment and treatment plan for each patient and in collaboration with each patient
3a: Be able to explain to patients, families, carers and colleagues the process and outcome of assessment, investigation and treatment or therapeutic plan
3c: Accurately assess the individual patient’s needs and whenever possible in agreement with the patient, formulate a realistic treatment plan for each patient for adult patients with common presenting problems.
3c: Be able to do the above with psychiatric problems as they present across the age range
3c: Consider the impact of the mental illness in an adult patient directly and indirectly on children and young people in the adult’s care or who are likely to come into contact with the adult.
7a: Define the clinical presentations and natural history of patients with severe and enduring mental illness

194
Expert Led Session (incorporating case discussion)
A Consultant led session based on the learning objectives above focussing on Psychosis
across the ages
Session coordinated by LEP Lead, with panel of 3 Expert Consultant Colleagues, representing
child, old age and general/liaison psychiatry
Journal Club Presentation
Choose 1 only:
Child and Adolescent:
Adult Outcomes of Child- and Adolescent-Onset Schizophrenia: Diagnostic Stability and
Predictive Validity Chris Hollis, Ph.D., MRCPsych. (Am J Psychiatry 2000; 157:1652–1659)
Double-blind comparison of first- and second-generation antipsychotics in early-onset
schizophrenia and schizo-affective disorder: findings from the treatment of early-onset
schizophrenia spectrum disorders (TEOSS) study. Sikich L1, Frazier JA, McClellan J, Findling
RL, Vitiello B, Ritz L, Ambler D, Puglia M, Maloney AE, Michael E, De Jong S, Slifka K, Noyes N,
Hlastala S, Pierson L, McNamara NK, Delporto-Bedoya D, Anderson R, Hamer RM, Lieberman
JA. Am J Psychiatry. 2008 Nov;165(11):1420-31. doi: 10.1176/appi.ajp.2008.08050756. Epub
2008 Sep 15.
General Adult:
The Myth of Schizophrenia as a Progressive Brain Disease, Robert B. Zipursky, Thomas
J. Reilly, Robin Murray. Schizophrenia Bulletin vol. 39 no. 6 pp. 1363–1372, 2013,
doi:10.1093/schbul/sbs135. Advance Access publication November 20, 2012
Köhler, S., van Os, J., de Graaf, R., Vollebergh, W., Verhey, F., & Krabbendam, L. (2007).
Psychosis risk as a function of age at onset. Social psychiatry and psychiatric epidemiology,
42(4), 288-294.
Older Adult:
Brunelle, S., Cole, M. G., & Elie, M. (2012). Risk factors for the late‐onset psychoses: a
systematic review of cohort studies. International journal of geriatric psychiatry, 27(3), 240-
252.
‘555’ Topics (5 slides on each topic with no more than 5 bullet points)
Choose one:
Choice of antipsychotic treatment in the three age groups

195
Differences in Psychological interventions for psychosis in the three age groups
Differences of Social interventions for psychosis in the three age groups
MCQs
1) If you are working with a 15 year old boy who is presenting with auditory hallucinations and a belief that they are being followed, which 4 question areas are most relevant?
A. Family history of psychosis
B. Recent drug use, including cannabis
C. Recent decline in motivation, academic performance and self-care
D. Recent change in affect
E. Recent change in concentration and energy levels
2) You learn that your patient has a strong family history of psychosis, is hearing voices in external space, and believes that thoughts are being put into his head from the television. Which of the following areas form part of your ongoing assessment?
A. Thyroid function test
B. Test of Prolactin Levels
C. Test of visual fields
D. Detailed early developmental history
E. Urine drugs screen
3) People with Schizophrenia have an increased rate of:
A. Premature death
B. Diabetes
C. Heart disease
D. Smoking
E. All of the above
2.
3. 4) Which of the following statements is FALSE with regards to cognitive impairment in schizophrenia:
A. It is consistent with the neurodevelopmental theory of schizophrenia
B. It is present in drug-naïve patients
C. It is present in the majority of patients with schizophrenia
D. It is not clearly related to specific symptoms
E. It is only found in chronic elderly patients
5) Schizophrenia in older adults is most accurately described by the term:
A. Late-onset schizophrenia
B. Very-late onset schizophrenia
C. Paraphrenia

196
D. Dementia praecox
E. Delusional disorder
6) All but the following are described as risk factors for late-onset psychosis:
A. Sensory impairment
B. Social isolation
C. Polypharmacy
D. Male gender
E. Age-related deterioration of frontal and temporal lobes
Additional Resources / Reading Materials
Child and Adolescent:
TrOn module: overview of child and adolescent psychiatry
https://www.aacap.org/App_Themes/AACAP/docs/resources_for_primary_care/cap_resources_for_medical_student_educators/Pediatric%20Psychosis.ppt
Emerging psychiatric syndromes associated with antivoltage-gated potassium channel complex antibodies Prüss H, Lennox BR. J Neurol Neurosurg Psychiatry 2016;0:1–6. doi:10.1136/jnnp-2015-313000
Old age
Karim, S., & Byrne, E. J. (2005). Treatment of psychosis in elderly people. Advances in Psychiatric
Treatment, 11(4), 286-296.)
Schizophrenia Michael J Owen, Akira Sawa, Preben B Mortensen. The lancet Vol 388 July 2, 2016

197
Session 2: Depression Across The Ages
Learning Objectives
The overall aim is for the trainee to gain an overview into the similarities and
differences of depression across the different age ranges.
By the end of the session, trainees should understand the commonality and differences
in presentation of depression in different age groups.
By the end of the session, trainees should understand the aetiology of depression in
different age groups.
By the end of the session, trainees should understand the assessment and treatment
process for depression in the different age groups.
Curriculum Links
1b: Recognise how the stage of cognitive and emotional development may influence the aetiology, presentation and management of mental health problems
2a: Be familiar with contemporary ICD or DSM diagnostic systems with the ability to discuss the advantages and limitations of each
2a: State the typical signs and symptoms of psychiatric disorders as they manifest across the age range, including affective disorder; anxiety disorders; disorders of cognitive impairment; psychotic disorders; personality disorders; substance misuse disorders; organic disorders; developmental disorders; and common disorders in childhood
2a: Use the diagnostic system accurately in identifying specific signs and symptoms that comprise syndromes and disorders across the age range
2b: Describe the various biological, psychological and social factors involved in the predisposition to, the onset of and the maintenance of psychiatric disorders across the age range, including trauma (as described, ILO 1, 1a) history
3a: Develop an individualised assessment and treatment plan for each patient and in collaboration with each patient
3a: Be able to explain to patients, families, carers and colleagues the process and outcome of assessment, investigation and treatment or therapeutic plan
3c: Accurately assess the individual patient’s needs and whenever possible in agreement with the patient, formulate a realistic treatment plan for each patient for adult patients with common presenting problems.
3c: Be able to do the above with psychiatric problems as they present across the age range
3c: Consider the impact of the mental illness in an adult patient directly and indirectly on children and young people in the adult’s care or who are likely to come into contact with the adult.
7a: Define the clinical presentations and natural history of patients with severe and enduring mental illness
Expert Led Session (incorporating case discussion)

198
A Consultant led session based on the learning objectives listed, which examines the
similarities and differences in depression across the ages
Session coordinated by LEP Lead, with panel of 3 Expert Consultant Colleagues,
representing child, old age and general/liaison psychiatry
Journal Club Presentation
Choose 1:
Child and Adolescent:
Clinical Messages: From the Treatment for Adolescents With Depression Study (TADS), John
S. March, M.D., M.P.H. Benedetto Vitiello, M.D. (Am J Psychiatry 2009; 166:1118–1123)
Recovery and Recurrence Following Treatment for Adolescent Major Depression. Curry J,
Silva S, Rohde P, et al. Arch Gen Psychiatry. 2011;68(3):263-
269.doi:10.1001/archgenpsychiatry.2010.150.
Psychological therapies versus antidepressant medication, alone and in combination for
depression in children and adolescents. Cox GR1, Callahan P, Churchill R, Hunot V, Merry SN,
Parker AG, Hetrick SE. Cochrane Database Syst Rev. 2012 Nov 14;11:CD008324. doi:
10.1002/14651858.CD008324.pub2.
General Adult:
Age and gender in the phenomenology of depression. Am J Geriatr Psychiatry. Brodaty H,
Cullen B, Thompson C, et al. Jul 2005;13(7):589-596
Older Adult:
Cuijpers, P., van Straten, A., Smit, F., & Andersson, G. (2009). Is psychotherapy for
depression equally effective in younger and older adults? A meta-regression analysis.
International Psychogeriatrics, 21(01), 16-24.
Prognosis of Depression in Old Age Compared to Middle Age: A Systematic Review of
Comparative Studies. Alex J. Mitchell, MRCPsych. Hari Subramaniam, MRCPsych. (Am J
Psychiatry 2005; 162:1588–1601)
Hegeman, J. M., Kok, R. M., Van der Mast, R. C., & Giltay, E. J. (2012). Phenomenology of
depression in older compared with younger adults: meta-analysis. The British Journal of
Psychiatry, 200(4), 275-281.
Cole, M. G., & Dendukuri, N. (2003). Risk factors for depression among elderly community
subjects: a systematic review and meta-analysis. American Journal of Psychiatry, 160(6),
1147-1156.Choose MW 2012 paper phenomenology

199
‘555’ Topics (5 slides on each topic with no more than 5 bullet points)
Choose 1:
SSRI use in CAMHS- risks and benefits
Prescribing of antidepressants and age-related considerations
Prognosis of depressive disorders
MCQs
1) Which of the following is TRUE:
A. Early-onset depression always has a better outcome than late-onset depression
B. Oxidative stress leads to neuronal cell death
C. ECT is not associated with irreversible memory problems
D. It is not possible to clinically monitor cognitive effects of ECT
E. Late-onset depression is not associated with vascular dementia
2) In dementia, it is TRUE that:
A. Depression may mimic its symptoms and signs
B. Late-onset depression is not associated with APOE e4
C. Depression is not a risk factor
D. Late-onset depression is always a prodrome of Alzheimer’s disease
E. Late-onset depression is a prodrome of vascular dementia
3). In terms of aetiology, early-onset depression can be more associated than late-onset depression
with:
A. Family history
B. Vascular disease
C. Reduced hippocampal volume
D. Smaller prefrontal lobe volume
E. Smaller caudate nuclear volume
4) All of the following are more prevalent in depression in later life, except:
A. Increased somatic complaints
B. Greater risk of psychotic symptoms
C. Hypochondriasis
D. Hypersomnia
E. Psychomotor disturbance
5) In what proportion of older people is depression comorbid with dementia?
A) 10%

200
B) 20%
C) 30%
D) 40%
E) 50%
6) Which of the 2 following blood tests can be most helpful in the assessment of a depressed child?
A. Thyroid Function Test
B. Full Blood Count
C. Urea and Electrolytes
D. Urine Drugs Screen
E. Inflammatory markers
7) Which of the 3 following interventions does NICE recommend in the treatment of depression in a
14 year old child?
A. Cognitive Behavioural Therapy
B. Interpersonal Therapy
C. Sertraline with Concurrent CBT
D. Fluoxetine with Concurrent Family Therapy
E. EMDR
Additional Resources / Reading Materials
Child and Adolescent:
Treatment of Resistant Depression in Adolescents (TORDIA): Week 24 Outcomes. Emslie, G. J.,
Mayes, T., Porta, G., Vitiello, B., Clarke, G., Wagner, K. D., … Brent, D. (2010). The American Journal
of Psychiatry, 167(7), 782–791. http://doi.org/10.1176/appi.ajp.2010.09040552
Old age
Allan, C. L., & Ebmeier, K. P. (2013). Review of treatment for late-life depression. Advances in
psychiatric treatment, 19(4), 302-309.
Rodda, J., Walker, Z., & Carter, J. (2011). Depression in older adults. BMJ,343.
Session 3: Liaison Psychiatry Across The Ages
Learning Objectives
The overall aim is for the trainee to gain an overview into the similarities and
differences of liaison across the different age ranges.

201
By the end of the session, trainees should understand the commonality and differences
in presentation of common conditions in liaison psychiatry in the different age groups.
By the end of the session, trainees should understand the assessment and treatment
process of common conditions in liaison psychiatry in the different age groups.
Curriculum Links
1b: Recognise how the stage of cognitive and emotional development may influence the aetiology, presentation and management of mental health problems
2a: Be familiar with contemporary ICD or DSM diagnostic systems with the ability to discuss the advantages and limitations of each
2a: State the typical signs and symptoms of psychiatric disorders as they manifest across the age range, including affective disorder; anxiety disorders; disorders of cognitive impairment; psychotic disorders; personality disorders; substance misuse disorders; organic disorders; developmental disorders; and common disorders in childhood
2a: Use the diagnostic system accurately in identifying specific signs and symptoms that comprise syndromes and disorders across the age range
2b: Describe the various biological, psychological and social factors involved in the predisposition to, the onset of and the maintenance of psychiatric disorders across the age range, including trauma
3a: Develop an individualised assessment and treatment plan for each patient and in collaboration with each patient
3a: Be able to explain to patients, families, carers and colleagues the process and outcome of assessment, investigation and treatment or therapeutic plan
3c: Accurately assess the individual patient’s needs and whenever possible in agreement with the patient, formulate a realistic treatment plan for each patient for adult patients with common presenting problems.
3c: Be able to do the above with psychiatric problems as they present across the age range
3c: Consider the impact of the mental illness in an adult patient directly and indirectly on children and young people in the adult’s care or who are likely to come into contact with the adult.
7a: Define the clinical presentations and natural history of patients with severe and enduring mental illness
7a: Define the role of rehabilitation and recovery services. Define the concept of recovery
7a: Define the concept of quality of life and how it can be measured
7a : Demonstrate an appreciation of the effect of chronic disease states on patients and their families
7a: Demonstrate an appreciation of the importance of co-operation and collaboration with primary healthcare services, social care services, and non-statutory services
Expert Led Session (incorporating case discussion)
A Consultant led session based on the learning objectives listed.
Session coordinated by LEP Lead, with panel of 3 Expert Consultant Colleagues, representing child, old age and general adult liaison psychiatry

202
Journal Club Presentation
Choose 1:
Child and Adolescent:
Psychological therapies for the management of chronic and recurrent pain in children and
adolescents. Eccleston, C., Palermo, T. M., Williams, A. C. D. C., Lewandowski, A., & Morley,
S. (2009). The Cochrane Library.
Adult Outcomes of Pediatric Recurrent Abdominal Pain: Do They Just Grow Out of It?
John V. Campo, Carlo Di Lorenzo, Laurel Chiappetta, Jeff Bridge, D. Kathleen Colborn, J.
Carlton Gartner, Paul Gaffney, Samuel Kocoshis, David Brent
Pediatrics Jul 2001, 108 (1) e1; DOI: 10.1542/peds.108.1.e1
General Adult:
Fava GA et al (2010) The spectrum of anxiety disorders in the medically ill. J Clin Psychiatry.
2010 Jul;71(7):910-4. doi: 10.4088/JCP.10m06000blu. Epub 2010 Jun 1.
Older Adult:
Esiwe, C., Baillon, S., Rajkonwar, A., Lindesay, J., Lo, N., & Dennis, M. (2015). Screening for
depression in older adults on an acute medical ward: the validity of NICE guidance in using
two questions. Age and ageing, afv018.
Jackson, T. A., Naqvi, S. H., & Sheehan, B. (2013). Screening for dementia in general hospital
inpatients: a systematic review and meta-analysis of available instruments. Age and ageing,
aft145.
Sheehan, B., Lall, R., Gage, H., Holland, C., Katz, J., & Mitchell, K. (2013). A 12-month follow-
up study of people with dementia referred to general hospital liaison psychiatry services.
Age and ageing, 42(6), 786-790.
‘555’ Topics (5 slides on each topic with no more than 5 bullet points)
Choose one:
Common psychiatric conditions, in (medical/surgical) hospital patients
Classification of somatoform disorders
Medically unexplained symptoms
MCQs
1) You have joined your consultant in a paediatric diabetes clinic, and you are asked to assess a
16year old boy who is doing well at school, but has not been able to attain control of their diabetes.
Which 3 areas must you consider?
A. Mood and concentration

203
B. Weight and body image
C. Paranoid and hallucinations
D. Post-traumatic symptoms
E. Alcohol and smoking
2) You are contacted about 14 year old girl who has been treated for a paracetamol overdose in
A&E. Her father has arrived and offered to take her home and bring her to see you tomorrow. He
does not want her admitted into the paediatric bed that has been identified. What 3 things do you
do?
A. Meet with the father and child and obtain consent to interview the child alone
B. Contact social services as this sounds suspicious
C. Meet with the father and child and ask why he wants to take her home
D. Admit the child to the ward under the Mental Health Act
E. Speak to the nurses in A&E to learn more about the child's presentation before the father
arrived, and what their interaction has been like
3) Factitious disorder:
A Is more common in Males
B Is less common in Healthcare workers
C Comprise 20% of referrals from General Medicine to Psychiatry
D Rarely involves presentations of chest pain
E Is commonly associated with depression
4) Which of the following is not true :
A Pancreatic cancer confers high risk of developing depression
B Paraneoplastic syndromes are commonly associated with small cell lung cancer
C Autoimmune Limbic encephalitis is always associated with neoplasms
D Body image disturbance is present in 50% of women with breast cancer
E Treatment with steroids can result in development of psychotic symptoms
5) Which is true with regards to differences in pharmacokinetics in older vs younger adults?
A) Older adults have reduced body fat
B) Older adults have increased body water
C) Creatinine and GFR are not effected by age
D) Volume of distribution of lipophilic drugs increases in older adults
E) The T½ of psychotropic drugs is constant across the adult age range
6) Regarding mental disorder in acute hospital patients, which statement is false:
A) >30% of inpatients have a mental disorder
B) 30-60% of outpatients have medically unexplained symptoms

204
C) Dementia and depression are the most frequent disorders in older adult inpatients
D) Depression is frequently unrecognised in older adult inpatients
E) The presence of mental disorder does not affect mortality
Additional Resources / Reading Materials
Child Psychiatry:
Paediatric liaison work by child and adolescent mental health services. Woodgate, M.,
Garralda, M. Child Adolesc Ment Health. 2006;11:19–24.
Medically unexplained symptoms in young people: The doctor’s dilemma. Geist, R., Weinstein,
M., Walker, L., & Campo, J. V. (2008). Paediatrics & Child Health, 13(6), 487–491.
Metaphors and medically unexplained symptoms: Schwartz, Eben S, The Lancet , Volume
386 , Issue 9995 , 734 – 735
General Adult:
Halford, J., & Brown, T. (2009). Cognitive–behavioural therapy as an adjunctive treatment in
chronic physical illness. Advances in psychiatric treatment, 15(4), 306-317.
Segal, T., & Ranjith, G. (2016). Psychiatric assessments on medical wards: a guide for general
psychiatrists. BJPsych Advances, 22(1), 8-15.
Older adult
Review of treatment for late-life depression Charlotte L. Allan & Klaus P. Ebmeier. Advances
in psychiatric treatment (2013), vol. 19, 302–309 doi: 10.1192/apt.bp.112.010835

205
Session 4: Impact of Mental Illness on Carers and Families
Learning Objectives
The overall aim is for the trainee to gain an overview into the impact of mental illness
on the families and carers of patients across the different age ranges.
By the end of the session, trainees should understand the impact of longstanding mental
illness on families/Carers.
By the end of the session, trainees should how to include families/Carers in the treatment
plan.
By the end of the session, trainees should understand challenges that families face and
impact of this on the therapeutic relationship between doctor/patient/family/carer.
Curriculum Links
1b: Recognise how the stage of cognitive and emotional development may influence the aetiology, presentation and management of mental health problems
2a: Be familiar with contemporary ICD or DSM diagnostic systems with the ability to discuss the advantages and limitations of each
2a: State the typical signs and symptoms of psychiatric disorders as they manifest across the age range, including affective disorder; anxiety disorders; disorders of cognitive impairment; psychotic disorders; personality disorders; substance misuse disorders; organic disorders; developmental disorders; and common disorders in childhood
2a: Use the diagnostic system accurately in identifying specific signs and symptoms that comprise syndromes and disorders across the age range
2b: Describe the various biological, psychological and social factors involved in the predisposition to, the onset of and the maintenance of psychiatric disorders across the age range, including trauma (as described, ILO 1, 1a) history
3a: Develop an individualised assessment and treatment plan for each patient and in collaboration with each patient
3a: Be able to explain to patients, families, carers and colleagues the process and outcome of assessment, investigation and treatment or therapeutic plan
3c: Accurately assess the individual patient’s needs and whenever possible in agreement with the patient, formulate a realistic treatment plan for each patient for adult patients with common presenting problems.
3c: Be able to do the above with psychiatric problems as they present across the age range
3c: Consider the impact of the mental illness in an adult patient directly and indirectly on children and young people in the adult’s care or who are likely to come into contact with the adult.
7a: Define the clinical presentations and natural history of patients with severe and enduring mental illness
7a: Define the role of rehabilitation and recovery services Define the concept of recovery
7a: Define the concept of quality of life and how it can be measured
7a: Awareness of disability/housing benefits that patients may be entitled to claim

206
7a : Demonstrate an appreciation of the effect of chronic disease states on patients and their families
7a: Demonstrate an appreciation of the impact of severe and enduring mental illness on patients, their families and carers
7a: Demonstrate an appreciation of the importance of co-operation and collaboration with primary healthcare services, social care services, and non-statutory services
Expert Led Session
Carer/family perspective of MH in the child, adult and older adult
Case Presentation
2x 30 minute cases highlighting the clinical presentations focusing on family/ carer perspective, for
any mental disorder, in two different age groups:
Child and Adolescent
Adult
Older People
Journal Club Presentation
Choose 1:
Child and Adolescent:
Postpartum depression predicts offspring mental health problems in adolescence
independently of parental lifetime psychopathology. Tjitte Verbeek , Claudi L.H. Bockting ,
Mariëlle G. van Pampus , Johan Ormel , Judith L. Meijer , Catharina A. Hartman , Huibert
Burger. Journal of Affective Disorders 136 (2012) 948–954
General Adult:
Ohaeri, JU (2003) The burden of caregiving in families with a mental illness: a review of 2002.
Current Opinion in Psychiatry, 16 (4), 457–465
Older Adult:
Lee DR, McKeith I, Mosimann U, Ghosh‐Nodyal A, Thomas AJ. Examining carer stress in
dementia: the role of subtype diagnosis and neuropsychiatric symptoms. International
journal of geriatric psychiatry. 2013 Feb 1;28(2):135-41.
‘555’ Topics (5 slides on each topic with no more than 5 bullet points)
What is meant by a Carers assessment?
What is meant by parenting assessment?
Nearest relative versus next of kin

207
Lasting Powers of Attorney
Burden of Care – Social impact
MCQs
1) You are working in an ADHD clinic with an ADHD nurse, a mother and son arrive after a period of
missed appointments, and both mother and son now want to recommence ADHD medication. The
mother is very angry and negative about her son, and then starts crying. What 3 things do you say to
her?
A. This is emotional cruelty and you will need to report her to social services
B. Untreated ADHD is a very difficult condition to live with, once he is on medication she will not
have any problems
C. Living with a child with a developmental disorder is very difficult, you recommend that she
speaks to her GP and requests a referral to a counsellor
D. Even when children are taking medication, there are often ongoing difficulties with
behaviour, you recommend that she joins the local ADHD support group
E. You acknowledge that children with developmental disorders may not be maturing and
becoming independent at the same rate as their peers and acknowledge the extra pressure
this places on her
2) You are asked to see 13 year old Hannah the younger sibling of 19 year old James who has been
diagnosed with schizophrenia. Hannah has been withdrawn and quiet and told her grandmother she
is hearing voices. What do you do?
A. Urgently start antipsychotics, psychosis is genetic
B. Meet with Hannah alone to learn more about the impact of mental illness on the whole
family
C. Tell the parents this is contagion and to ignore it
D. Assess Hannah for depression and anxiety
E. Recommend parents try to structure activities alone with Hannah
3) The following is true regarding carers of older adults:
A) They have better mental health if they have fewer than 8 people in their social network
B) They are less likely to be depressed if they are women
C) They are more likely to have osteoarthritis than non-carers
D) They consult their GP more often after the care role has ended
E) They have a lower risk of hypertension than non-carers
4) Regarding carers which statement is false:
A) There are over 6.5 million carers in the UK
B) Most carers are male
C) 3 in 5 people will be carers at some point in their lives

208
D) Carers provide around £120 billion worth of unpaid care annually
E) The number of carers over the age of 65 is increasing faster than any other age group
Additional Resources / Reading Materials
Child and Adolescent:
http://www.nhs.uk/conditions/social-care-and-support-guide/pages/young-carers-
rights.aspx
http://www.youngminds.org.uk/for_parents/worried_about_your_child/young_carers
The effect of ADHD on the life of an individual, their family, and community from preschool
to adult life: V A Harpin, Arch Dis Child 2005;90:suppl 1 i2-i7 doi:10.1136/adc.2004.059006
Kuhn, E. S., & Laird, R. D. (2014). Family support programs and adolescent mental health:
review of evidence. Adolescent Health, Medicine and Therapeutics, 5, 127–142.
http://doi.org/10.2147/AHMT.S48057
General Adult:
Meeting the mental and physical healthcare needs of carers Irene Cormac & Peter Tihanyi.
Advances in Psychiatric Treatment (2006), vol. 12, 162–172
Old age
Carers UK. (2015). Facts about carers. [online] Available at: https://www.carersuk.org/for-
professionals/policy/policy-library/facts-about-carers-2015 [Accessed 01/08/16])